(+)-alpha-viniferin multiple interactions ISO RGD:734432 6480464 [NFE2L2 protein results in increased expression of HMOX1] affects the reaction [alpha-viniferin results in decreased susceptibility to Lipopolysaccharides] more ... CTD PMID:24859013 (+)-alpha-viniferin affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to alpha-viniferin CTD PMID:24859013 (+)-catechin increases expression ISO RGD:734431 6480464 Catechin results in increased expression of NFE2L2 protein CTD PMID:16799064 (+)-epicatechin-3-O-gallate multiple interactions ISO RGD:734431 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein, BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] CTD PMID:29061316 (+)-isoborneol multiple interactions ISO RGD:734432 6480464 isoborneol inhibits the reaction [Ceruletide results in decreased expression of NFE2L2 protein] CTD PMID:33166053 (+)-pilocarpine increases expression ISO RGD:734431 6480464 Pilocarpine results in increased expression of NFE2L2 protein CTD PMID:32234387 (+)-schisandrin B affects localization ISO RGD:734432 6480464 schizandrin B affects the localization of NFE2L2 protein CTD PMID:21250784 (+)-schisandrin B multiple interactions ISO RGD:734431 6480464 [Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NFE2L2 mRNA more ... CTD PMID:25946486 (+)-taxifolin increases expression ISO RGD:734431 6480464 taxifolin results in increased expression of NFE2L2 protein CTD PMID:16799064 (+)-taxifolin multiple interactions EXP 6480464 Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]] more ... CTD PMID:35465754 (+)-taxifolin multiple interactions ISO RGD:734432 6480464 Chlorpyrifos inhibits the reaction [taxifolin results in decreased expression of NFE2L2 protein] CTD PMID:31152760 (+)-taxifolin decreases expression ISO RGD:734432 6480464 taxifolin results in decreased expression of NFE2L2 protein CTD PMID:31152760 (+)-trans-(S)-allethrin increases expression ISO RGD:734431 6480464 bioallethrin results in increased expression of NFE2L2 protein CTD PMID:35511042 (+)-trans-(S)-allethrin multiple interactions ISO RGD:734431 6480464 Vitamin E inhibits the reaction [bioallethrin results in increased expression of NFE2L2 protein] CTD PMID:35511042 (-)-epigallocatechin 3-gallate increases expression ISO RGD:734431 6480464 epigallocatechin gallate results in increased expression of NFE2L2 mRNA, epigallocatechin gallate results in increased expression of NFE2L2 protein CTD PMID:16799064 , PMID:29572906 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:734431 6480464 epigallocatechin gallate results in decreased expression of NFE2L2 protein CTD PMID:35218280 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:734432 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with epigallocatechin gallate] results in increased expression of NFE2L2 mRNA, [Formaldehyde co-treated with epigallocatechin gallate] results in increased expression of NFE2L2 protein CTD PMID:30395894 , PMID:33410021 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:734431 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein more ... CTD PMID:29061316 , PMID:29572906 (-)-epigallocatechin 3-gallate affects localization ISO RGD:734432 6480464 epigallocatechin gallate affects the localization of NFE2L2 protein CTD PMID:25585349 (-)-epigallocatechin 3-gallate increases expression ISO RGD:734432 6480464 epigallocatechin gallate results in increased expression of NFE2L2 mRNA CTD PMID:25585349 (-)-selegiline multiple interactions EXP 6480464 NFE2L2 mutant form inhibits the reaction [Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of NQO1 protein]] more ... CTD PMID:22019741 (-)-selegiline multiple interactions ISO RGD:734431 6480464 Selegiline inhibits the reaction [Smoke analog affects the localization of NFE2L2 protein] CTD PMID:28108387 (-)-selegiline increases localization EXP 6480464 Selegiline results in increased localization of NFE2L2 protein CTD PMID:22019741 (E)-cinnamyl alcohol multiple interactions ISO RGD:734431 6480464 NFE2L2 mRNA promotes the reaction [cinnamyl alcohol results in increased expression of HMOX1 mRNA] CTD PMID:26244607 (R)-lipoic acid multiple interactions ISO RGD:734431 6480464 [Paraquat co-treated with Thioctic Acid] results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:17197552 more ... (R)-lipoic acid affects localization ISO RGD:734431 6480464 Thioctic Acid affects the localization of NFE2L2 protein CTD PMID:30758914 (R)-lipoic acid increases expression ISO RGD:734431 6480464 Thioctic Acid results in increased expression of NFE2L2 mRNA, Thioctic Acid results in increased expression of NFE2L2 protein CTD PMID:23649336 more ... (R)-lipoic acid increases expression EXP 6480464 Thioctic Acid results in increased expression of NFE2L2 protein CTD PMID:20237067 (R)-lipoic acid increases activity EXP 6480464 Thioctic Acid results in increased activity of NFE2L2 protein CTD PMID:20237067 (R)-lipoic acid multiple interactions EXP 6480464 [Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA more ... CTD PMID:20237067 more ... (R)-lipoic acid decreases expression ISO RGD:734432 6480464 Thioctic Acid results in decreased expression of NFE2L2 mRNA, Thioctic Acid results in decreased expression of NFE2L2 protein CTD PMID:22488045 (R)-lipoic acid multiple interactions ISO RGD:734432 6480464 [Thioctic Acid co-treated with cyanoginosin LR] results in increased expression of NFE2L2 protein more ... CTD PMID:22488045 more ... (R)-mevalonic acid multiple interactions EXP 6480464 Mevalonic Acid affects the reaction [Simvastatin results in increased localization of NFE2L2 protein] CTD PMID:18787804 (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] more ... CTD PMID:22389237 more ... (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:734431 6480464 alpha-Tocopherol promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] CTD PMID:36058301 (S)-colchicine multiple interactions ISO RGD:734431 6480464 [dihydroactinidiolide co-treated with Colchicine] results in increased expression of NFE2L2 mRNA CTD PMID:33617922 (S)-duloxetine hydrochloride affects localization ISO RGD:734431 6480464 Duloxetine Hydrochloride affects the localization of NFE2L2 protein CTD PMID:29134401 (S)-naringenin multiple interactions ISO RGD:734431 6480464 [naringenin co-treated with Paraquat] results in increased expression of NFE2L2 protein more ... CTD PMID:24561720 , PMID:31254498 (S)-naringenin increases activity ISO RGD:734431 6480464 naringenin results in increased activity of NFE2L2 protein CTD PMID:31254498 (S)-naringenin increases expression ISO RGD:734431 6480464 naringenin results in increased expression of NFE2L2 mRNA CTD PMID:24561720 (Z)-ligustilide decreases methylation ISO RGD:734432 6480464 ligustilide results in decreased methylation of NFE2L2 promoter CTD PMID:23441843 (Z)-ligustilide affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to ligustilide CTD PMID:30243965 (Z)-ligustilide increases methylation ISO RGD:734431 6480464 ligustilide results in increased methylation of NFE2L2 promoter CTD PMID:30243965 (Z)-ligustilide multiple interactions ISO RGD:734431 6480464 ligustilide results in increased expression of and affects the localization of NFE2L2 protein CTD PMID:30243965 1,1'-azobis(N,N-dimethylformamide) affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Diamide CTD PMID:19303893 1,2,3-Trichloropropane increases activity ISO RGD:734432 6480464 1 more ... CTD PMID:30114225 , PMID:30203046 1,2-dibromoethane increases activity ISO RGD:734432 6480464 Ethylene Dibromide results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 1,2-dichloroethane increases expression ISO RGD:734432 6480464 ethylene dichloride results in increased expression of NFE2L2 mRNA CTD PMID:30664321 1,2-dichloroethane multiple interactions ISO RGD:734432 6480464 [ethylene dichloride co-treated with Ethanol] results in increased expression of NFE2L2 protein, Ethanol promotes the reaction [ethylene dichloride results in increased expression of NFE2L2 mRNA] CTD PMID:30664321 1,2-dimethylhydrazine multiple interactions ISO RGD:734432 6480464 [1 more ... CTD PMID:22206623 , PMID:26388957 1,2-dimethylhydrazine decreases expression ISO RGD:734432 6480464 1, 2-Dimethylhydrazine results in decreased expression of NFE2L2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of NFE2L2 protein CTD PMID:30720227 1,2-dimethylhydrazine multiple interactions EXP 6480464 zingerone inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of NFE2L2 protein] CTD PMID:30720227 1,2-dimethylhydrazine affects response to substance ISO RGD:734432 6480464 [NFE2L2 protein affects the susceptibility to 1 more ... CTD PMID:26388957 1,2-naphthoquinone affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to 1 more ... CTD PMID:19303893 , PMID:21384861 1,2-naphthoquinone increases activity ISO RGD:734432 6480464 1, 2-naphthoquinone results in increased activity of NFE2L2 protein CTD PMID:21384861 more ... 1,2-naphthoquinone multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 1, 2-naphthoquinone] CTD PMID:20932822 1,3-dichloropropan-2-ol increases expression EXP 6480464 1, 3-dichloro-2-propanol results in increased expression of NFE2L2 protein CTD PMID:26143167 1,4,7-triazonane increases expression ISO RGD:734431 6480464 1 more ... CTD PMID:32869927 1,4-benzoquinone multiple interactions ISO RGD:734432 6480464 quinone results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:25437431 1,4-benzoquinone multiple interactions ISO RGD:734431 6480464 NFE2L2 mRNA affects the reaction [quinone results in increased expression of GSS protein] more ... CTD PMID:21059386 , PMID:28645578 1,4-dichlorobenzene increases activity ISO RGD:734432 6480464 4-dichlorobenzene results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 1,4-dithiothreitol multiple interactions ISO RGD:734431 6480464 Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] CTD PMID:24489685 1,4-naphthoquinone affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to 1, 4-naphthoquinone CTD PMID:31166132 1,4-phenylenediamine increases expression ISO RGD:734431 6480464 4-phenylenediamine results in increased expression of NFE2L2 protein CTD PMID:19033392 1,4-phenylenediamine decreases expression ISO RGD:734431 6480464 4-phenylenediamine results in decreased expression of NFE2L2 mRNA CTD PMID:31967339 1,4-phenylenediamine multiple interactions ISO RGD:734431 6480464 NFE2L2 mRNA promotes the reaction [4-phenylenediamine results in increased expression of HMOX1 mRNA] CTD PMID:26244607 1-Amino-2,4-dibromoanthraquinone increases activity ISO RGD:734432 6480464 1-amino-2, 4-dibromoanthraquinone results in increased activity of NFE2L2 protein CTD PMID:30203046 1-benzofuran increases activity ISO RGD:734432 6480464 benzofuran results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 1-bromopropane multiple interactions ISO RGD:734432 6480464 NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GCLC mRNA] more ... CTD PMID:20211940 1-bromopropane decreases expression EXP 6480464 1-bromopropane results in decreased expression of NFE2L2 mRNA CTD PMID:27452781 1-bromopropane decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to 1-bromopropane CTD PMID:20211940 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NFE2L2 protein] more ... CTD PMID:19033392 more ... 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:734431 6480464 Dinitrochlorobenzene results in decreased expression of NFE2L2 mRNA CTD PMID:31967339 1-chloro-2,4-dinitrobenzene affects expression ISO RGD:734432 6480464 Dinitrochlorobenzene affects the expression of NFE2L2 protein CTD PMID:28219650 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:734431 6480464 Dinitrochlorobenzene results in increased expression of NFE2L2 protein CTD PMID:19033392 more ... 1-chloro-2,4-dinitrobenzene affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Dinitrochlorobenzene, NFE2L2 affects the susceptibility to Dinitrochlorobenzene CTD PMID:19303893 , PMID:23564646 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:734432 6480464 Dinitrochlorobenzene affects the localization of and results in increased activity of NFE2L2 protein more ... CTD PMID:18785192 , PMID:28219650 1-fluoro-2,4-dinitrobenzene increases expression ISO RGD:734431 6480464 Dinitrofluorobenzene results in increased expression of NFE2L2 protein CTD PMID:19427879 , PMID:26022718 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to 1-Methyl-4-phenyl-1 more ... CTD PMID:22746536 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:24991814 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:734432 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:24991814 more ... 1-naphthyl isothiocyanate multiple interactions ISO RGD:734432 6480464 NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA] more ... CTD PMID:19181614 1-naphthyl isothiocyanate multiple interactions ISO RGD:734431 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NFE2L2 mRNA CTD PMID:27344345 1-nitropyrene multiple interactions ISO RGD:734431 6480464 1-nitropyrene results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:28633978 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:734431 6480464 LPAR1 protein affects the reaction [lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein], lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein CTD PMID:25398768 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:734432 6480464 [[ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased abundance of lysophosphatidic acid] which results in decreased expression of NFE2L2 CTD PMID:25398768 1-tert-Butoxy-2-propanol increases activity ISO RGD:734432 6480464 propylene glycol mono-t-butyl ether results in increased activity of NFE2L2 protein CTD PMID:30114225 13,14-dihydro-Delta(12)-prostaglandin J2 multiple interactions EXP 6480464 NFE2L2 protein affects the reaction [9-deoxy-9 more ... CTD PMID:22982731 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:734431 6480464 15-deoxy-delta(12 more ... CTD PMID:19136476 , PMID:21728338 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:22245093 17alpha-ethynylestradiol multiple interactions ISO RGD:734432 6480464 Ethinyl Estradiol promotes the reaction [IL1B protein results in increased expression of NFE2L2 mRNA] CTD PMID:12072388 17alpha-ethynylestradiol increases activity ISO RGD:734432 6480464 Ethinyl Estradiol results in increased activity of NFE2L2 protein CTD PMID:30114225 17beta-estradiol increases methylation ISO RGD:734431 6480464 Estradiol results in increased methylation of NFE2L2 promoter CTD PMID:24894866 17beta-estradiol increases activity ISO RGD:734432 6480464 Estradiol results in increased activity of NFE2L2 protein CTD PMID:30114225 17beta-estradiol decreases expression ISO RGD:734431 6480464 Estradiol results in decreased expression of NFE2L2 mRNA, Estradiol results in decreased expression of NFE2L2 protein CTD PMID:23492819 more ... 17beta-estradiol affects localization EXP 6480464 Estradiol affects the localization of NFE2L2 protein CTD PMID:23027624 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of NFE2L2 mRNA, Estradiol affects the expression of NFE2L2 protein CTD PMID:22389237 , PMID:24777823 17beta-estradiol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] more ... CTD PMID:22389237 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of NFE2L2 mRNA, Estradiol results in decreased expression of NFE2L2 protein CTD PMID:23027624 more ... 17beta-estradiol multiple interactions ISO RGD:734431 6480464 Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:23492819 more ... 17beta-hydroxy-5alpha-androstan-3-one decreases activity ISO RGD:734432 6480464 Dihydrotestosterone results in decreased activity of NFE2L2 protein CTD PMID:30114225 1H-pyrazole affects localization ISO RGD:734432 6480464 pyrazole affects the localization of NFE2L2 protein CTD PMID:25478736 2''-galloylhyperin multiple interactions ISO RGD:734432 6480464 2''-galloylhyperin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NFE2L2 protein] CTD PMID:30849337 2''-galloylhyperin multiple interactions ISO RGD:734431 6480464 2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein] CTD PMID:28213291 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects localization ISO RGD:734432 6480464 2' more ... CTD PMID:31029725 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [2' more ... CTD PMID:31029725 2,2',4,4',5,5'-hexachlorobiphenyl increases activity ISO RGD:734432 6480464 2 more ... CTD PMID:30114225 , PMID:30203046 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:734431 6480464 2 more ... CTD PMID:31173147 2,2-Bis(bromomethyl)propane-1,3-diol increases expression ISO RGD:734431 6480464 2 more ... CTD PMID:22019925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:734432 6480464 Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA CTD PMID:24058054 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:734432 6480464 Tetrachlorodibenzodioxin results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734432 6480464 Tetrachlorodibenzodioxin results in increased expression of NFE2L2 exon mutant form, Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin CTD PMID:21846477 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects localization ISO RGD:734431 6480464 Tetrachlorodibenzodioxin affects the localization of NFE2L2 mRNA CTD PMID:20599494 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:734431 6480464 Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734431 6480464 Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:734431 6480464 ammonium metavanadate affects the reaction [Tetrachlorodibenzodioxin affects the localization of NFE2L2 mRNA] more ... CTD PMID:20599494 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] more ... CTD PMID:19497421 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:734432 6480464 [CYP2A5 promoter mutant form results in decreased activity of NFE2L2 protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin more ... CTD PMID:16214954 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:20951181 , PMID:32109520 2,3-dimethoxynaphthalene-1,4-dione decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to 2 more ... CTD PMID:20932822 2,4,6-trinitrobenzenesulfonic acid affects expression EXP 6480464 Trinitrobenzenesulfonic Acid affects the expression of NFE2L2 protein CTD PMID:33412153 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA CTD PMID:31428839 , PMID:31669340 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:31428839 more ... 2,4-dinitrobromobenzene increases expression ISO RGD:734431 6480464 1-bromo-2, 4-dinitrobenzene results in increased expression of NFE2L2 protein CTD PMID:26022718 2,4-dinitroiodobenzene increases expression ISO RGD:734431 6480464 1-iodo-2, 4-dinitrobenzene results in increased expression of NFE2L2 protein CTD PMID:19427879 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of NFE2L2 mRNA CTD PMID:21346803 2,5-di-tert-butylbenzene-1,4-diol increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to 2, 5-di-tert-butylhydroquinone CTD PMID:12842875 2,6-di-tert-butyl-4-methylphenol decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Butylated Hydroxytoluene CTD PMID:10535991 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of NFE2L2 mRNA CTD PMID:21346803 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile affects localization ISO RGD:734431 6480464 Verapamil affects the localization of NFE2L2 protein CTD PMID:21525764 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 mRNA] CTD PMID:30526075 2-(chloromethyl)pyridine increases activity ISO RGD:734432 6480464 2-chloromethylpyridine results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 2-acetamidofluorene increases expression ISO RGD:734432 6480464 2-Acetylaminofluorene results in increased expression of NFE2L2 mRNA CTD PMID:21607683 2-acetamidofluorene increases activity ISO RGD:734432 6480464 2-Acetylaminofluorene results in increased activity of NFE2L2 protein CTD PMID:30114225 2-amino-2-deoxy-D-galactopyranose decreases expression EXP 6480464 Galactosamine results in decreased expression of NFE2L2 protein CTD PMID:22310181 2-amino-2-deoxy-D-galactopyranose increases activity ISO RGD:734432 6480464 Galactosamine results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:734432 6480464 [Galactosamine co-treated with lipopolysaccharide more ... CTD PMID:28887131 , PMID:30236599 2-amino-2-deoxy-D-galactopyranose affects localization EXP 6480464 Galactosamine affects the localization of NFE2L2 protein CTD PMID:22310181 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein], mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein] CTD PMID:22310181 2-aminoethoxydiphenylborane multiple interactions ISO RGD:734431 6480464 2-aminoethoxydiphenylborane inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein] CTD PMID:33408296 2-chloroethanol multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA] more ... CTD PMID:31585129 2-chloroethanol increases expression EXP 6480464 Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA, Ethylene Chlorohydrin results in increased expression of NFE2L2 protein CTD PMID:31585129 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid increases expression EXP 6480464 anacardic acid results in increased expression of NFE2L2 mRNA CTD PMID:29054681 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions EXP 6480464 [anacardic acid results in increased susceptibility to manganese chloride] which results in increased expression of NFE2L2 mRNA more ... CTD PMID:29054681 2-hydroxyethyl methacrylate increases expression ISO RGD:734431 6480464 hydroxyethyl methacrylate results in increased expression of NFE2L2 protein CTD PMID:30497689 2-methylcholine affects expression ISO RGD:734431 6480464 beta-methylcholine affects the expression of NFE2L2 mRNA CTD PMID:21179406 2-tert-butylhydroquinone multiple interactions ISO RGD:734431 6480464 1 more ... CTD PMID:10874044 more ... 2-tert-butylhydroquinone increases response to substance ISO RGD:734431 6480464 NFE2L2 protein mutant form results in increased susceptibility to 2-tert-butylhydroquinone CTD PMID:23589329 2-tert-butylhydroquinone increases expression ISO RGD:734431 6480464 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein CTD PMID:12446695 more ... 2-tert-butylhydroquinone affects localization ISO RGD:734431 6480464 2-tert-butylhydroquinone affects the localization of NFE2L2 protein CTD PMID:25003661 more ... 2-tert-butylhydroquinone increases activity ISO RGD:734431 6480464 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein CTD PMID:19715681 more ... 2-tert-butylhydroquinone decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to 2-tert-butylhydroquinone CTD PMID:20932822 2-tert-butylhydroquinone increases ubiquitination ISO RGD:734432 6480464 2-tert-butylhydroquinone results in increased ubiquitination of NFE2L2 protein CTD PMID:18512965 2-tert-butylhydroquinone affects binding ISO RGD:734432 6480464 2-tert-butylhydroquinone binds to NFE2L2 protein CTD PMID:19786557 2-tert-butylhydroquinone affects localization EXP 6480464 2-tert-butylhydroquinone affects the localization of NFE2L2 protein CTD PMID:17676812 more ... 2-tert-butylhydroquinone increases activity EXP 6480464 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein CTD PMID:18852027 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone affects the localization of and results in increased activity of NFE2L2 protein more ... CTD PMID:15319326 more ... 2-tert-butylhydroquinone increases stability ISO RGD:734432 6480464 2-tert-butylhydroquinone results in increased stability of NFE2L2 protein CTD PMID:22275372 2-tert-butylhydroquinone increases expression ISO RGD:734432 6480464 2-tert-butylhydroquinone results in increased expression of NFE2L2 mRNA, 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein CTD PMID:19183254 more ... 2-tert-butylhydroquinone multiple interactions ISO RGD:734432 6480464 2-tert-butylhydroquinone inhibits the reaction [2 more ... CTD PMID:10473555 more ... 2-tert-butylhydroquinone increases activity ISO RGD:734432 6480464 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein, [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased activity of GATA3 protein CTD PMID:22250088 , PMID:23945499 2-tert-butylhydroquinone increases expression EXP 6480464 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein CTD PMID:17676812 more ... 2-tert-butylhydroquinone affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to 2-tert-butylhydroquinone CTD PMID:22250088 20-hydroxyecdysone multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein]], Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein] CTD PMID:26048653 20-hydroxyecdysone increases response to substance EXP 6480464 NFE2L2 results in increased susceptibility to Ecdysterone CTD PMID:26048653 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:734432 6480464 3 more ... CTD PMID:24378064 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:734431 6480464 3 more ... CTD PMID:30768972 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:734431 6480464 [Lipopolysaccharides co-treated with IFNG protein] promotes the reaction [3 more ... CTD PMID:30768972 3,3',4,4',5-pentachlorobiphenyl affects expression ISO RGD:734432 6480464 3 more ... CTD PMID:31563530 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:734432 6480464 3 more ... CTD PMID:33096110 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:734432 6480464 [resveratrol co-treated with 3 more ... CTD PMID:24231106 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:734432 6480464 [CYP2A5 promoter mutant form results in decreased activity of NFE2L2 protein] which results in decreased susceptibility to tetrabromobisphenol A CTD PMID:29788535 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:734431 6480464 [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA, [rosemarinic acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA CTD PMID:33476690 3,3'-diindolylmethane increases expression ISO RGD:734431 6480464 3 more ... CTD PMID:23583297 3,3'-diindolylmethane multiple interactions ISO RGD:734431 6480464 sulforaphane promotes the reaction [3 more ... CTD PMID:23583297 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:734432 6480464 [NFE2L2 gene mutant form results in increased susceptibility to 3 more ... CTD PMID:30825315 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to 3 more ... CTD PMID:30825315 3,6-diaminoacridine increases activity ISO RGD:734431 6480464 Proflavine results in increased activity of NFE2L2 protein CTD PMID:30818834 3-hydroxybutyric acid multiple interactions ISO RGD:734432 6480464 [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of 3-Hydroxybutyric Acid CTD PMID:20086057 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:734431 6480464 [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA, [rosemarinic acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA CTD PMID:33476690 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:734432 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased activity of NFE2L2 protein CTD PMID:33412187 3-methylcholanthrene increases expression ISO RGD:734432 6480464 Methylcholanthrene results in increased expression of NFE2L2 mRNA, Methylcholanthrene results in increased expression of NFE2L2 protein CTD PMID:16723119 more ... 3-methylcholanthrene multiple interactions ISO RGD:734431 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to NFE2L2 promoter] CTD PMID:20348232 3-methylcholanthrene multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Methylcholanthrene results in increased expression of PSMB5 mRNA] CTD PMID:16723119 3-Nitrobenzanthrone multiple interactions ISO RGD:734431 6480464 [NFE2L2 protein affects the metabolism of 3-nitrobenzanthrone] which affects the abundance of 3-aminobenzanthrone CTD PMID:31746589 3-Nitrobenzanthrone affects metabolic processing ISO RGD:734431 6480464 NFE2L2 protein affects the metabolism of 3-nitrobenzanthrone CTD PMID:31746589 3-Nitrobenzanthrone affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to 3-nitrobenzanthrone CTD PMID:31746589 3-Nitrofluoranthene multiple interactions ISO RGD:734431 6480464 3-nitrofluoranthene results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:28633978 3-nitropropanoic acid multiple interactions EXP 6480464 [naringin co-treated with 3-nitropropionic acid] affects the localization of NFE2L2 protein CTD PMID:22871521 3-O-Caffeoyl-1-O-methylquinic acid affects localization ISO RGD:734431 6480464 3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein CTD PMID:16631525 3-O-Caffeoyl-1-O-methylquinic acid multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] more ... CTD PMID:16631525 3-phenylprop-2-enal increases activity ISO RGD:734432 6480464 cinnamaldehyde results in increased activity of NFE2L2 protein CTD PMID:31187328 3-phenylprop-2-enal multiple interactions ISO RGD:734432 6480464 cinnamaldehyde inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NFE2L2 protein] more ... CTD PMID:28219650 , PMID:31187328 3-phenylprop-2-enal increases expression ISO RGD:734431 6480464 cinnamaldehyde analog results in increased expression of NFE2L2 protein, cinnamaldehyde results in increased expression of NFE2L2 protein CTD PMID:18482591 , PMID:19033392 3-phenylprop-2-enal affects expression ISO RGD:734432 6480464 cinnamaldehyde affects the expression of NFE2L2 protein CTD PMID:28219650 3-phenylprop-2-enal affects response to substance ISO RGD:734432 6480464 NFE2L2 affects the susceptibility to cinnamaldehyde CTD PMID:23564646 3-phenylprop-2-enal multiple interactions ISO RGD:734431 6480464 [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein affects the localization of RELA protein] more ... CTD PMID:20351055 more ... 3-phenylprop-2-enal affects localization ISO RGD:734431 6480464 cinnamaldehyde affects the localization of NFE2L2 protein CTD PMID:18304597 , PMID:21469739 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of NFE2L2 mRNA CTD PMID:19162173 3H-1,2-dithiole-3-thione increases activity ISO RGD:734432 6480464 1, 2-dithiol-3-thione results in increased activity of NFE2L2 protein CTD PMID:22495766 3H-1,2-dithiole-3-thione multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:18367636 , PMID:22495766 4,4'-diaminodiphenylmethane decreases expression ISO RGD:734432 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of NFE2L2 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases activity ISO RGD:734432 6480464 4, 4'-diaminodiphenylmethane results in increased activity of NFE2L2 protein CTD PMID:30203046 4,6-dioxoheptanoic acid multiple interactions ISO RGD:734432 6480464 NFE2L2 gene mutant form affects the reaction [succinylacetone results in increased expression of CYP2A5 mRNA], NFE2L2 gene mutant form inhibits the reaction [succinylacetone results in increased expression of ALAS1 mRNA] CTD PMID:22859313 4-hydroxy-TEMPO multiple interactions EXP 6480464 tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] CTD PMID:25204689 4-Hydroxybenzyl isothiocyanate increases expression EXP 6480464 4-hydroxybenzyl isothiocyanate results in increased expression of NFE2L2 protein CTD PMID:22664424 4-hydroxyestrone decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to 4-hydroxyestrone CTD PMID:25231996 4-hydroxyestrone decreases expression ISO RGD:734431 6480464 4-hydroxyestrone results in decreased expression of NFE2L2 mRNA CTD PMID:25231996 4-hydroxynon-2-enal affects localization ISO RGD:734431 6480464 4-hydroxy-2-nonenal affects the localization of NFE2L2 protein CTD PMID:29108775 , PMID:30849339 4-hydroxynon-2-enal multiple interactions ISO RGD:734431 6480464 AKR7A2 protein affects the reaction [NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal] CTD PMID:30849339 4-hydroxynon-2-enal affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal CTD PMID:30849339 4-hydroxynon-2-enal multiple interactions EXP 6480464 NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GCLC mRNA], NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA] CTD PMID:24291486 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of NFE2L2 protein CTD PMID:24291486 4-hydroxynon-2-enal decreases activity ISO RGD:734432 6480464 4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein CTD PMID:16322078 4-hydroxynon-2-enal multiple interactions ISO RGD:734432 6480464 4-hydroxy-2-nonenal affects the localization of and results in increased activity of NFE2L2 protein more ... CTD PMID:16322078 more ... 4-hydroxynon-2-enal affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal CTD PMID:24423726 4-hydroxyphenyl retinamide increases expression ISO RGD:734432 6480464 Fenretinide results in increased expression of NFE2L2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:734431 6480464 Fenretinide results in increased expression of NFE2L2 protein CTD PMID:25246272 4-nitrobenzaldehyde multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 4-nitrobenzaldehyde] CTD PMID:20932822 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA], 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 protein] CTD PMID:20399799 4-phenylbutyric acid multiple interactions ISO RGD:734432 6480464 ALPI protein inhibits the reaction [4-phenylbutyric acid results in increased phosphorylation of NFE2L2 protein] CTD PMID:32407927 5-aminolevulinic acid multiple interactions ISO RGD:734432 6480464 NFE2L2 gene mutant form inhibits the reaction [Aminolevulinic Acid results in increased expression of CYP2A5 mRNA], NFE2L2 gene mutant form promotes the reaction [Aminolevulinic Acid results in increased expression of HMOX1 mRNA] CTD PMID:22859313 5-aza-2'-deoxycytidine multiple interactions ISO RGD:734432 6480464 [Decitabine co-treated with trichostatin A] results in decreased methylation of NFE2L2 promoter, [trichostatin A co-treated with Decitabine] results in decreased methylation of NFE2L2 promoter CTD PMID:26991801 , PMID:31181187 5-aza-2'-deoxycytidine multiple interactions ISO RGD:734431 6480464 Decitabine inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] CTD PMID:26409248 5-fluorouracil affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Fluorouracil CTD PMID:18692501 5-fluorouracil affects expression ISO RGD:734431 6480464 Fluorouracil affects the expression of NFE2L2 mRNA CTD PMID:34151400 5-fluorouracil decreases expression ISO RGD:734432 6480464 Fluorouracil results in decreased expression of NFE2L2 protein CTD PMID:35101590 5-fluorouracil decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Fluorouracil CTD PMID:20722640 5-fluorouracil decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Fluorouracil CTD PMID:21489257 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA], NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein] CTD PMID:27725188 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases activity ISO RGD:734432 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30114225 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:33661552 6alpha-methylprednisolone multiple interactions EXP 6480464 Methylprednisolone inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] CTD PMID:26093215 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:22406437 7,12-dimethyltetraphene multiple interactions ISO RGD:734432 6480464 [9 more ... CTD PMID:32553695 7,12-dimethyltetraphene increases activity ISO RGD:734432 6480464 9 more ... CTD PMID:30114225 7,12-dimethyltetraphene increases expression ISO RGD:734432 6480464 9 more ... CTD PMID:32553695 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:24995432 , PMID:33759307 7,12-dimethyltetraphene multiple interactions EXP 6480464 betulin inhibits the reaction [9 more ... CTD PMID:24995432 , PMID:33759307 7,8-dihydroxycoumarin multiple interactions ISO RGD:734431 6480464 [sodium arsenite co-treated with daphnetin] results in increased expression of NFE2L2 protein more ... CTD PMID:30738023 8-(4-chlorophenylthio)-cAMP increases expression ISO RGD:734432 6480464 8-((4-chlorophenyl)thio)cyclic-3', 5'-AMP results in increased expression of NFE2L2 mRNA CTD PMID:27160211 9,10-phenanthroquinone affects localization ISO RGD:734431 6480464 9, 10-phenanthrenequinone affects the localization of NFE2L2 protein CTD PMID:29108775 9-cis-retinoic acid multiple interactions EXP 6480464 [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] results in increased activity of NFE2L2 protein CTD PMID:15150131 [6]-Shogaol multiple interactions ISO RGD:734432 6480464 KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein] more ... CTD PMID:23899529 , PMID:25148906 [6]-Shogaol increases expression ISO RGD:734432 6480464 shogaol analog results in increased expression of NFE2L2 protein CTD PMID:23899529 [6]-Shogaol increases expression ISO RGD:734431 6480464 shogaol analog results in increased expression of NFE2L2 protein CTD PMID:23899529 [6]-Shogaol affects localization ISO RGD:734431 6480464 shogaol affects the localization of NFE2L2 protein more ... CTD PMID:25148906 [6]-Shogaol multiple interactions ISO RGD:734431 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] more ... CTD PMID:25148906 [6]-Shogaol affects localization ISO RGD:734432 6480464 shogaol affects the localization of NFE2L2 protein CTD PMID:25148906 abamectin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in decreased expression of NFE2L2 mRNA] CTD PMID:34748272 abamectin decreases expression EXP 6480464 abamectin results in decreased expression of NFE2L2 mRNA CTD PMID:34748272 acetic acid decreases expression EXP 6480464 Acetic Acid results in decreased expression of NFE2L2 mRNA CTD PMID:29518435 , PMID:30594690 acetic acid multiple interactions EXP 6480464 Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of NFE2L2 mRNA], Plant Extracts inhibits the reaction [Acetic Acid results in decreased expression of NFE2L2 mRNA] CTD PMID:29518435 , PMID:30594690 acrolein affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Acrolein CTD PMID:19303893 acrolein increases expression ISO RGD:734432 6480464 Acrolein results in increased expression of NFE2L2 protein CTD PMID:28482051 , PMID:30608172 acrolein increases expression ISO RGD:734431 6480464 Acrolein results in increased expression of NFE2L2 protein CTD PMID:28109747 acrolein increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Acrolein CTD PMID:27633142 acrolein decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Acrolein CTD PMID:18367636 acrolein affects localization ISO RGD:734432 6480464 Acrolein affects the localization of NFE2L2 protein CTD PMID:12763045 acrolein increases response to substance ISO RGD:734431 6480464 NFE2L2 gene mutant form results in increased susceptibility to Acrolein CTD PMID:19608619 acrolein decreases expression ISO RGD:734431 6480464 Acrolein results in decreased expression of NFE2L2 protein CTD PMID:17197552 , PMID:18258206 acrolein multiple interactions ISO RGD:734431 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFE2L2 mRNA more ... CTD PMID:17197552 more ... acrolein increases activity ISO RGD:734431 6480464 Acrolein results in increased activity of NFE2L2 protein CTD PMID:12084617 acrolein affects localization ISO RGD:734431 6480464 Acrolein affects the localization of NFE2L2 protein CTD PMID:12084617 , PMID:18048804 acrolein multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:18028974 more ... acrolein affects localization EXP 6480464 Acrolein affects the localization of NFE2L2 protein CTD PMID:25145656 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of NFE2L2 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:734431 6480464 Acrylamide results in increased expression of NFE2L2 mRNA CTD PMID:32763439 acrylamide affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to Acrylamide CTD PMID:33872730 acrylamide multiple interactions ISO RGD:734432 6480464 [Acrylamide co-treated with Streptozocin] results in decreased expression of NFE2L2 mRNA more ... CTD PMID:32014472 more ... acrylamide multiple interactions EXP 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein] more ... CTD PMID:29426002 acrylamide decreases expression ISO RGD:734431 6480464 Acrylamide results in decreased expression of NFE2L2 mRNA, Acrylamide results in decreased expression of NFE2L2 protein CTD PMID:28159594 acrylamide affects localization ISO RGD:734432 6480464 Acrylamide affects the localization of NFE2L2 protein CTD PMID:28526328 acrylamide multiple interactions ISO RGD:734431 6480464 salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 mRNA], salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 protein] CTD PMID:28159594 acrylamide increases expression ISO RGD:734432 6480464 Acrylamide results in increased expression of NFE2L2 mRNA, Acrylamide results in increased expression of NFE2L2 protein CTD PMID:27836571 , PMID:34896238 actinomycin D multiple interactions ISO RGD:734431 6480464 Dactinomycin inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein], Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA] CTD PMID:22019695 , PMID:24632381 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of NFE2L2 protein CTD PMID:25154877 aflatoxin B1 increases expression ISO RGD:734431 6480464 Aflatoxin B1 results in increased expression of NFE2L2 protein CTD PMID:34089297 aflatoxin B1 decreases expression ISO RGD:734432 6480464 Aflatoxin B1 results in decreased expression of NFE2L2 mRNA, Aflatoxin B1 results in decreased expression of NFE2L2 protein CTD PMID:35063475 aflatoxin B1 multiple interactions ISO RGD:734432 6480464 Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 mRNA], Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] CTD PMID:35063475 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NFE2L2 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:734431 6480464 Aflatoxin B1 results in increased methylation of NFE2L2 intron CTD PMID:30157460 aflatoxin B1 decreases activity ISO RGD:734432 6480464 Aflatoxin B1 results in decreased activity of NFE2L2 protein CTD PMID:30203046 aflatoxin B1 decreases methylation ISO RGD:734431 6480464 Aflatoxin B1 results in decreased methylation of NFE2L2 gene CTD PMID:27153756 aflatoxin B1 increases response to substance EXP 6480464 NFE2L2 gene mutant form results in increased susceptibility to Aflatoxin B1 CTD PMID:27071940 aflatoxin B1 multiple interactions EXP 6480464 [Aflatoxin B1 co-treated with caryophyllene] results in increased expression of NFE2L2 protein, Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] CTD PMID:25154877 , PMID:34506763 AL 8810 multiple interactions ISO RGD:734431 6480464 AL 8810 inhibits the reaction [Oxidopamine affects the localization of NFE2L2 protein] CTD PMID:33486071 alachlor increases activity ISO RGD:734431 6480464 alachlor results in increased activity of NFE2L2 protein CTD PMID:20143881 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of NFE2L2 mRNA, Glucose results in decreased expression of NFE2L2 protein CTD PMID:21818840 more ... aldehydo-D-glucose affects localization ISO RGD:734432 6480464 Glucose affects the localization of NFE2L2 protein CTD PMID:33270355 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of NFE2L2 mRNA, Glucose results in increased expression of NFE2L2 protein CTD PMID:29211853 aldehydo-D-glucose affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to Glucose CTD PMID:20086057 aldehydo-D-glucose multiple interactions ISO RGD:734432 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]] more ... CTD PMID:17928392 more ... aldehydo-D-glucose increases localization ISO RGD:734432 6480464 Glucose deficiency results in increased localization of NFE2L2 protein CTD PMID:17928392 aldehydo-D-glucose increases expression ISO RGD:734431 6480464 Glucose deficiency results in increased expression of NFE2L2 mRNA more ... CTD PMID:20103708 more ... aldehydo-D-glucose decreases expression ISO RGD:734431 6480464 Glucose results in decreased expression of NFE2L2 mRNA, Glucose results in decreased expression of NFE2L2 protein CTD PMID:21333731 more ... aldehydo-D-glucose multiple interactions ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] more ... CTD PMID:21333731 more ... aldehydo-D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein more ... CTD PMID:20028456 more ... aldosterone increases activity EXP 6480464 Aldosterone results in increased activity of NFE2L2 protein CTD PMID:25204689 aldosterone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein], tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] CTD PMID:25204689 all-trans-retinal increases expression ISO RGD:734431 6480464 Retinaldehyde results in increased expression of NFE2L2 mRNA CTD PMID:25331497 , PMID:27751755 all-trans-retinoic acid decreases expression ISO RGD:734431 6480464 Tretinoin results in decreased expression of NFE2L2 mRNA CTD PMID:15498508 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of NFE2L2 protein CTD PMID:30267739 all-trans-retinoic acid multiple interactions ISO RGD:734432 6480464 Tretinoin inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 protein]] more ... CTD PMID:22308036 , PMID:29964319 all-trans-retinoic acid increases expression ISO RGD:734431 6480464 Tretinoin results in increased expression of NFE2L2 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of NFE2L2 mRNA CTD PMID:20488242 all-trans-retinoic acid multiple interactions ISO RGD:734431 6480464 Tretinoin inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein], Tretinoin inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] CTD PMID:25003661 , PMID:30309986 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA CTD PMID:33396045 allicin multiple interactions ISO RGD:734431 6480464 allicin inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 protein] CTD PMID:27561292 alloxan decreases expression EXP 6480464 Alloxan results in decreased expression of NFE2L2 mRNA CTD PMID:33359794 alloxan multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]] more ... CTD PMID:33359794 alloxan affects localization EXP 6480464 Alloxan affects the localization of NFE2L2 protein CTD PMID:33359794 allyl isothiocyanate increases expression EXP 6480464 allyl isothiocyanate results in increased expression of NFE2L2 protein CTD PMID:22664424 allyl isothiocyanate multiple interactions EXP 6480464 allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein], allyl isothiocyanate inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] CTD PMID:30927557 allyl isothiocyanate increases activity ISO RGD:734432 6480464 allyl isothiocyanate results in increased activity of NFE2L2 protein CTD PMID:24036144 allyl isothiocyanate multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [allyl isothiocyanate results in increased expression of GCLC mRNA], NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to allyl isothiocyanate] CTD PMID:20932822 , PMID:24036144 alpha-D-galactose affects localization EXP 6480464 Galactose affects the localization of NFE2L2 protein CTD PMID:25892055 alpha-D-galactose multiple interactions EXP 6480464 Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein] CTD PMID:25892055 alpha-linolenic acid multiple interactions ISO RGD:734431 6480464 NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of CYP2A6 mRNA] more ... CTD PMID:28555106 alpha-linolenic acid multiple interactions EXP 6480464 alpha-Linolenic Acid inhibits the reaction [Cholesterol promotes the reaction [Particulate Matter results in increased expression of NFE2L2 mRNA]] more ... CTD PMID:30672636 alpha-pinene multiple interactions ISO RGD:734431 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFE2L2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NFE2L2 mRNA CTD PMID:32699268 alternariol affects localization ISO RGD:734431 6480464 alternariol affects the localization of NFE2L2 protein CTD PMID:23154127 , PMID:35405071 alternariol multiple interactions ISO RGD:734431 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alternariol co-treated with altertoxin II] affects the localization of NFE2L2 protein] more ... CTD PMID:35405071 aminoguanidine multiple interactions ISO RGD:734431 6480464 pimagedine inhibits the reaction [Pyruvaldehyde affects the localization of NFE2L2 protein] CTD PMID:33930484 amitraz decreases expression EXP 6480464 amitraz results in decreased expression of NFE2L2 protein CTD PMID:31029719 amitraz multiple interactions EXP 6480464 KEAP1 protein affects the reaction [amitraz results in decreased expression of NFE2L2 protein] CTD PMID:31029719 amlexanox increases expression ISO RGD:734432 6480464 amlexanox results in increased expression of NFE2L2 protein CTD PMID:31697998 amlexanox multiple interactions ISO RGD:734432 6480464 [Acetaminophen co-treated with amlexanox] results in increased expression of NFE2L2 protein more ... CTD PMID:31697998 ammonia increases abundance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased abundance of Ammonia CTD PMID:29618784 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NFE2L2 mRNA CTD PMID:16483693 ammonium chloride multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [Ammonium Chloride results in increased activity of NFE2L2 protein] more ... CTD PMID:27867098 ammonium chloride increases expression ISO RGD:734431 6480464 Ammonium Chloride results in increased expression of NFE2L2 mRNA CTD PMID:27867098 Ammothamnine multiple interactions EXP 6480464 oxymatrine promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] CTD PMID:27713174 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of NFE2L2 mRNA CTD PMID:30779732 andrographolide increases activity EXP 6480464 andrographolide results in increased activity of NFE2L2 protein CTD PMID:25110055 andrographolide decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in decreased susceptibility to andrographolide CTD PMID:29355602 andrographolide multiple interactions ISO RGD:734432 6480464 NFE2L2 gene mutant form inhibits the reaction [andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]] CTD PMID:29355602 andrographolide multiple interactions ISO RGD:734431 6480464 andrographolide results in increased expression of and affects the localization of NFE2L2 protein, NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]] CTD PMID:27297870 , PMID:35724838 anethole multiple interactions EXP 6480464 anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 mRNA], anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 protein] CTD PMID:35430261 angelica lactone affects activity ISO RGD:734432 6480464 angelica lactone affects the activity of NFE2L2 protein CTD PMID:11309284 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:734431 6480464 pyrazolanthrone inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] more ... CTD PMID:16631525 , PMID:23535287 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:734432 6480464 pyrazolanthrone inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein], pyrazolanthrone inhibits the reaction [Triclosan results in increased expression of NFE2L2 protein] CTD PMID:25449124 , PMID:34160118 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein] more ... CTD PMID:17640564 more ... anthra[1,9-cd]pyrazol-6(2H)-one decreases expression ISO RGD:734431 6480464 pyrazolanthrone results in decreased expression of NFE2L2 protein CTD PMID:25649257 anthranilic acid increases activity ISO RGD:734432 6480464 anthranilic acid results in increased activity of NFE2L2 protein CTD PMID:30114225 antimycin A increases expression ISO RGD:734431 6480464 Antimycin A results in increased expression of NFE2L2 mRNA CTD PMID:35430258 antimycin A multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NFE2L2 mRNA] CTD PMID:35430258 apigenin multiple interactions EXP 6480464 Apigenin affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:22864849 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] CTD PMID:24291008 apocynin multiple interactions ISO RGD:734431 6480464 [acetovanillone co-treated with AGT protein] results in increased expression of and affects the localization of NFE2L2 protein CTD PMID:27983965 arachidonic acid multiple interactions EXP 6480464 NFE2L2 gene mutant form inhibits the reaction [Arachidonic Acid metabolite results in increased expression of HMOX1 protein] CTD PMID:27012417 arachidonic acid increases expression EXP 6480464 Arachidonic Acid metabolite results in increased expression of NFE2L2 protein CTD PMID:27012417 arachidonyl-2'-chloroethylamide decreases expression ISO RGD:734432 6480464 arachidonyl-2-chloroethylamide results in decreased expression of NFE2L2 mRNA CTD PMID:26847930 arachidonyl-2'-chloroethylamide multiple interactions ISO RGD:734432 6480464 FOXO1 protein affects the reaction [arachidonyl-2-chloroethylamide results in decreased expression of NFE2L2 mRNA] CTD PMID:26847930 aristolochic acid A multiple interactions ISO RGD:734432 6480464 aristolochic acid I results in decreased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:24530882 aristolochic acid A decreases expression ISO RGD:734432 6480464 aristolochic acid I results in decreased expression of NFE2L2 mRNA CTD PMID:24530882 Aroclor 1254 increases expression ISO RGD:734431 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of NFE2L2 mRNA CTD PMID:17851650 Aroclor 1254 increases expression ISO RGD:734432 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of NFE2L2 mRNA CTD PMID:25270620 Aroclor 1254 decreases expression ISO RGD:734432 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NFE2L2 mRNA CTD PMID:23650126 arsane multiple interactions ISO RGD:734431 6480464 [Arsenic results in increased abundance of Hydrogen Peroxide] which results in increased expression of and results in increased localization of NFE2L2 protein more ... CTD PMID:14567983 more ... arsane increases expression ISO RGD:734431 6480464 Arsenic results in increased expression of NFE2L2 mRNA CTD PMID:35490796 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NFE2L2 protein, sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NFE2L2 protein] CTD PMID:30835071 arsane increases methylation ISO RGD:734431 6480464 Arsenic results in increased methylation of NFE2L2 promoter CTD PMID:29247444 arsane decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Arsenic CTD PMID:19538980 arsane multiple interactions ISO RGD:734432 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with biochanin A] results in increased expression of NFE2L2 mRNA more ... CTD PMID:23000044 more ... arsane affects response to substance ISO RGD:734432 6480464 NFE2L2 mRNA affects the susceptibility to Arsenic, NFE2L2 protein affects the susceptibility to Arsenic CTD PMID:19786557 , PMID:23000044 arsane increases expression ISO RGD:734432 6480464 Arsenic results in increased expression of NFE2L2 mRNA, Arsenic results in increased expression of NFE2L2 protein CTD PMID:19786557 more ... arsane increases activity ISO RGD:734432 6480464 Arsenic results in increased activity of NFE2L2 protein CTD PMID:19808700 arsane affects binding ISO RGD:734432 6480464 Arsenic binds to NFE2L2 protein CTD PMID:19786557 arsenic acid affects localization ISO RGD:734432 6480464 arsenic acid affects the localization of NFE2L2 protein CTD PMID:19429247 arsenic acid multiple interactions ISO RGD:734432 6480464 Sodium Selenite promotes the reaction [arsenic acid affects the localization of NFE2L2 protein] CTD PMID:19429247 arsenic atom decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Arsenic CTD PMID:19538980 arsenic atom increases expression ISO RGD:734431 6480464 Arsenic results in increased expression of NFE2L2 mRNA CTD PMID:35490796 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NFE2L2 protein, sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NFE2L2 protein] CTD PMID:30835071 arsenic atom increases methylation ISO RGD:734431 6480464 Arsenic results in increased methylation of NFE2L2 promoter CTD PMID:29247444 arsenic atom increases expression ISO RGD:734432 6480464 Arsenic results in increased expression of NFE2L2 mRNA, Arsenic results in increased expression of NFE2L2 protein CTD PMID:19786557 more ... arsenic atom multiple interactions ISO RGD:734432 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with biochanin A] results in increased expression of NFE2L2 mRNA more ... CTD PMID:23000044 more ... arsenic atom affects response to substance ISO RGD:734432 6480464 NFE2L2 mRNA affects the susceptibility to Arsenic, NFE2L2 protein affects the susceptibility to Arsenic CTD PMID:19786557 , PMID:23000044 arsenic atom affects binding ISO RGD:734432 6480464 Arsenic binds to NFE2L2 protein CTD PMID:19786557 arsenic atom increases activity ISO RGD:734432 6480464 Arsenic results in increased activity of NFE2L2 protein CTD PMID:19808700 arsenic atom multiple interactions ISO RGD:734431 6480464 [Arsenic results in increased abundance of Hydrogen Peroxide] which results in increased expression of and results in increased localization of NFE2L2 protein more ... CTD PMID:14567983 more ... arsenic trichloride multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [arsenic trichloride results in increased expression of NQO1 mRNA] CTD PMID:19276070 arsenite(3-) multiple interactions ISO RGD:734431 6480464 [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased susceptibility to arsenite more ... CTD PMID:18550526 more ... arsenite(3-) increases activity ISO RGD:734432 6480464 arsenite results in increased activity of NFE2L2 protein CTD PMID:25701757 , PMID:33412187 arsenite(3-) decreases expression ISO RGD:734431 6480464 arsenite results in decreased expression of NFE2L2 mRNA, arsenite results in decreased expression of NFE2L2 protein CTD PMID:28688901 arsenite(3-) increases expression ISO RGD:734432 6480464 arsenite results in increased expression of NFE2L2 mRNA, arsenite results in increased expression of NFE2L2 protein CTD PMID:32980394 arsenite(3-) affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to arsenite CTD PMID:22476201 arsenite(3-) increases expression ISO RGD:734431 6480464 arsenite results in increased expression of NFE2L2 mRNA, arsenite results in increased expression of NFE2L2 protein CTD PMID:22476201 more ... arsenite(3-) affects localization ISO RGD:734432 6480464 arsenite affects the localization of NFE2L2 protein CTD PMID:19429247 arsenite(3-) multiple interactions ISO RGD:734432 6480464 [Dexamethasone co-treated with arsenite] results in increased activity of NFE2L2 protein more ... CTD PMID:10473555 more ... arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of NFE2L2 mRNA, Arsenic Trioxide results in decreased expression of NFE2L2 protein CTD PMID:24327821 more ... arsenous acid multiple interactions ISO RGD:734431 6480464 [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:19350554 more ... arsenous acid multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:22488045 more ... arsenous acid affects localization ISO RGD:734431 6480464 Arsenic Trioxide affects the localization of NFE2L2 protein CTD PMID:19350554 more ... arsenous acid decreases response to substance ISO RGD:734431 6480464 NFE2L2 mRNA results in decreased susceptibility to Arsenic Trioxide, NFE2L2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22684020 , PMID:26708503 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of NFE2L2 mRNA, Arsenic Trioxide results in increased expression of NFE2L2 protein CTD PMID:27592447 more ... arsenous acid increases expression ISO RGD:734431 6480464 Arsenic Trioxide results in increased expression of NFE2L2 mRNA, Arsenic Trioxide results in increased expression of NFE2L2 protein CTD PMID:22155346 more ... arsenous acid decreases expression ISO RGD:734432 6480464 Arsenic Trioxide results in decreased expression of NFE2L2 protein CTD PMID:24157283 , PMID:33603344 arsenous acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein] more ... CTD PMID:24327821 more ... arsenous acid affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid increases expression ISO RGD:734432 6480464 Arsenic Trioxide results in increased expression of NFE2L2 mRNA, Arsenic Trioxide results in increased expression of NFE2L2 protein CTD PMID:22488045 , PMID:26187899 arsenous acid decreases expression ISO RGD:734431 6480464 Arsenic Trioxide results in decreased expression of NFE2L2 protein CTD PMID:22155346 , PMID:27561292 artesunate affects localization ISO RGD:734431 6480464 artesunate affects the localization of NFE2L2 protein CTD PMID:26340163 asperuloside multiple interactions ISO RGD:734432 6480464 [asperuloside co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein more ... CTD PMID:33974900 asperuloside affects localization ISO RGD:734432 6480464 asperuloside affects the localization of NFE2L2 protein CTD PMID:33974900 astaxanthin multiple interactions EXP 6480464 [astaxanthine co-treated with Cyclophosphamide] results in increased expression of NFE2L2 protein more ... CTD PMID:20038455 , PMID:23272707 astaxanthin multiple interactions ISO RGD:734432 6480464 astaxanthine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which affects the localization of NFE2L2 protein] CTD PMID:33008094 astaxanthin multiple interactions ISO RGD:734431 6480464 [astaxanthine co-treated with Docosahexaenoic Acids] results in increased expression of NFE2L2 mRNA more ... CTD PMID:24157545 , PMID:33212048 astaxanthin increases expression ISO RGD:734431 6480464 astaxanthine results in increased expression of NFE2L2 mRNA CTD PMID:24157545 , PMID:33212048 astaxanthin increases expression EXP 6480464 astaxanthine results in increased expression of NFE2L2 protein CTD PMID:20038455 astilbin multiple interactions ISO RGD:734431 6480464 astilbin promotes the reaction [Cisplatin affects the localization of NFE2L2 protein] CTD PMID:29471006 astilbin multiple interactions ISO RGD:734432 6480464 astilbin promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] CTD PMID:29471006 astragaloside IV multiple interactions ISO RGD:734432 6480464 [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein CTD PMID:25422538 astragaloside IV affects localization ISO RGD:734432 6480464 astragaloside A affects the localization of NFE2L2 protein CTD PMID:25422538 atorvastatin calcium increases expression ISO RGD:734432 6480464 Atorvastatin results in increased expression of NFE2L2 mRNA CTD PMID:30511338 atorvastatin calcium multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein], Atorvastatin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein] CTD PMID:32259528 atorvastatin calcium multiple interactions ISO RGD:734432 6480464 [PPARGC1B protein affects the susceptibility to Atorvastatin] which affects the expression of NFE2L2 mRNA, Atorvastatin inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NFE2L2 protein] CTD PMID:30511338 , PMID:32976958 ATP multiple interactions ISO RGD:734431 6480464 [Lipopolysaccharides co-treated with Adenosine Triphosphate] affects the localization of NFE2L2 protein, Luteolin promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] affects the localization of NFE2L2 protein] CTD PMID:34217685 atrazine multiple interactions EXP 6480464 lycopene promotes the reaction [Atrazine results in increased expression of NFE2L2 mRNA] CTD PMID:27102619 atrazine multiple interactions ISO RGD:734432 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of NFE2L2 mRNA], Lycopene inhibits the reaction [Atrazine results in increased expression of NFE2L2 protein] CTD PMID:30360616 atrazine increases expression ISO RGD:734432 6480464 Atrazine results in increased expression of NFE2L2 mRNA, Atrazine results in increased expression of NFE2L2 protein CTD PMID:30360616 atrazine increases expression EXP 6480464 Atrazine results in increased expression of NFE2L2 mRNA CTD PMID:27102619 auraptene affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to aurapten CTD PMID:19150646 aureusidin increases expression EXP 6480464 aureusidin results in increased expression of NFE2L2 mRNA CTD PMID:31790703 aureusidin multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [aureusidin affects the localization of NFE2L2 protein] more ... CTD PMID:31790703 azathioprine multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Azathioprine results in increased activity of NQO1 protein] CTD PMID:21803983 bafilomycin A1 multiple interactions ISO RGD:734431 6480464 bafilomycin A1 promotes the reaction [[Particulate Matter co-treated with Vitamin D] results in increased expression of NFE2L2 protein] more ... CTD PMID:30698894 bafilomycin A1 increases expression ISO RGD:734431 6480464 bafilomycin A1 results in increased expression of NFE2L2 protein CTD PMID:30698894 BAPTA affects localization ISO RGD:734431 6480464 1 more ... CTD PMID:21443188 BAPTA multiple interactions ISO RGD:734431 6480464 1 more ... CTD PMID:21443188 Bardoxolone methyl multiple interactions ISO RGD:734431 6480464 bardoxolone methyl results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:27358234 more ... Bardoxolone methyl increases localization ISO RGD:734431 6480464 bardoxolone methyl results in increased localization of NFE2L2 protein CTD PMID:21723306 Bardoxolone methyl increases expression ISO RGD:734432 6480464 bardoxolone methyl results in increased expression of NFE2L2 mRNA, bardoxolone methyl results in increased expression of NFE2L2 protein CTD PMID:21289052 , PMID:24530882 Bardoxolone methyl decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in decreased susceptibility to bardoxolone methyl CTD PMID:27633142 Bardoxolone methyl increases activity EXP 6480464 bardoxolone methyl results in increased activity of NFE2L2 protein CTD PMID:24798383 Bardoxolone methyl multiple interactions ISO RGD:734432 6480464 bardoxolone methyl inhibits the reaction [aristolochic acid I results in decreased expression of and affects the localization of NFE2L2 protein], bardoxolone methyl inhibits the reaction [aristolochic acid I results in decreased expression of NFE2L2 mRNA] CTD PMID:24530882 Bardoxolone methyl increases expression ISO RGD:734431 6480464 bardoxolone methyl results in increased expression of NFE2L2 protein CTD PMID:25246272 , PMID:27358234 bathocuproine disulfonic acid multiple interactions ISO RGD:734431 6480464 [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of NFE2L2 mRNA CTD PMID:15477007 bendiocarb increases activity ISO RGD:734431 6480464 bendiocarb results in increased activity of NFE2L2 protein CTD PMID:20143881 benfotiamine multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of GCLM mRNA] more ... CTD PMID:29860433 benzene affects localization ISO RGD:734432 6480464 Benzene affects the localization of NFE2L2 protein CTD PMID:35661779 benzo[a]pyrene multiple interactions ISO RGD:734431 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Benzo(a)pyrene affects the localization of NFE2L2 protein] more ... CTD PMID:21256954 more ... benzo[a]pyrene affects localization ISO RGD:734431 6480464 Benzo(a)pyrene affects the localization of NFE2L2 protein CTD PMID:35405071 benzo[a]pyrene increases activity ISO RGD:734432 6480464 Benzo(a)pyrene results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 benzo[a]pyrene decreases expression ISO RGD:734432 6480464 Benzo(a)pyrene results in decreased expression of NFE2L2 protein CTD PMID:26546711 , PMID:35777681 benzo[a]pyrene decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Benzo(a)pyrene CTD PMID:23056183 benzo[a]pyrene increases expression ISO RGD:734432 6480464 Benzo(a)pyrene metabolite results in increased expression of NFE2L2 mRNA more ... CTD PMID:15034205 more ... benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of NFE2L2 mRNA CTD PMID:19497421 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] CTD PMID:19497421 benzo[a]pyrene multiple interactions ISO RGD:734432 6480464 [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA more ... CTD PMID:11961136 more ... benzo[a]pyrene increases expression ISO RGD:734431 6480464 Benzo(a)pyrene results in increased expression of NFE2L2 mRNA, Benzo(a)pyrene results in increased expression of NFE2L2 protein CTD PMID:20106945 more ... benzo[a]pyrene affects activity ISO RGD:734431 6480464 Benzo(a)pyrene affects the activity of NFE2L2 protein CTD PMID:20624995 Benzo[k]fluoranthene increases expression ISO RGD:734432 6480464 benzo(k)fluoranthene results in increased expression of NFE2L2 mRNA CTD PMID:26377693 benzopyran multiple interactions EXP 6480464 Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] CTD PMID:25154877 benzoquinones multiple interactions ISO RGD:734432 6480464 Benzoquinones analog results in increased activity of and affects the localization of NFE2L2 protein CTD PMID:21651925 benzoquinones decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Benzoquinones analog CTD PMID:21651925 benzyl isothiocyanate multiple interactions ISO RGD:734432 6480464 benzyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:20932822 , PMID:28821405 benzyl isothiocyanate increases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in increased susceptibility to benzyl isothiocyanate CTD PMID:28821405 benzyl isothiocyanate increases expression EXP 6480464 benzyl isothiocyanate results in increased expression of NFE2L2 protein CTD PMID:22664424 benzyl isothiocyanate affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to benzyl isothiocyanate CTD PMID:19303893 beraprost multiple interactions ISO RGD:734432 6480464 beraprost inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA] CTD PMID:28887131 berberine increases expression ISO RGD:734431 6480464 Berberine results in increased expression of NFE2L2 protein CTD PMID:23954465 berberine increases activity ISO RGD:734431 6480464 Berberine results in increased activity of NFE2L2 protein CTD PMID:30818834 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [Bortezomib results in increased expression of NFE2L2 mRNA], Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein] CTD PMID:23523906 , PMID:35121005 berberine increases expression EXP 6480464 Berberine results in increased expression of NFE2L2 protein CTD PMID:23523906 berberine multiple interactions ISO RGD:734431 6480464 NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]] more ... CTD PMID:23954465 Bergenin multiple interactions ISO RGD:734432 6480464 bergenin affects the reaction [Pyruvaldehyde affects the expression of NFE2L2 protein] CTD PMID:29148590 beta-naphthoflavone increases expression ISO RGD:734431 6480464 beta-Naphthoflavone results in increased expression of NFE2L2 protein CTD PMID:12446695 beta-propiolactone decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Propiolactone CTD PMID:20932822 beta-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] CTD PMID:22389237 Betanin multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:33661552 betulin multiple interactions EXP 6480464 betulin inhibits the reaction [9 more ... CTD PMID:33759307 bezafibrate increases activity ISO RGD:734432 6480464 Bezafibrate results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 bifenthrin decreases expression EXP 6480464 bifenthrin results in decreased expression of NFE2L2 mRNA, bifenthrin results in decreased expression of NFE2L2 protein CTD PMID:29775722 bifenthrin decreases expression ISO RGD:734431 6480464 bifenthrin results in decreased expression of NFE2L2 mRNA, bifenthrin results in decreased expression of NFE2L2 protein CTD PMID:32061760 bifenthrin increases expression EXP 6480464 bifenthrin results in increased expression of NFE2L2 mRNA, bifenthrin results in increased expression of NFE2L2 protein CTD PMID:29793499 , PMID:30102949 bilirubin IXalpha affects localization ISO RGD:734432 6480464 Bilirubin affects the localization of NFE2L2 protein CTD PMID:23628428 bilirubin IXalpha multiple interactions ISO RGD:734432 6480464 Bilirubin promotes the reaction [NFE2L2 protein results in increased expression of CYP2A5 mRNA] CTD PMID:23628428 biochanin A multiple interactions ISO RGD:734432 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with biochanin A] results in increased expression of NFE2L2 mRNA CTD PMID:33410021 biphenyl-4-amine multiple interactions ISO RGD:734432 6480464 4-biphenylamine results in increased expression of and affects the localization of NFE2L2 protein CTD PMID:25601990 bis(2-chloroethyl) sulfide increases expression ISO RGD:734432 6480464 Mustard Gas results in increased expression of NFE2L2 mRNA CTD PMID:15674844 , PMID:18955075 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of NFE2L2 protein CTD PMID:32050098 bis(2-ethylhexyl) phthalate affects expression ISO RGD:734431 6480464 Diethylhexyl Phthalate affects the expression of NFE2L2 protein CTD PMID:34822940 bis(2-ethylhexyl) phthalate increases activity ISO RGD:734432 6480464 Diethylhexyl Phthalate results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:734431 6480464 Diethylhexyl Phthalate analog results in decreased expression of NFE2L2 protein more ... CTD PMID:31112013 , PMID:34822940 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein] more ... CTD PMID:26361869 more ... bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA, Diethylhexyl Phthalate results in increased expression of NFE2L2 protein CTD PMID:22672789 more ... bisdemethoxycurcumin affects localization ISO RGD:734432 6480464 bisdemethoxycurcumin affects the localization of NFE2L2 protein CTD PMID:17535857 bisdemethoxycurcumin multiple interactions ISO RGD:734432 6480464 [demethoxycurcumin co-treated with bisdemethoxycurcumin] affects the localization of NFE2L2 protein, NFE2L2 protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA] CTD PMID:17535857 bisphenol A increases expression ISO RGD:734431 6480464 bisphenol A results in increased expression of NFE2L2 mRNA, bisphenol A results in increased expression of NFE2L2 protein CTD PMID:23360430 more ... bisphenol A decreases expression ISO RGD:734431 6480464 bisphenol A results in decreased expression of NFE2L2 protein CTD PMID:34664771 bisphenol A decreases expression ISO RGD:734432 6480464 bisphenol A results in decreased expression of NFE2L2 mRNA CTD PMID:33221593 bisphenol A multiple interactions EXP 6480464 Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein] more ... CTD PMID:31091348 more ... bisphenol A affects expression ISO RGD:734431 6480464 bisphenol A affects the expression of NFE2L2 mRNA CTD PMID:30903817 bisphenol A decreases phosphorylation ISO RGD:734431 6480464 bisphenol A results in decreased phosphorylation of NFE2L2 protein CTD PMID:29275510 bisphenol A affects methylation ISO RGD:734432 6480464 bisphenol A affects the methylation of NFE2L2 promoter CTD PMID:27334623 bisphenol A multiple interactions ISO RGD:734432 6480464 bisphenol A promotes the reaction [NFE2L2 protein binds to SREBF1 promoter] CTD PMID:28796629 bisphenol A decreases methylation ISO RGD:734432 6480464 bisphenol A results in decreased methylation of NFE2L2 promoter CTD PMID:28796629 bisphenol A increases expression ISO RGD:734432 6480464 bisphenol A results in increased expression of NFE2L2 mRNA, bisphenol A results in increased expression of NFE2L2 protein CTD PMID:28796629 , PMID:34281243 bisphenol A decreases expression EXP 6480464 bisphenol A analog results in decreased expression of NFE2L2 mRNA more ... CTD PMID:27208089 more ... bisphenol A multiple interactions ISO RGD:734431 6480464 2-aminoethoxydiphenylborane inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein] more ... CTD PMID:33408296 , PMID:33841860 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NFE2L2 mRNA CTD PMID:25181051 bisphenol A increases stability ISO RGD:734431 6480464 bisphenol A results in increased stability of NFE2L2 protein modified form CTD PMID:23360430 bixin decreases ubiquitination ISO RGD:734431 6480464 bixin results in decreased ubiquitination of NFE2L2 protein CTD PMID:30698894 bleomycin A2 multiple interactions EXP 6480464 Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein] more ... CTD PMID:23523906 more ... bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of NFE2L2 mRNA, Bleomycin results in decreased expression of NFE2L2 protein CTD PMID:26093215 , PMID:26768587 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of NFE2L2 protein CTD PMID:23523906 bleomycin A2 affects localization ISO RGD:734432 6480464 Bleomycin affects the localization of NFE2L2 protein CTD PMID:23570914 bleomycin A2 multiple interactions ISO RGD:734432 6480464 caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] more ... CTD PMID:23570914 bleomycin A2 decreases expression ISO RGD:734432 6480464 Bleomycin results in decreased expression of NFE2L2 protein CTD PMID:23570914 bleomycin A2 increases phosphorylation ISO RGD:734432 6480464 Bleomycin results in increased phosphorylation of NFE2L2 protein CTD PMID:23570914 boric acid affects localization ISO RGD:734432 6480464 boric acid affects the localization of NFE2L2 protein CTD PMID:30196486 boric acid affects localization ISO RGD:734431 6480464 boric acid affects the localization of NFE2L2 protein CTD PMID:30196486 boric acid multiple interactions ISO RGD:734432 6480464 EIF2AK3 protein affects the reaction [boric acid affects the localization of NFE2L2 protein] CTD PMID:30196486 bortezomib increases expression ISO RGD:734431 6480464 [Bortezomib results in increased expression of NFE2L2 protein] which results in increased expression of CBR3 mRNA, Bortezomib results in increased expression of NFE2L2 protein CTD PMID:20806931 bortezomib multiple interactions EXP 6480464 Berberine inhibits the reaction [Bortezomib results in increased expression of NFE2L2 mRNA] CTD PMID:35121005 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of NFE2L2 mRNA CTD PMID:35121005 bortezomib increases activity ISO RGD:734431 6480464 Bortezomib results in increased activity of NFE2L2 protein CTD PMID:30818834 brefeldin A multiple interactions ISO RGD:734431 6480464 Brefeldin A inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] CTD PMID:20805060 bromobenzene increases localization ISO RGD:734432 6480464 bromobenzene results in increased localization of NFE2L2 protein CTD PMID:18078705 bromobenzene increases expression ISO RGD:734431 6480464 bromobenzene analog results in increased expression of NFE2L2 protein CTD PMID:19427879 bromocriptine increases localization ISO RGD:734431 6480464 Bromocriptine results in increased localization of NFE2L2 protein CTD PMID:21867702 bromosulfophthalein affects abundance ISO RGD:734432 6480464 NFE2L2 protein affects the abundance of Sulfobromophthalein CTD PMID:19246623 bromosulfophthalein increases transport ISO RGD:734432 6480464 NFE2L2 protein results in increased transport of Sulfobromophthalein CTD PMID:19246623 bromosulfophthalein increases glutathionylation ISO RGD:734432 6480464 NFE2L2 protein results in increased glutathionylation of Sulfobromophthalein CTD PMID:19246623 Brusatol decreases expression ISO RGD:734431 6480464 brusatol results in decreased expression of NFE2L2 protein CTD PMID:27639429 more ... Brusatol multiple interactions EXP 6480464 brusatol inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which affects the localization of NFE2L2 protein] CTD PMID:34695510 Brusatol multiple interactions ISO RGD:734431 6480464 [brusatol results in increased ubiquitination of and results in increased degradation of NFE2L2 protein] which results in increased susceptibility to Cisplatin more ... CTD PMID:21205897 more ... bucladesine increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Bucladesine CTD PMID:22859313 bucladesine multiple interactions ISO RGD:734432 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Bucladesine] which results in increased expression of ALAS1 mRNA more ... CTD PMID:22859313 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of NFE2L2 mRNA CTD PMID:24136188 busulfan multiple interactions ISO RGD:734432 6480464 Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] more ... CTD PMID:32416107 busulfan decreases expression ISO RGD:734432 6480464 Busulfan results in decreased expression of NFE2L2 protein CTD PMID:32416107 but-2-en-4-olide increases activity ISO RGD:734431 6480464 butenolide results in increased activity of NFE2L2 protein CTD PMID:30244016 butane-2,3-dione affects localization EXP 6480464 Diacetyl affects the localization of NFE2L2 protein CTD PMID:25145656 butein affects localization ISO RGD:734431 6480464 butein affects the localization of NFE2L2 protein CTD PMID:23318726 butylated hydroxyanisole multiple interactions ISO RGD:734431 6480464 Butylated Hydroxyanisole results in increased stability of and results in increased expression of NFE2L2 protein CTD PMID:22530035 butylated hydroxyanisole affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to Butylated Hydroxyanisole CTD PMID:30844440 butylated hydroxyanisole multiple interactions EXP 6480464 Butylated Hydroxyanisole inhibits the reaction [Estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]] CTD PMID:23027624 butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of NFE2L2 protein CTD PMID:23027624 butylated hydroxyanisole multiple interactions ISO RGD:734432 6480464 [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA more ... CTD PMID:11895860 more ... butylated hydroxyanisole affects activity ISO RGD:734432 6480464 Butylated Hydroxyanisole affects the activity of NFE2L2 protein CTD PMID:11309284 Butylbenzyl phthalate decreases expression ISO RGD:734432 6480464 butylbenzyl phthalate results in decreased expression of NFE2L2 mRNA CTD PMID:27923775 butyric acid decreases expression ISO RGD:734431 6480464 Butyric Acid results in decreased expression of NFE2L2 mRNA CTD PMID:30439556 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of NFE2L2 mRNA more ... CTD PMID:17573173 more ... cadmium atom increases localization ISO RGD:734431 6480464 Cadmium results in increased localization of NFE2L2 protein CTD PMID:31756223 cadmium atom increases activity ISO RGD:734432 6480464 Cadmium results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 cadmium atom decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Cadmium CTD PMID:23056183 cadmium atom multiple interactions ISO RGD:734432 6480464 [NFE2L2 protein affects the susceptibility to [Cadmium Chloride results in increased abundance of Cadmium]] which affects the activity of GPT protein more ... CTD PMID:10473555 more ... cadmium atom affects localization ISO RGD:734431 6480464 Cadmium affects the localization of NFE2L2 protein CTD PMID:16959797 cadmium atom multiple interactions ISO RGD:734431 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2L2 protein more ... CTD PMID:16959797 more ... cadmium atom increases activity ISO RGD:734431 6480464 Cadmium results in increased activity of NFE2L2 promoter, Cadmium results in increased activity of NFE2L2 protein CTD PMID:21172416 , PMID:21643505 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of NFE2L2 mRNA, Cadmium results in increased expression of NFE2L2 protein CTD PMID:21787725 more ... cadmium dichloride multiple interactions ISO RGD:734431 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2L2 protein more ... CTD PMID:10874044 more ... cadmium dichloride affects activity ISO RGD:734431 6480464 Cadmium Chloride affects the activity of NFE2L2 protein CTD PMID:25596134 cadmium dichloride decreases expression ISO RGD:734431 6480464 Cadmium Chloride results in decreased expression of NFE2L2 mRNA CTD PMID:25596134 cadmium dichloride affects localization ISO RGD:734431 6480464 Cadmium Chloride affects the localization of NFE2L2 protein CTD PMID:16959797 more ... cadmium dichloride increases expression ISO RGD:734431 6480464 Cadmium Chloride results in increased expression of NFE2L2 protein CTD PMID:15878868 more ... cadmium dichloride decreases response to substance EXP 6480464 NFE2L2 protein results in decreased susceptibility to Cadmium Chloride CTD PMID:19682480 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of NFE2L2 mRNA more ... CTD PMID:19682480 , PMID:34695510 cadmium dichloride increases activity EXP 6480464 Cadmium Chloride results in increased activity of NFE2L2 protein CTD PMID:19682480 cadmium dichloride affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Cadmium Chloride CTD PMID:19303893 cadmium dichloride increases stability ISO RGD:734432 6480464 Cadmium Chloride results in increased stability of NFE2L2 protein CTD PMID:12441344 cadmium dichloride decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Cadmium Chloride, NFE2L2 results in decreased susceptibility to Cadmium Chloride CTD PMID:18367636 more ... cadmium dichloride affects ubiquitination ISO RGD:734432 6480464 Cadmium Chloride affects the ubiquitination of NFE2L2 protein CTD PMID:18512965 cadmium dichloride increases localization ISO RGD:734432 6480464 Cadmium Chloride results in increased localization of NFE2L2 protein CTD PMID:17303623 cadmium dichloride multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:10874044 more ... cafestol multiple interactions ISO RGD:734432 6480464 [cafestol co-treated with kahweol palmitate] affects the activity of NFE2L2 protein more ... CTD PMID:11309284 , PMID:18028974 cafestol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] CTD PMID:17110534 calciol multiple interactions EXP 6480464 Cholecalciferol inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:29653100 more ... calciol multiple interactions ISO RGD:734432 6480464 [Cholecalciferol co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein CTD PMID:33974900 calcitriol increases expression ISO RGD:734431 6480464 Calcitriol results in increased expression of NFE2L2 mRNA CTD PMID:12040012 calcium atom increases abundance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased abundance of Calcium CTD PMID:29618784 calcium(0) increases abundance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased abundance of Calcium CTD PMID:29618784 calycosin multiple interactions EXP 6480464 7, 3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of NFE2L2 protein] CTD PMID:31726037 calyculin a decreases activity ISO RGD:734432 6480464 calyculin A results in decreased activity of NFE2L2 protein CTD PMID:30114225 camptothecin multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [Camptothecin results in increased expression of TERT mRNA] CTD PMID:30851366 camptothecin increases activity ISO RGD:734431 6480464 Camptothecin results in increased activity of NFE2L2 protein CTD PMID:30851366 cannabidiol multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [Cannabidiol results in increased expression of HMOX1 protein] CTD PMID:32708634 cannabidiol increases expression ISO RGD:734431 6480464 Cannabidiol results in increased expression of NFE2L2 mRNA, Cannabidiol results in increased expression of NFE2L2 protein CTD PMID:27714895 more ... capsaicin multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [Capsaicin results in increased localization of NFE2L2 protein] CTD PMID:17979524 capsaicin increases localization ISO RGD:734431 6480464 Capsaicin results in increased localization of NFE2L2 protein CTD PMID:17979524 carbamazepine affects expression ISO RGD:734431 6480464 Carbamazepine affects the expression of NFE2L2 mRNA CTD PMID:25979313 carbamazepine increases activity ISO RGD:734431 6480464 Carbamazepine results in increased activity of NFE2L2 protein CTD PMID:24752500 carbendazim increases expression ISO RGD:734431 6480464 carbendazim results in increased expression of NFE2L2 protein CTD PMID:30851412 carbon disulfide affects localization EXP 6480464 Carbon Disulfide affects the localization of NFE2L2 protein CTD PMID:27530093 carbon monoxide multiple interactions ISO RGD:734432 6480464 Carbon Monoxide inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] more ... CTD PMID:18845810 carbon monoxide increases expression EXP 6480464 Carbon Monoxide results in increased expression of NFE2L2 mRNA, Carbon Monoxide results in increased expression of NFE2L2 protein CTD PMID:25348283 , PMID:34032369 carbon monoxide multiple interactions EXP 6480464 [NFE2L2 protein co-treated with Carbon Monoxide] results in increased expression of GCLC mRNA more ... CTD PMID:25348283 , PMID:34032369 carbon monoxide increases localization EXP 6480464 Carbon Monoxide results in increased localization of NFE2L2 protein CTD PMID:18845810 carbon monoxide increases localization ISO RGD:734432 6480464 Carbon Monoxide results in increased localization of NFE2L2 protein CTD PMID:18845810 carbon monoxide increases expression ISO RGD:734432 6480464 Carbon Monoxide results in increased expression of NFE2L2 mRNA CTD PMID:18845810 carbon monoxide decreases phosphorylation ISO RGD:734432 6480464 Carbon Monoxide results in decreased phosphorylation of NFE2L2 protein CTD PMID:18845810 carfilzomib increases activity ISO RGD:734431 6480464 carfilzomib results in increased activity of NFE2L2 protein CTD PMID:30818834 carmustine affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Carmustine CTD PMID:19303893 carnosic acid multiple interactions ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased activity of NFE2L2 protein] more ... CTD PMID:26577515 more ... carnosic acid increases activity ISO RGD:734431 6480464 salvin results in increased activity of NFE2L2 protein CTD PMID:26577515 Carnosol multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [IFNG protein results in increased abundance of Nitrites]], NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] CTD PMID:23942037 Carnosol increases localization ISO RGD:734431 6480464 carnosol results in increased localization of NFE2L2 protein CTD PMID:20116392 Carnosol multiple interactions ISO RGD:734431 6480464 [NFE2L2 mutant form inhibits the reaction [carnosol results in increased expression of HMOX1 protein]] which results in increased expression of ICAM1 protein more ... CTD PMID:20116392 carrageenan affects localization EXP 6480464 Carrageenan affects the localization of NFE2L2 protein CTD PMID:28844677 carrageenan multiple interactions EXP 6480464 procyanidin B2 inhibits the reaction [Carrageenan affects the localization of NFE2L2 protein] CTD PMID:28844677 catalpol multiple interactions ISO RGD:734431 6480464 [catalpol co-treated with Saponins co-treated with triptolide] affects the localization of NFE2L2 protein more ... CTD PMID:30682494 CCCP multiple interactions ISO RGD:734431 6480464 [[Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [SQSTM1 protein binds to KEAP1 protein]] promotes the reaction [KEAP1 protein binds to NFE2L2 protein]] which results in decreased activity of NFE2L2 protein, [Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [SQSTM1 protein binds to KEAP1 protein]] promotes the reaction [KEAP1 protein binds to NFE2L2 protein] CTD PMID:30715550 cefuroxime decreases activity ISO RGD:734432 6480464 Cefuroxime results in decreased activity of NFE2L2 protein CTD PMID:30203046 celastrol multiple interactions EXP 6480464 celastrol inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] more ... CTD PMID:26768587 , PMID:30588110 celastrol increases activity ISO RGD:734432 6480464 celastrol results in increased activity of NFE2L2 protein CTD PMID:29643811 celastrol increases expression ISO RGD:734432 6480464 celastrol results in increased expression of NFE2L2 mRNA CTD PMID:29643811 celastrol increases expression EXP 6480464 celastrol results in increased expression of NFE2L2 protein CTD PMID:26768587 ceric oxide affects localization ISO RGD:734431 6480464 ceric oxide affects the localization of NFE2L2 protein CTD PMID:19429248 ceruletide decreases expression ISO RGD:734432 6480464 Ceruletide results in decreased expression of NFE2L2 protein CTD PMID:33166053 ceruletide multiple interactions ISO RGD:734432 6480464 isoborneol inhibits the reaction [Ceruletide results in decreased expression of NFE2L2 protein] CTD PMID:33166053 chalcone multiple interactions ISO RGD:734431 6480464 Chalcone analog results in decreased ubiquitination of and results in decreased degradation of and affects the localization of NFE2L2 protein, NFE2L2 promotes the reaction [Chalcone analog results in increased abundance of Glutathione] CTD PMID:31299238 chalcones increases expression EXP 6480464 Chalcones analog results in increased expression of NFE2L2 protein CTD PMID:23963778 chenodeoxycholic acid multiple interactions ISO RGD:734431 6480464 [Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of FTL mRNA more ... CTD PMID:17724089 chenodeoxycholic acid increases expression ISO RGD:734432 6480464 Chenodeoxycholic Acid results in increased expression of NFE2L2 mRNA CTD PMID:25582706 chenodeoxycholic acid decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Chenodeoxycholic Acid CTD PMID:17724089 chitosan multiple interactions ISO RGD:734431 6480464 [Chitosan metabolite results in decreased susceptibility to Copper] which results in increased phosphorylation of NFE2L2 protein CTD PMID:25542178 chitosan multiple interactions EXP 6480464 Chitosan analog inhibits the reaction [Doxorubicin affects the localization of NFE2L2 protein] more ... CTD PMID:30928397 chitosan affects localization EXP 6480464 Chitosan analog affects the localization of NFE2L2 protein CTD PMID:30928397 chlorambucil multiple interactions ISO RGD:734431 6480464 [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil, Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil] CTD PMID:19608619 chlorambucil affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Chlorambucil CTD PMID:19303893 chlorambucil multiple interactions ISO RGD:734432 6480464 Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Chlorambucil] more ... CTD PMID:19303893 , PMID:20932822 chlorambucil increases response to substance ISO RGD:734431 6480464 NFE2L2 gene mutant form results in increased susceptibility to Chlorambucil CTD PMID:19608619 chlormidazole increases activity ISO RGD:734431 6480464 chlormidazole results in increased activity of NFE2L2 protein CTD PMID:30818834 chloroacetaldehyde decreases expression ISO RGD:734431 6480464 chloroacetaldehyde results in decreased expression of NFE2L2 mRNA CTD PMID:25596134 chloroacetaldehyde affects activity ISO RGD:734431 6480464 chloroacetaldehyde affects the activity of NFE2L2 protein CTD PMID:25596134 chlorogenic acid decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in decreased susceptibility to Chlorogenic Acid CTD PMID:29136249 chlorogenic acid multiple interactions ISO RGD:734431 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] more ... CTD PMID:29136249 chlorogenic acid multiple interactions ISO RGD:734432 6480464 [Chlorogenic Acid co-treated with Acetaminophen] affects the localization of and results in increased activity of NFE2L2 protein, Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] CTD PMID:29136249 , PMID:33242462 chlorogenic acid increases response to substance ISO RGD:734431 6480464 NFE2L2 results in increased susceptibility to Chlorogenic Acid CTD PMID:29136249 chlorogenic acid affects localization ISO RGD:734431 6480464 Chlorogenic Acid affects the localization of NFE2L2 protein CTD PMID:29136249 chlorogenic acid increases localization ISO RGD:734432 6480464 Chlorogenic Acid results in increased localization of NFE2L2 protein CTD PMID:15944151 chloropicrin decreases expression ISO RGD:734431 6480464 chloropicrin results in decreased expression of NFE2L2 mRNA CTD PMID:26352163 chlorpromazine decreases expression EXP 6480464 Chlorpromazine results in decreased expression of NFE2L2 mRNA CTD PMID:25596134 chlorpromazine affects activity EXP 6480464 Chlorpromazine affects the activity of NFE2L2 protein CTD PMID:25596134 chlorpyrifos increases expression ISO RGD:734431 6480464 Chlorpyrifos results in increased expression of NFE2L2 mRNA CTD PMID:23850137 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of NFE2L2 mRNA CTD PMID:30497708 , PMID:31823260 chlorpyrifos affects expression ISO RGD:734431 6480464 Chlorpyrifos affects the expression of NFE2L2 protein CTD PMID:28887667 , PMID:33930485 chlorpyrifos decreases expression ISO RGD:734431 6480464 Chlorpyrifos results in decreased expression of NFE2L2 mRNA, Chlorpyrifos results in decreased expression of NFE2L2 protein CTD PMID:30835941 chlorpyrifos multiple interactions EXP 6480464 [Edaravone co-treated with Chlorpyrifos] results in increased expression of NFE2L2 protein more ... CTD PMID:30497708 more ... chlorpyrifos affects response to substance EXP 6480464 NFE2L2 protein affects the susceptibility to Chlorpyrifos CTD PMID:30758894 chlorpyrifos multiple interactions ISO RGD:734432 6480464 Chlorpyrifos inhibits the reaction [taxifolin results in decreased expression of NFE2L2 protein] CTD PMID:31152760 chlorpyrifos multiple interactions ISO RGD:734431 6480464 Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of NFE2L2 protein] more ... CTD PMID:23850137 more ... cholesterol increases expression EXP 6480464 Cholesterol results in increased expression of NFE2L2 mRNA CTD PMID:30672636 cholesterol multiple interactions EXP 6480464 alpha-Linolenic Acid inhibits the reaction [Cholesterol promotes the reaction [Particulate Matter results in increased expression of NFE2L2 mRNA]] more ... CTD PMID:30672636 cholic acid increases expression ISO RGD:734432 6480464 Cholic Acid results in increased expression of NFE2L2 mRNA CTD PMID:25582706 choline multiple interactions ISO RGD:734432 6480464 [Methionine deficiency co-treated with Choline deficiency] affects the localization of NFE2L2 protein more ... CTD PMID:20350562 chromium atom multiple interactions ISO RGD:734431 6480464 [chromous chloride results in increased abundance of Chromium] which results in decreased expression of NFE2L2 protein CTD PMID:30359721 chromium(6+) multiple interactions ISO RGD:734432 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 mRNA, [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 protein CTD PMID:25820237 chromium(6+) increases activity ISO RGD:734431 6480464 chromium hexavalent ion results in increased activity of NFE2L2 protein CTD PMID:30715550 chromium(6+) multiple interactions ISO RGD:734431 6480464 chromium hexavalent ion promotes the reaction [NFE2L2 protein binds to SIRT3 promoter] CTD PMID:30715550 chrysin multiple interactions EXP 6480464 chrysin affects the localization of and results in increased activity of NFE2L2 protein more ... CTD PMID:22864849 , PMID:33121995 chrysin decreases expression ISO RGD:734431 6480464 chrysin results in decreased expression of NFE2L2 mRNA, chrysin results in decreased expression of NFE2L2 protein CTD PMID:23994249 chrysin multiple interactions ISO RGD:734431 6480464 chrysin inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Doxorubicin] CTD PMID:23994249 cidofovir anhydrous affects activity ISO RGD:734431 6480464 Cidofovir affects the activity of NFE2L2 protein CTD PMID:25596134 cidofovir anhydrous affects expression ISO RGD:734431 6480464 Cidofovir affects the expression of NFE2L2 mRNA CTD PMID:25596134 cilostazol increases expression ISO RGD:734431 6480464 cilostazol results in increased expression of NFE2L2 protein CTD PMID:20131233 cilostazol increases response to substance ISO RGD:734431 6480464 NFE2L2 results in increased susceptibility to cilostazol CTD PMID:20131233 cilostazol multiple interactions ISO RGD:734431 6480464 NFE2L2 mutant form inhibits the reaction [cilostazol results in increased expression of HMOX1 protein] CTD PMID:20131233 cinnamyl alcohol multiple interactions ISO RGD:734431 6480464 NFE2L2 mRNA promotes the reaction [cinnamyl alcohol results in increased expression of HMOX1 mRNA] CTD PMID:26244607 ciprofibrate increases activity ISO RGD:734432 6480464 ciprofibrate results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 cisplatin decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Cisplatin, NFE2L2 results in decreased susceptibility to Cisplatin CTD PMID:20530669 more ... cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of NFE2L2 mRNA, Cisplatin results in decreased expression of NFE2L2 protein CTD PMID:32259551 more ... cisplatin decreases expression ISO RGD:734432 6480464 Cisplatin results in decreased expression of NFE2L2 mRNA, Cisplatin results in decreased expression of NFE2L2 protein CTD PMID:33952797 more ... cisplatin affects expression EXP 6480464 Cisplatin affects the expression of NFE2L2 protein CTD PMID:30125553 cisplatin affects localization ISO RGD:734431 6480464 Cisplatin affects the localization of NFE2L2 protein CTD PMID:29471006 cisplatin affects activity ISO RGD:734431 6480464 Cisplatin affects the activity of NFE2L2 protein CTD PMID:25596134 cisplatin affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Cisplatin CTD PMID:23933386 cisplatin increases expression ISO RGD:734432 6480464 Cisplatin results in increased expression of NFE2L2 mRNA, Cisplatin results in increased expression of NFE2L2 protein CTD PMID:23384965 more ... cisplatin increases expression ISO RGD:734431 6480464 Cisplatin results in increased expression of NFE2L2 mRNA CTD PMID:27594783 more ... cisplatin multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:24291008 more ... cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of NFE2L2 mRNA, Cisplatin results in increased expression of NFE2L2 protein CTD PMID:24291008 more ... cisplatin decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Cisplatin CTD PMID:20605904 , PMID:20932822 cisplatin multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:20605904 more ... cisplatin affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Cisplatin CTD PMID:19303893 cisplatin increases response to substance ISO RGD:734431 6480464 NFE2L2 mutant form results in increased susceptibility to Cisplatin CTD PMID:24817946 cisplatin multiple interactions ISO RGD:734431 6480464 [brusatol results in increased ubiquitination of and results in increased degradation of NFE2L2 protein] which results in increased susceptibility to Cisplatin more ... CTD PMID:20530669 more ... citraconic acid multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA] more ... CTD PMID:27277809 citraconic acid multiple interactions ISO RGD:734431 6480464 citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein], NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] CTD PMID:28289076 citraconic acid affects localization ISO RGD:734431 6480464 citraconic acid affects the localization of NFE2L2 protein CTD PMID:27277809 clodronic acid affects activity ISO RGD:734431 6480464 Clodronic Acid affects the activity of NFE2L2 protein CTD PMID:25596134 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of NFE2L2 protein CTD PMID:20180811 clofibrate increases expression ISO RGD:734432 6480464 Clofibrate results in increased expression of NFE2L2 mRNA CTD PMID:25270620 clorgyline increases expression ISO RGD:734431 6480464 Clorgyline results in increased expression of NFE2L2 mRNA CTD PMID:19691856 clozapine affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Clozapine CTD PMID:21540358 cobalt atom multiple interactions ISO RGD:734432 6480464 [[tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA more ... CTD PMID:20528745 cobalt atom increases activity ISO RGD:734431 6480464 Cobalt results in increased activity of NFE2L2 promoter CTD PMID:21643505 cobalt dichloride multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of NFE2L2 protein] more ... CTD PMID:27297870 , PMID:29966676 cobalt dichloride affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to cobaltous chloride CTD PMID:29966676 cocaine multiple interactions ISO RGD:734432 6480464 Cocaine results in increased activity of and affects the localization of NFE2L2 protein more ... CTD PMID:30393195 coenzyme Q10 multiple interactions ISO RGD:734432 6480464 coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of NFE2L2 mRNA] CTD PMID:33271250 coenzyme Q10 multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA], coenzyme Q10 inhibits the reaction [Vincristine results in decreased expression of NFE2L2 mRNA] CTD PMID:27174133 , PMID:34939713 colistin decreases expression ISO RGD:734432 6480464 Colistin results in decreased expression of NFE2L2 protein CTD PMID:34560125 coniferyl aldehyde multiple interactions ISO RGD:734431 6480464 coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein more ... CTD PMID:26275128 coniferyl aldehyde increases expression ISO RGD:734432 6480464 coniferaldehyde results in increased expression of NFE2L2 protein CTD PMID:26275128 copper atom multiple interactions EXP 6480464 [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA CTD PMID:20302851 copper atom multiple interactions ISO RGD:734431 6480464 [Chelating Agents binds to Copper] which affects the expression of NFE2L2 mRNA more ... CTD PMID:25542178 , PMID:30911355 copper atom decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene results in decreased susceptibility to Copper CTD PMID:24462598 copper atom multiple interactions ISO RGD:734432 6480464 NFE2L2 gene promotes the reaction [Copper results in increased expression of MT1 mRNA] CTD PMID:24462598 copper atom increases activity ISO RGD:734431 6480464 Copper results in increased activity of NFE2L2 promoter CTD PMID:21643505 copper(0) multiple interactions EXP 6480464 [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA CTD PMID:20302851 copper(0) multiple interactions ISO RGD:734431 6480464 [Chelating Agents binds to Copper] which affects the expression of NFE2L2 mRNA more ... CTD PMID:25542178 , PMID:30911355 copper(0) decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene results in decreased susceptibility to Copper CTD PMID:24462598 copper(0) multiple interactions ISO RGD:734432 6480464 NFE2L2 gene promotes the reaction [Copper results in increased expression of MT1 mRNA] CTD PMID:24462598 copper(0) increases activity ISO RGD:734431 6480464 Copper results in increased activity of NFE2L2 promoter CTD PMID:21643505 copper(II) sulfate decreases expression ISO RGD:734431 6480464 Copper Sulfate results in decreased expression of NFE2L2 mRNA CTD PMID:19549813 copper(II) sulfate multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA] CTD PMID:22003191 corilagin multiple interactions ISO RGD:734432 6480464 corilagin inhibits the reaction [TNFSF11 protein results in decreased expression of NFE2L2 mRNA] CTD PMID:35307913 cortisol multiple interactions ISO RGD:734431 6480464 [Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein] more ... CTD PMID:22606287 , PMID:33476690 cortisol multiple interactions EXP 6480464 [HSD11B1 protein affects the susceptibility to Hydrocortisone] which results in decreased activity of NFE2L2 protein more ... CTD PMID:22606287 cortisone multiple interactions ISO RGD:734431 6480464 [HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein], [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]] CTD PMID:22606287 cortisone multiple interactions EXP 6480464 [HSD11B1 protein affects the susceptibility to Cortisone] which results in decreased activity of NFE2L2 protein CTD PMID:22606287 corynoline multiple interactions ISO RGD:734432 6480464 corynoline promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NFE2L2 protein] CTD PMID:34477289 coumarin affects activity ISO RGD:734432 6480464 coumarin affects the activity of NFE2L2 protein CTD PMID:11309284 coumarin increases activity ISO RGD:734432 6480464 coumarin results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 creatinine multiple interactions ISO RGD:734432 6480464 [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased abundance of Creatinine CTD PMID:28710020 crocin-1 multiple interactions EXP 6480464 crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein], crocin inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 protein] CTD PMID:32259551 , PMID:32920515 crotonaldehyde affects localization ISO RGD:734431 6480464 2-butenal affects the localization of NFE2L2 protein CTD PMID:21238556 crotonaldehyde decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to 2-butenal CTD PMID:21238556 crotonaldehyde multiple interactions ISO RGD:734431 6480464 NFE2L2 protein promotes the reaction [2-butenal results in increased expression of HMOX1 protein] CTD PMID:21238556 cumene hydroperoxide increases response to substance ISO RGD:734431 6480464 NFE2L2 gene mutant form results in increased susceptibility to cumene hydroperoxide CTD PMID:19608619 cumene hydroperoxide affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to cumene hydroperoxide CTD PMID:19303893 cumene hydroperoxide multiple interactions ISO RGD:734431 6480464 [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide, Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide] CTD PMID:19608619 cumene hydroperoxide multiple interactions ISO RGD:734432 6480464 Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide]], NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide] CTD PMID:20932822 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of NFE2L2 mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:734431 6480464 [Curcumin co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA more ... CTD PMID:17449203 more ... curcumin increases expression EXP 6480464 Curcumin analog results in increased expression of NFE2L2 protein, Curcumin results in increased expression of NFE2L2 protein CTD PMID:30946834 curcumin increases expression ISO RGD:734431 6480464 Curcumin results in increased expression of NFE2L2 mRNA, Curcumin results in increased expression of NFE2L2 protein CTD PMID:31521693 curcumin increases activity ISO RGD:734432 6480464 Curcumin results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:31187328 curcumin decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in decreased susceptibility to Curcumin CTD PMID:29571711 curcumin decreases methylation ISO RGD:734432 6480464 Curcumin analog results in decreased methylation of NFE2L2 promoter CTD PMID:26991801 curcumin affects localization ISO RGD:734431 6480464 Curcumin affects the localization of NFE2L2 protein, Curcumin analog affects the localization of NFE2L2 protein CTD PMID:23954767 curcumin increases localization EXP 6480464 Curcumin results in increased localization of NFE2L2 protein CTD PMID:18006204 curcumin affects localization EXP 6480464 Curcumin affects the localization of NFE2L2 protein CTD PMID:17640564 curcumin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] more ... CTD PMID:17640564 more ... curcumin increases expression ISO RGD:734432 6480464 Curcumin analog results in increased expression of NFE2L2 mRNA more ... CTD PMID:18321868 more ... curcumin affects localization ISO RGD:734432 6480464 Curcumin affects the localization of NFE2L2 protein CTD PMID:17535857 more ... curcumin multiple interactions ISO RGD:734432 6480464 [Curcumin co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA more ... CTD PMID:17535857 more ... cyanidin cation increases activity EXP 6480464 cyanidin results in increased activity of NFE2L2 protein CTD PMID:27166148 cyanidin cation affects expression ISO RGD:734432 6480464 cyanidin affects the expression of NFE2L2 protein CTD PMID:26505893 cycloheximide multiple interactions ISO RGD:734431 6480464 [SB 203580 co-treated with Cycloheximide] inhibits the reaction [Quercetin results in decreased expression of NFE2L2 protein] more ... CTD PMID:22019695 more ... cycloheximide decreases expression ISO RGD:734432 6480464 Cycloheximide results in decreased expression of NFE2L2 protein CTD PMID:12441344 more ... cycloheximide multiple interactions ISO RGD:734432 6480464 [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Cycloheximide] results in increased expression of NFE2L2 protein more ... CTD PMID:12441344 more ... cycloheximide decreases expression ISO RGD:734431 6480464 Cycloheximide results in decreased expression of NFE2L2 protein CTD PMID:25896339 cyclophosphamide multiple interactions EXP 6480464 [astaxanthine co-treated with Cyclophosphamide] results in increased expression of NFE2L2 protein, Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 protein] CTD PMID:20038455 , PMID:20433640 cyclophosphamide increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Cyclophosphamide CTD PMID:27633142 cyclophosphamide multiple interactions ISO RGD:734432 6480464 Cyclophosphamide promotes the reaction [NFE2L2 gene mutant form results in decreased expression of CAT protein] more ... CTD PMID:27633142 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of NFE2L2 protein CTD PMID:20038455 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of NFE2L2 protein CTD PMID:20038455 , PMID:20433640 cyclosporin A increases expression ISO RGD:734432 6480464 Cyclosporine results in increased expression of NFE2L2 protein CTD PMID:23958496 cyclosporin A affects activity ISO RGD:734431 6480464 Cyclosporine affects the activity of NFE2L2 protein CTD PMID:25596134 cyclosporin A affects activity EXP 6480464 Cyclosporine affects the activity of NFE2L2 protein CTD PMID:25596134 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of NFE2L2 mRNA, Cyclosporine results in decreased expression of NFE2L2 protein CTD PMID:25596134 , PMID:33710703 cyclosporin A increases expression ISO RGD:734431 6480464 Cyclosporine results in increased expression of NFE2L2 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions EXP 6480464 nilotinib inhibits the reaction [Cyclosporine results in decreased expression of NFE2L2 protein] CTD PMID:33710703 cyfluthrin increases expression ISO RGD:734431 6480464 cyfluthrin results in increased expression of NFE2L2 mRNA CTD PMID:31330490 cyfluthrin multiple interactions ISO RGD:734431 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of NFE2L2 mRNA] CTD PMID:31330490 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA CTD PMID:33396045 cylindrospermopsin increases expression ISO RGD:734432 6480464 cylindrospermopsin results in increased expression of NFE2L2 mRNA CTD PMID:20936652 Cynaropicrin affects localization ISO RGD:734431 6480464 cynaropicrin affects the localization of NFE2L2 protein CTD PMID:25680693 Cynaropicrin increases expression ISO RGD:734431 6480464 cynaropicrin results in increased expression of NFE2L2 mRNA CTD PMID:25680693 Cynaropicrin multiple interactions ISO RGD:734431 6480464 AHR mutant form inhibits the reaction [cynaropicrin affects the localization of NFE2L2 protein] more ... CTD PMID:25680693 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA CTD PMID:33396045 cypermethrin decreases expression ISO RGD:734432 6480464 cypermethrin results in decreased expression of NFE2L2 mRNA, cypermethrin results in decreased expression of NFE2L2 protein CTD PMID:31907151 cypermethrin increases expression ISO RGD:734431 6480464 cypermethrin results in increased expression of NFE2L2 mRNA CTD PMID:32028016 cyproconazole increases activity ISO RGD:734432 6480464 cyproconazole results in increased activity of NFE2L2 protein CTD PMID:30114225 cyproterone acetate increases activity ISO RGD:734432 6480464 Cyproterone Acetate results in increased activity of NFE2L2 protein CTD PMID:30203046 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of NFE2L2 mRNA, Glucose results in decreased expression of NFE2L2 protein CTD PMID:21818840 more ... D-glucose affects localization ISO RGD:734432 6480464 Glucose affects the localization of NFE2L2 protein CTD PMID:33270355 D-glucose increases expression EXP 6480464 Glucose results in increased expression of NFE2L2 mRNA, Glucose results in increased expression of NFE2L2 protein CTD PMID:29211853 D-glucose affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to Glucose CTD PMID:20086057 D-glucose decreases expression ISO RGD:734431 6480464 Glucose results in decreased expression of NFE2L2 mRNA, Glucose results in decreased expression of NFE2L2 protein CTD PMID:21333731 more ... D-glucose multiple interactions ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] more ... CTD PMID:21333731 more ... D-glucose multiple interactions ISO RGD:734432 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]] more ... CTD PMID:17928392 more ... D-glucose increases localization ISO RGD:734432 6480464 Glucose deficiency results in increased localization of NFE2L2 protein CTD PMID:17928392 D-glucose increases expression ISO RGD:734431 6480464 Glucose deficiency results in increased expression of NFE2L2 mRNA more ... CTD PMID:20103708 more ... D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein more ... CTD PMID:20028456 more ... D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of NFE2L2 mRNA CTD PMID:19575532 dapagliflozin multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein] more ... CTD PMID:32259528 , PMID:33412153 dazomet increases activity ISO RGD:734431 6480464 dazomet results in increased activity of NFE2L2 protein CTD PMID:20143881 DDE decreases expression ISO RGD:734431 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA, Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein CTD PMID:25263748 DDE multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:25263748 DDT increases expression ISO RGD:734431 6480464 DDT results in increased expression of NFE2L2 mRNA CTD PMID:31521043 decabromodiphenyl ether decreases expression ISO RGD:734432 6480464 decabromobiphenyl ether results in decreased expression of NFE2L2 protein CTD PMID:31039416 decabromodiphenyl ether multiple interactions ISO RGD:734431 6480464 Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of NFE2L2 protein] CTD PMID:33675858 decabromodiphenyl ether increases expression ISO RGD:734431 6480464 decabromobiphenyl ether results in increased expression of NFE2L2 mRNA, decabromobiphenyl ether results in increased expression of NFE2L2 protein CTD PMID:34571075 decabromodiphenyl ether decreases expression ISO RGD:734431 6480464 decabromobiphenyl ether results in decreased expression of NFE2L2 mRNA, decabromobiphenyl ether results in decreased expression of NFE2L2 protein CTD PMID:33675858 , PMID:35266255 delta-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] CTD PMID:22389237 demethoxycurcumin affects localization ISO RGD:734432 6480464 demethoxycurcumin affects the localization of NFE2L2 protein CTD PMID:17535857 demethoxycurcumin multiple interactions ISO RGD:734432 6480464 [demethoxycurcumin co-treated with bisdemethoxycurcumin] affects the localization of NFE2L2 protein, NFE2L2 protein affects the reaction [demethoxycurcumin results in increased expression of HMOX1 mRNA] CTD PMID:17535857 Dendrobine multiple interactions ISO RGD:734431 6480464 dendrobine promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] more ... CTD PMID:36058301 deoxycholic acid multiple interactions ISO RGD:734431 6480464 [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA, [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA CTD PMID:17724089 deoxycholic acid increases expression ISO RGD:734432 6480464 Deoxycholic Acid results in increased expression of NFE2L2 mRNA CTD PMID:25582706 deoxynivalenol increases activity ISO RGD:734431 6480464 deoxynivalenol analog results in increased activity of NFE2L2 protein, deoxynivalenol results in increased activity of NFE2L2 protein CTD PMID:30244016 deoxynivalenol multiple interactions ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of NFE2L2 mRNA] CTD PMID:34677630 deoxynivalenol increases expression ISO RGD:734431 6480464 deoxynivalenol results in increased expression of NFE2L2 mRNA CTD PMID:34677630 deoxynivalenol increases expression ISO RGD:734432 6480464 deoxynivalenol results in increased expression of NFE2L2 mRNA CTD PMID:34400200 desferrioxamine B multiple interactions ISO RGD:734431 6480464 Deferoxamine inhibits the reaction [Nitroprusside results in decreased expression of NFE2L2 protein] more ... CTD PMID:26945724 , PMID:31066958 desferrioxamine B multiple interactions ISO RGD:734432 6480464 Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] CTD PMID:32416107 desipramine affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Desipramine CTD PMID:21540358 dexamethasone decreases expression ISO RGD:734432 6480464 Dexamethasone results in decreased expression of NFE2L2 mRNA CTD PMID:17627975 dexamethasone affects expression ISO RGD:734432 6480464 Dexamethasone affects the expression of NFE2L2 protein CTD PMID:28940008 dexamethasone multiple interactions ISO RGD:734431 6480464 [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide co-treated with Dexamethasone] affects the localization of NFE2L2 protein more ... CTD PMID:33476690 , PMID:35405071 dexamethasone multiple interactions ISO RGD:734432 6480464 [Dexamethasone co-treated with Arsenic] results in increased activity of NFE2L2 protein more ... CTD PMID:26363199 more ... dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [NFE2L2 protein results in increased expression of GSTA2 mRNA] CTD PMID:15870285 dexmedetomidine multiple interactions EXP 6480464 atipamezole inhibits the reaction [Dexmedetomidine inhibits the reaction [lipopolysaccharide more ... CTD PMID:30597158 dextran sulfate affects response to substance ISO RGD:734432 6480464 NFE2L2 affects the susceptibility to Dextran Sulfate CTD PMID:20404090 dextran sulfate multiple interactions ISO RGD:734432 6480464 [asperuloside co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein more ... CTD PMID:23056183 more ... dextran sulfate decreases expression ISO RGD:734432 6480464 Dextran Sulfate results in decreased expression of NFE2L2 mRNA, Dextran Sulfate results in decreased expression of NFE2L2 protein CTD PMID:23261717 more ... dextromethorphan multiple interactions ISO RGD:734432 6480464 [PRKCD protein affects the susceptibility to Dextromethorphan] which affects the activity of and affects the localization of NFE2L2 protein more ... CTD PMID:34740715 diallyl disulfide multiple interactions EXP 6480464 diallyl disulfide inhibits the reaction [Carbon Tetrachloride results in decreased expression of and affects the localization of NFE2L2 protein] CTD PMID:24293383 diallyl disulfide decreases expression ISO RGD:734432 6480464 diallyl disulfide results in decreased expression of NFE2L2 mRNA CTD PMID:34896185 diallyl disulfide multiple interactions ISO RGD:734432 6480464 diallyl disulfide affects the reaction [lipopolysaccharide more ... CTD PMID:34896185 , PMID:35526736 diallyl disulfide decreases degradation ISO RGD:734432 6480464 diallyl disulfide results in decreased degradation of NFE2L2 protein CTD PMID:34896185 Diallyl sulfide multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [allyl sulfide results in increased expression of NQO1 mRNA] CTD PMID:17353348 Diallyl sulfide multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA], allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 protein] CTD PMID:31585129 diallyl trisulfide increases activity EXP 6480464 diallyl trisulfide results in increased activity of NFE2L2 protein CTD PMID:20237067 diallyl trisulfide increases localization ISO RGD:734432 6480464 diallyl trisulfide results in increased localization of NFE2L2 protein CTD PMID:30317421 diallyl trisulfide multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] more ... CTD PMID:24489685 diallyl trisulfide multiple interactions ISO RGD:734432 6480464 diallyl trisulfide results in increased expression of and affects the localization of NFE2L2 protein, NFE2L2 gene mutant form inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein] CTD PMID:24489685 diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of NFE2L2 mRNA, diallyl trisulfide results in increased expression of NFE2L2 protein CTD PMID:18768114 more ... diallyl trisulfide multiple interactions EXP 6480464 [diallyl trisulfide promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA more ... CTD PMID:20237067 more ... diarsenic trioxide affects localization ISO RGD:734431 6480464 Arsenic Trioxide affects the localization of NFE2L2 protein CTD PMID:19350554 more ... diarsenic trioxide decreases expression ISO RGD:734431 6480464 Arsenic Trioxide results in decreased expression of NFE2L2 protein CTD PMID:22155346 , PMID:27561292 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of NFE2L2 mRNA, Arsenic Trioxide results in increased expression of NFE2L2 protein CTD PMID:27592447 more ... diarsenic trioxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein] more ... CTD PMID:24327821 more ... diarsenic trioxide decreases response to substance ISO RGD:734431 6480464 NFE2L2 mRNA results in decreased susceptibility to Arsenic Trioxide, NFE2L2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22684020 , PMID:26708503 diarsenic trioxide decreases expression ISO RGD:734432 6480464 Arsenic Trioxide results in decreased expression of NFE2L2 protein CTD PMID:24157283 , PMID:33603344 diarsenic trioxide increases expression ISO RGD:734431 6480464 Arsenic Trioxide results in increased expression of NFE2L2 mRNA, Arsenic Trioxide results in increased expression of NFE2L2 protein CTD PMID:22155346 more ... diarsenic trioxide multiple interactions ISO RGD:734431 6480464 [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:19350554 more ... diarsenic trioxide affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:22488045 more ... diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of NFE2L2 mRNA, Arsenic Trioxide results in decreased expression of NFE2L2 protein CTD PMID:24327821 more ... diarsenic trioxide increases expression ISO RGD:734432 6480464 Arsenic Trioxide results in increased expression of NFE2L2 mRNA, Arsenic Trioxide results in increased expression of NFE2L2 protein CTD PMID:22488045 , PMID:26187899 dibenziodolium multiple interactions ISO RGD:734431 6480464 diphenyleneiodonium inhibits the reaction [phenethyl isothiocyanate affects the localization of NFE2L2 protein] CTD PMID:26945724 dibutyl phthalate increases expression ISO RGD:734432 6480464 Dibutyl Phthalate results in increased expression of NFE2L2 mRNA, Dibutyl Phthalate results in increased expression of NFE2L2 protein CTD PMID:21266533 more ... dibutyl phthalate multiple interactions EXP 6480464 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... CTD PMID:30910607 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NFE2L2 protein CTD PMID:30910607 , PMID:35690178 dibutyl phthalate multiple interactions ISO RGD:734432 6480464 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... CTD PMID:28295950 , PMID:30910607 dichloroacetic acid increases expression ISO RGD:734432 6480464 Dichloroacetic Acid results in increased expression of NFE2L2 mRNA CTD PMID:28962523 dichloroacetyl chloride decreases expression ISO RGD:734432 6480464 2 more ... CTD PMID:32073640 dichloroacetyl chloride multiple interactions ISO RGD:734432 6480464 2-tert-butylhydroquinone inhibits the reaction [2 more ... CTD PMID:32073640 dichloromethane multiple interactions ISO RGD:734432 6480464 [[Particulate Matter co-treated with Methylene Chloride] results in increased abundance of Polycyclic Aromatic Hydrocarbons] which affects the expression of NFE2L2 mRNA CTD PMID:29335169 dichloromethane increases expression ISO RGD:734431 6480464 Methylene Chloride results in increased expression of NFE2L2 mRNA CTD PMID:34280354 dichloromethane increases activity ISO RGD:734432 6480464 Methylene Chloride results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 dichlorvos increases activity ISO RGD:734431 6480464 Dichlorvos results in increased activity of NFE2L2 protein CTD PMID:20143881 dichlorvos multiple interactions ISO RGD:734432 6480464 PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 mRNA], PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 protein] CTD PMID:25891459 , PMID:26814074 dichlorvos decreases expression ISO RGD:734432 6480464 Dichlorvos results in decreased expression of NFE2L2 mRNA, Dichlorvos results in decreased expression of NFE2L2 protein CTD PMID:25891459 , PMID:26814074 diclofenac multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [Diclofenac results in increased expression of SRXN1 mRNA] CTD PMID:24752500 diclofenac increases stability ISO RGD:734431 6480464 Diclofenac results in increased stability of NFE2L2 protein CTD PMID:24752500 diethyl maleate multiple interactions ISO RGD:734432 6480464 NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA] more ... CTD PMID:12235164 , PMID:22003191 diethyl maleate increases activity ISO RGD:734432 6480464 diethyl maleate results in increased activity of NFE2L2 protein CTD PMID:30114225 diethyl maleate increases expression ISO RGD:734431 6480464 diethyl maleate results in increased expression of NFE2L2 protein CTD PMID:27358234 diethyl maleate affects localization ISO RGD:734431 6480464 diethyl maleate affects the localization of NFE2L2 protein CTD PMID:27982581 diethyl maleate multiple interactions ISO RGD:734431 6480464 [diethyl maleate co-treated with TNF protein] results in decreased expression of NFE2L2 protein more ... CTD PMID:20806931 more ... diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of NFE2L2 protein CTD PMID:21465251 diethyl maleate decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to diethyl maleate CTD PMID:12235164 diethyl maleate affects localization ISO RGD:734432 6480464 diethyl maleate affects the localization of NFE2L2 protein CTD PMID:12235164 dihydroactinidiolide multiple interactions ISO RGD:734431 6480464 [dihydroactinidiolide co-treated with amyloid beta-protein (25-35)] results in increased expression of NFE2L2 mRNA more ... CTD PMID:33617922 dihydroartemisinin affects localization ISO RGD:734431 6480464 artenimol analog affects the localization of NFE2L2 protein CTD PMID:26340163 dihydrolipoic acid multiple interactions EXP 6480464 [dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA, dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer] CTD PMID:20237067 dihydrolipoic acid increases expression EXP 6480464 dihydrolipoic acid results in increased expression of NFE2L2 protein CTD PMID:20237067 dihydrolipoic acid increases activity EXP 6480464 dihydrolipoic acid results in increased activity of NFE2L2 protein CTD PMID:20237067 dihydroxyacetone increases expression ISO RGD:734431 6480464 Dihydroxyacetone results in increased expression of NFE2L2 protein CTD PMID:32506039 Diisodecyl phthalate multiple interactions ISO RGD:734432 6480464 [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein CTD PMID:27871981 dimethyl fumarate multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTH1 mRNA] more ... CTD PMID:28289076 , PMID:28790194 dimethyl fumarate increases expression ISO RGD:734432 6480464 Dimethyl Fumarate results in increased expression of NFE2L2 protein CTD PMID:29950142 dimethyl fumarate multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of COX3 mRNA] more ... CTD PMID:23942037 more ... dimethyl fumarate affects localization ISO RGD:734431 6480464 Dimethyl Fumarate affects the localization of NFE2L2 protein CTD PMID:27277809 dimethyl sulfoxide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] CTD PMID:26497626 dimethyl sulfoxide multiple interactions EXP 155882543 dimethyl sulfoxide promotes the reaction [ischemia-reperfusion injury increases expression of Nfe2l2 protein in nucleus] RGD dimethyl sulfoxide multiple interactions ISO RGD:734432 6480464 Dimethyl Sulfoxide promotes the reaction [NFE2L2 protein binds to AHR promoter], JDP2 protein affects the reaction [Dimethyl Sulfoxide promotes the reaction [NFE2L2 protein binds to AHR promoter]] CTD PMID:33723743 dimethyl sulfoxide decreases expression EXP 6480464 Dimethyl Sulfoxide results in decreased expression of NFE2L2 protein CTD PMID:26497626 dimethylarsinic acid multiple interactions ISO RGD:734431 6480464 [Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:24161444 , PMID:33434570 dioscin multiple interactions EXP 6480464 dioscin inhibits the reaction [Doxorubicin results in decreased expression of and affects the localization of NFE2L2 protein], NR1H4 protein affects the reaction [dioscin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]] CTD PMID:28082111 dioscin multiple interactions EXP 15090820 dioscin inhibited the reaction [thioacetamide decreased expression of Nfe2L2 protein in liver] RGD diosmetin multiple interactions EXP 6480464 diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFE2L2 protein] more ... CTD PMID:35191607 dioxygen multiple interactions EXP 6480464 [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein more ... CTD PMID:20028456 more ... dioxygen increases expression ISO RGD:734431 6480464 Oxygen deficiency results in increased expression of NFE2L2 mRNA, Oxygen deficiency results in increased expression of NFE2L2 protein CTD PMID:34023435 dioxygen decreases expression ISO RGD:734432 6480464 Oxygen deficiency results in decreased expression of NFE2L2 protein CTD PMID:30096613 dioxygen increases expression ISO RGD:734432 6480464 Oxygen deficiency results in increased expression of NFE2L2 mRNA, Oxygen deficiency results in increased expression of NFE2L2 protein CTD PMID:31610156 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of NFE2L2 mRNA, Oxygen deficiency results in increased expression of NFE2L2 protein CTD PMID:31629700 dioxygen affects localization ISO RGD:734432 6480464 Oxygen affects the localization of NFE2L2 protein CTD PMID:30529165 dioxygen affects response to substance ISO RGD:734432 6480464 [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the susceptibility to Oxygen deficiency, NFE2L2 protein affects the susceptibility to Oxygen CTD PMID:30096613 , PMID:30529165 dioxygen affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Oxygen deficiency CTD PMID:29966676 dioxygen increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Oxygen deficiency CTD PMID:29255069 dioxygen multiple interactions ISO RGD:734431 6480464 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein] more ... CTD PMID:27286880 more ... dioxygen affects expression ISO RGD:734432 6480464 Oxygen deficiency affects the expression of NFE2L2 mRNA, Oxygen deficiency affects the expression of NFE2L2 protein CTD PMID:25448280 dioxygen multiple interactions ISO RGD:734432 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of A4GALT mRNA more ... CTD PMID:25922074 more ... dioxygen decreases expression ISO RGD:734431 6480464 Oxygen deficiency results in decreased expression of NFE2L2 mRNA, Oxygen deficiency results in decreased expression of NFE2L2 protein CTD PMID:25596134 , PMID:31885778 dioxygen affects activity ISO RGD:734431 6480464 Oxygen deficiency affects the activity of NFE2L2 protein CTD PMID:25596134 diprotium oxide multiple interactions ISO RGD:734432 6480464 [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NFE2L2 mRNA CTD PMID:29335169 diquat increases expression ISO RGD:734432 6480464 Diquat results in increased expression of NFE2L2 protein CTD PMID:20826540 diquat decreases expression ISO RGD:734432 6480464 Diquat results in decreased expression of NFE2L2 protein CTD PMID:33475796 diquat increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Diquat CTD PMID:16962985 , PMID:22762311 diquat decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Diquat CTD PMID:23056183 diquat increases activity ISO RGD:734431 6480464 Diquat results in increased activity of NFE2L2 protein CTD PMID:20143881 , PMID:21172416 diquat multiple interactions ISO RGD:734432 6480464 Ascorbic Acid inhibits the reaction [Diquat results in decreased expression of NFE2L2 protein] more ... CTD PMID:20826540 more ... diquat increases activity ISO RGD:734432 6480464 Diquat results in increased activity of NFE2L2 protein CTD PMID:16962985 disodium selenite multiple interactions ISO RGD:734432 6480464 Sodium Selenite promotes the reaction [arsenic acid affects the localization of NFE2L2 protein], Sodium Selenite promotes the reaction [arsenite affects the localization of NFE2L2 protein] CTD PMID:19429247 disodium selenite multiple interactions ISO RGD:734431 6480464 Sodium Selenite affects the reaction [Mercuric Chloride affects the localization of NFE2L2 protein], Sodium Selenite affects the reaction [methylmercuric chloride affects the localization of NFE2L2 protein] CTD PMID:24816296 disodium selenite multiple interactions EXP 6480464 [Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA], Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] CTD PMID:26085057 dithionite(2-) multiple interactions ISO RGD:734431 6480464 [dihydroactinidiolide co-treated with Dithionite] results in increased expression of NFE2L2 mRNA CTD PMID:33617922 diuron increases expression EXP 6480464 Diuron results in increased expression of NFE2L2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:734432 6480464 dorsomorphin inhibits the reaction [amlexanox inhibits the reaction [Acetaminophen results in decreased expression of NFE2L2 protein]] CTD PMID:31697998 dorsomorphin multiple interactions ISO RGD:734431 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:24211276 more ... doxorubicin affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Doxorubicin CTD PMID:19303893 doxorubicin affects localization EXP 6480464 Doxorubicin affects the localization of NFE2L2 protein CTD PMID:30928397 doxorubicin decreases expression ISO RGD:734432 6480464 Doxorubicin results in decreased expression of NFE2L2 mRNA, Doxorubicin results in decreased expression of NFE2L2 protein CTD PMID:29061315 more ... doxorubicin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] more ... CTD PMID:25268985 more ... doxorubicin decreases activity EXP 6480464 Doxorubicin results in decreased activity of NFE2L2 protein CTD PMID:25268985 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of NFE2L2 mRNA, Doxorubicin results in decreased expression of NFE2L2 protein CTD PMID:25169008 more ... doxorubicin increases expression EXP 6480464 [Doxorubicin results in increased expression of NFE2L2 protein] which results in increased expression of GSTP1 mRNA more ... CTD PMID:24211725 more ... doxorubicin decreases expression ISO RGD:734431 6480464 Doxorubicin results in decreased expression of NFE2L2 mRNA, Doxorubicin results in decreased expression of NFE2L2 protein CTD PMID:26969377 , PMID:29803840 doxorubicin decreases response to substance ISO RGD:734431 6480464 NFE2L2 mRNA results in decreased susceptibility to Doxorubicin, NFE2L2 protein results in decreased susceptibility to Doxorubicin CTD PMID:23994249 , PMID:26708503 doxorubicin multiple interactions ISO RGD:734431 6480464 [Doxorubicin co-treated with resveratrol] results in decreased expression of NFE2L2 protein more ... CTD PMID:23994249 more ... doxorubicin increases expression ISO RGD:734432 6480464 Doxorubicin results in increased expression of NFE2L2 mRNA CTD PMID:21040762 more ... doxorubicin multiple interactions ISO RGD:734432 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of NFE2L2 mRNA more ... CTD PMID:21040762 more ... echinacoside multiple interactions ISO RGD:734431 6480464 echinacoside results in increased activity of and affects the localization of NFE2L2 protein CTD PMID:22735309 echinacoside multiple interactions EXP 6480464 [echinacoside co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein CTD PMID:31412289 edaravone affects localization ISO RGD:734432 6480464 Edaravone affects the localization of NFE2L2 protein CTD PMID:25422538 edaravone multiple interactions EXP 6480464 [Edaravone co-treated with Chlorpyrifos] results in increased expression of NFE2L2 protein, Edaravone promotes the reaction [Carbon Monoxide results in increased expression of NFE2L2 protein] CTD PMID:25348283 , PMID:30758894 elemental selenium decreases expression ISO RGD:734431 6480464 Selenium results in decreased expression of NFE2L2 mRNA CTD PMID:19244175 elemental selenium affects activity ISO RGD:734432 6480464 Selenium affects the activity of NFE2L2 protein CTD PMID:18279678 elemental selenium multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] CTD PMID:18279678 elemental selenium multiple interactions ISO RGD:734431 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA CTD PMID:19244175 ellagic acid affects localization ISO RGD:734431 6480464 Ellagic Acid affects the localization of NFE2L2 protein CTD PMID:22386815 ellagic acid increases expression ISO RGD:734432 6480464 Ellagic Acid results in increased expression of NFE2L2 mRNA CTD PMID:30503583 ellagic acid multiple interactions ISO RGD:734432 6480464 Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mRNA] CTD PMID:30503583 ellagic acid increases expression ISO RGD:734431 6480464 Ellagic Acid results in increased expression of NFE2L2 mRNA, Ellagic Acid results in increased expression of NFE2L2 protein CTD PMID:22386815 , PMID:23546295 ellagic acid multiple interactions ISO RGD:734431 6480464 [Paraquat co-treated with Ellagic Acid] results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:23546295 ellagic acid affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Ellagic Acid CTD PMID:22386815 emodin multiple interactions ISO RGD:734432 6480464 Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of NFE2L2 protein], Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of NFE2L2 mRNA] CTD PMID:26139382 emodin affects localization EXP 6480464 Emodin affects the localization of NFE2L2 protein CTD PMID:34971761 emodin multiple interactions EXP 6480464 [[Emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]] which binds to NFE2L2 protein more ... CTD PMID:34971761 enalapril decreases expression EXP 6480464 Enalapril results in decreased expression of NFE2L2 mRNA CTD PMID:18765277 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of NFE2L2 mRNA CTD PMID:31464424 epalrestat multiple interactions ISO RGD:734432 6480464 epalrestat affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:28204799 epalrestat multiple interactions ISO RGD:734431 6480464 epalrestat affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:28204799 epoxiconazole increases activity ISO RGD:734432 6480464 epoxiconazole results in increased activity of NFE2L2 protein CTD PMID:30114225 epoxomicin increases expression ISO RGD:734432 6480464 epoxomicin results in increased expression of NFE2L2 protein CTD PMID:22558124 epoxomicin multiple interactions ISO RGD:734431 6480464 NFE2L2 protein alternative form inhibits the reaction [epoxomicin results in increased expression of CDH1 protein] CTD PMID:35124418 epoxomicin increases expression ISO RGD:734431 6480464 epoxomicin results in increased expression of NFE2L2 protein CTD PMID:22558124 erastin multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] CTD PMID:31323261 erastin increases expression EXP 6480464 erastin results in increased expression of NFE2L2 protein CTD PMID:32937103 erastin multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] CTD PMID:31323261 erastin multiple interactions EXP 6480464 NFE2L2 protein promotes the reaction [erastin results in increased expression of FTH1 protein] more ... CTD PMID:32937103 erdosteine multiple interactions ISO RGD:734432 6480464 erdosteine promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] CTD PMID:26193055 erdosteine multiple interactions EXP 6480464 [erdosteine co-treated with Isoproterenol] results in increased expression of NFE2L2 protein CTD PMID:33210414 ergosta-4,6,8(14),22-tetraen-3-one multiple interactions ISO RGD:734431 6480464 ergosta-4 more ... CTD PMID:28578904 eriodictyol increases expression ISO RGD:734431 6480464 eriodictyol results in increased expression of NFE2L2 protein CTD PMID:16799064 eriodictyol increases expression EXP 6480464 eriodictyol results in increased expression of NFE2L2 mRNA, eriodictyol results in increased expression of NFE2L2 protein CTD PMID:28978146 eriodictyol multiple interactions EXP 6480464 eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA], eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein] CTD PMID:28978146 erythromycin A multiple interactions ISO RGD:734431 6480464 Erythromycin inhibits the reaction [Particulate Matter results in increased activity of NFE2L2 protein], Erythromycin inhibits the reaction [Vehicle Emissions results in increased activity of NFE2L2 protein] CTD PMID:23291319 esculetin increases localization ISO RGD:734431 6480464 esculetin results in increased localization of NFE2L2 protein CTD PMID:20933534 esculetin affects localization ISO RGD:734431 6480464 esculetin affects the localization of NFE2L2 protein CTD PMID:30171828 etacrynic acid multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Ethacrynic Acid] CTD PMID:20932822 etacrynic acid multiple interactions ISO RGD:734431 6480464 Ethacrynic Acid results in increased expression of and affects the localization of NFE2L2 protein, ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]] CTD PMID:26945724 , PMID:35724838 etacrynic acid affects localization ISO RGD:734431 6480464 Ethacrynic Acid affects the localization of NFE2L2 protein CTD PMID:20934533 more ... etacrynic acid affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Ethacrynic Acid CTD PMID:19303893 etacrynic acid increases expression ISO RGD:734431 6480464 Ethacrynic Acid results in increased expression of NFE2L2 protein CTD PMID:20934533 ethanol multiple interactions EXP 6480464 [Dietary Fats co-treated with Ethanol] results in decreased expression of NFE2L2 mRNA more ... CTD PMID:17347304 more ... ethanol affects expression ISO RGD:734432 6480464 Ethanol affects the expression of NFE2L2 protein CTD PMID:35526736 ethanol increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Ethanol CTD PMID:34116071 ethanol increases activity ISO RGD:734432 6480464 Ethanol results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 ethanol decreases expression ISO RGD:734431 6480464 Ethanol results in decreased expression of NFE2L2 mRNA, Ethanol results in decreased expression of NFE2L2 protein CTD PMID:30853489 more ... ethanol increases expression ISO RGD:734432 6480464 Ethanol results in increased expression of NFE2L2 protein CTD PMID:22996800 more ... ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of NFE2L2 mRNA, Ethanol results in decreased expression of NFE2L2 protein CTD PMID:26460608 more ... ethanol decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Ethanol CTD PMID:23994065 ethanol increases expression ISO RGD:734431 6480464 Ethanol results in increased expression of NFE2L2 protein CTD PMID:23994065 ethanol multiple interactions ISO RGD:734432 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] more ... CTD PMID:22552773 more ... ethanol multiple interactions ISO RGD:734431 6480464 [[Ethanol affects the activity of CYP2E1 protein] which affects the localization of NFE2L2 protein] which results in increased expression of CYP2A6 more ... CTD PMID:22484158 more ... ethanol affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to Ethanol CTD PMID:22627062 , PMID:30248482 ethanol decreases expression ISO RGD:734432 6480464 Ethanol results in decreased expression of NFE2L2 mRNA CTD PMID:15513904 , PMID:34995708 ethanol affects localization ISO RGD:734431 6480464 Ethanol affects the localization of NFE2L2 protein CTD PMID:17433488 , PMID:22530035 ethionamide multiple interactions ISO RGD:734431 6480464 NFE2L2 mRNA promotes the reaction [Ethionamide results in increased susceptibility to arsenic trioxide] CTD PMID:26708503 ethoxyquin multiple interactions ISO RGD:734431 6480464 NFE2L2 protein promotes the reaction [Ethoxyquin results in increased expression of AKR1B10 mRNA] CTD PMID:21277289 ethoxyquin affects activity ISO RGD:734432 6480464 Ethoxyquin affects the activity of NFE2L2 protein CTD PMID:11309284 ethoxyquin multiple interactions ISO RGD:734432 6480464 [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA more ... CTD PMID:15833929 , PMID:15919853 Ethyl phenylglycidate decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to ethyl 3-phenylglycidate CTD PMID:20932822 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:734431 6480464 Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]] more ... CTD PMID:21443188 ethylene glycol dimethacrylate multiple interactions ISO RGD:734431 6480464 NFE2L2 mRNA promotes the reaction [ethylene dimethacrylate results in increased expression of HMOX1 mRNA] CTD PMID:26244607 etoposide decreases response to substance ISO RGD:734431 6480464 NFE2L2 mRNA results in decreased susceptibility to Etoposide, NFE2L2 protein results in decreased susceptibility to Etoposide CTD PMID:26708503 , PMID:33148531 etoposide multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [Etoposide results in increased expression of SRXN1 protein] more ... CTD PMID:27982581 , PMID:33148531 eugenol affects expression ISO RGD:734431 6480464 Eugenol affects the expression of NFE2L2 protein CTD PMID:17275817 eugenol decreases expression ISO RGD:734431 6480464 Eugenol results in decreased expression of NFE2L2 mRNA CTD PMID:31967339 eugenol multiple interactions ISO RGD:734431 6480464 Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA] CTD PMID:17275817 falcarindiol multiple interactions EXP 6480464 falcarindiol inhibits the reaction [KEAP1 protein results in decreased activity of NFE2L2 protein] CTD PMID:20026152 farrerol affects localization ISO RGD:734432 6480464 farrerol affects the localization of NFE2L2 protein CTD PMID:26111761 farrerol multiple interactions ISO RGD:734432 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [farrerol affects the localization of NFE2L2 protein] more ... CTD PMID:26111761 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein CTD PMID:18775883 fenofibrate increases activity ISO RGD:734432 6480464 Fenofibrate results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 fenofibrate multiple interactions ISO RGD:734432 6480464 Fenofibrate inhibits the reaction [triptolide results in increased expression of NFE2L2 mRNA], Fenofibrate inhibits the reaction [triptolide results in increased expression of NFE2L2 protein] CTD PMID:31241159 fenofibrate multiple interactions ISO RGD:734431 6480464 Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein] CTD PMID:32730863 fenofibrate affects activity EXP 6480464 Fenofibrate affects the activity of NFE2L2 protein CTD PMID:25596134 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of NFE2L2 mRNA CTD PMID:25596134 fenofibrate affects activity ISO RGD:734431 6480464 Fenofibrate affects the activity of NFE2L2 protein CTD PMID:25596134 fenpyroximate increases activity ISO RGD:734431 6480464 fenpyroximate results in increased activity of NFE2L2 protein CTD PMID:30818834 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA CTD PMID:33396045 ferroheme b multiple interactions ISO RGD:734431 6480464 NFE2L2 mutant form inhibits the reaction [Heme results in increased expression of HMOX1 mRNA] CTD PMID:10874044 ferrostatin-1 multiple interactions ISO RGD:734432 6480464 ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] CTD PMID:32416107 ferulic acid multiple interactions ISO RGD:734432 6480464 ferulic acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mRNA] CTD PMID:30503583 ferulic acid increases expression ISO RGD:734432 6480464 ferulic acid results in increased expression of NFE2L2 mRNA CTD PMID:30503583 fisetin increases expression ISO RGD:734431 6480464 fisetin results in increased expression of NFE2L2 protein CTD PMID:16799064 fisetin multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [fisetin results in decreased expression of MMP2 protein] more ... CTD PMID:30076913 flufenacet increases activity ISO RGD:734431 6480464 FOE 5043 results in increased activity of NFE2L2 protein CTD PMID:20143881 fluoranthene multiple interactions ISO RGD:734432 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFE2L2 mRNA CTD PMID:28329830 fluorescein 5-isothiocyanate multiple interactions ISO RGD:734432 6480464 [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein CTD PMID:27871981 fluoxastrobin increases activity ISO RGD:734431 6480464 fluoxastrobin results in increased activity of NFE2L2 protein CTD PMID:30818834 flutamide affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Flutamide CTD PMID:21540358 flutamide increases expression EXP 6480464 Flutamide results in increased expression of NFE2L2 mRNA CTD PMID:24136188 fluvastatin multiple interactions EXP 6480464 Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein] more ... CTD PMID:35465754 folic acid multiple interactions ISO RGD:734432 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NFE2L2 mRNA CTD PMID:22206623 folic acid multiple interactions ISO RGD:734431 6480464 [Folic Acid co-treated with Arsenic] results in increased expression of NFE2L2 mRNA CTD PMID:35490796 formaldehyde multiple interactions ISO RGD:734432 6480464 [Formaldehyde co-treated with epigallocatechin gallate] results in increased expression of NFE2L2 protein CTD PMID:30395894 formetanate increases activity ISO RGD:734431 6480464 formetanate results in increased activity of NFE2L2 protein CTD PMID:20143881 formononetin multiple interactions ISO RGD:734431 6480464 [formononetin co-treated with Hydrogen Peroxide] results in increased expression of NFE2L2 mRNA more ... CTD PMID:34077701 fructose multiple interactions ISO RGD:734432 6480464 Fructose promotes the reaction [PPARD gene mutant form results in increased phosphorylation of NFE2L2 protein], Plant Preparations inhibits the reaction [Fructose results in increased expression of NFE2L2 protein] CTD PMID:27531227 , PMID:29289645 fructose multiple interactions EXP 6480464 [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein] more ... CTD PMID:32259528 fructose multiple interactions ISO RGD:734431 6480464 [Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein, Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein] CTD PMID:32730863 fructose increases expression ISO RGD:734432 6480464 Fructose results in increased expression of NFE2L2 protein CTD PMID:27531227 fulvestrant multiple interactions ISO RGD:734431 6480464 fulvestrant inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] CTD PMID:19781563 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein], fulvestrant inhibits the reaction [Phytoestrogens affects the localization of NFE2L2 protein] CTD PMID:24726523 fumonisin B1 increases expression ISO RGD:734432 6480464 fumonisin B1 results in increased expression of NFE2L2 mRNA CTD PMID:16221962 fumonisin B1 affects expression ISO RGD:734432 6480464 fumonisin B1 affects the expression of NFE2L2 mRNA CTD PMID:35697133 fumonisin B1 multiple interactions ISO RGD:734431 6480464 [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 mRNA more ... CTD PMID:33496827 fumonisin B1 decreases methylation ISO RGD:734431 6480464 fumonisin B1 results in decreased methylation of NFE2L2 promoter CTD PMID:33496827 fumonisin B1 increases expression ISO RGD:734431 6480464 fumonisin B1 results in increased expression of NFE2L2 mRNA, fumonisin B1 results in increased expression of NFE2L2 protein CTD PMID:33496827 fumonisin B1 increases methylation ISO RGD:734431 6480464 fumonisin B1 results in increased methylation of NFE2L2 mRNA CTD PMID:33496827 furan increases activity ISO RGD:734432 6480464 furan results in increased activity of NFE2L2 protein CTD PMID:30203046 furazolidone increases expression ISO RGD:734431 6480464 Furazolidone results in increased expression of NFE2L2 protein CTD PMID:26687534 furazolidone multiple interactions ISO RGD:734431 6480464 CDKN1A mutant form inhibits the reaction [Furazolidone results in increased expression of NFE2L2 protein], CDKN1A protein promotes the reaction [Furazolidone results in increased expression of NFE2L2 protein] CTD PMID:26687534 furosemide decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Furosemide CTD PMID:24813929 furosemide increases localization ISO RGD:734432 6480464 Furosemide results in increased localization of NFE2L2 protein CTD PMID:18078705 Fusaric acid increases phosphorylation ISO RGD:734431 6480464 Fusaric Acid results in increased phosphorylation of NFE2L2 protein CTD PMID:30582969 gadolinium atom multiple interactions ISO RGD:734431 6480464 [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFE2L2 mRNA CTD PMID:34878122 gadolinium trichloride multiple interactions ISO RGD:734431 6480464 [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFE2L2 mRNA CTD PMID:34878122 galactose multiple interactions EXP 6480464 Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein] CTD PMID:25892055 galactose affects localization EXP 6480464 Galactose affects the localization of NFE2L2 protein CTD PMID:25892055 galangin decreases expression ISO RGD:734431 6480464 galangin results in decreased expression of NFE2L2 protein CTD PMID:29113808 galangin multiple interactions EXP 6480464 [Cadmium co-treated with galangin] results in increased expression of NFE2L2 protein CTD PMID:35384154 gallic acid multiple interactions ISO RGD:734431 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein more ... CTD PMID:29061316 , PMID:30853489 gallic acid multiple interactions EXP 6480464 [Gallic Acid co-treated with Dust] results in increased expression of NFE2L2 mRNA, Gallic Acid affects the reaction [[Dietary Fats co-treated with Dust] affects the expression of NFE2L2 mRNA] CTD PMID:33953864 , PMID:34745924 gallocatechin multiple interactions ISO RGD:734431 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein, BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] CTD PMID:29061316 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of NFE2L2 mRNA CTD PMID:17785943 gamma-tocopherol increases expression ISO RGD:734432 6480464 gamma-Tocopherol results in increased expression of NFE2L2 mRNA, gamma-Tocopherol results in increased expression of NFE2L2 protein CTD PMID:19115203 gamma-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] CTD PMID:22389237 Gastrodin multiple interactions ISO RGD:734432 6480464 [gastrodin co-treated with Dietary Fats] results in increased phosphorylation of NFE2L2 protein, gastrodin affects the reaction [Glutamic Acid affects the localization of NFE2L2 protein] CTD PMID:26634892 , PMID:31698019 Gastrodin increases expression ISO RGD:734432 6480464 gastrodin results in increased expression of NFE2L2 protein CTD PMID:31698019 Gastrodin multiple interactions EXP 6480464 gastrodin inhibits the reaction [3, 3'-iminodipropionitrile results in decreased expression of NFE2L2 protein] CTD PMID:31468582 Gastrodin multiple interactions ISO RGD:734431 6480464 [gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein more ... CTD PMID:26634892 gemcitabine decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Gemcitabine CTD PMID:21489257 Genipin multiple interactions ISO RGD:734432 6480464 [Lipopolysaccharides co-treated with genipin] results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 genistein decreases expression ISO RGD:734432 6480464 Genistein results in decreased expression of NFE2L2 mRNA CTD PMID:24967385 genistein multiple interactions ISO RGD:734432 6480464 Genistein inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] CTD PMID:30734460 genistein increases expression ISO RGD:734431 6480464 Genistein results in increased expression of NFE2L2 protein CTD PMID:21573189 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [lead acetate results in decreased expression of NFE2L2 protein] CTD PMID:26797587 genistein increases expression ISO RGD:734432 6480464 Genistein results in increased expression of NFE2L2 mRNA CTD PMID:23295412 , PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NFE2L2 mRNA CTD PMID:30458643 gentamycin multiple interactions EXP 6480464 Cholecalciferol inhibits the reaction [Gentamicins results in decreased expression of NFE2L2 mRNA] CTD PMID:30458643 Geraniin multiple interactions ISO RGD:734432 6480464 Geraniin promotes the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of NFE2L2 protein] CTD PMID:27181634 geraniol increases expression ISO RGD:734431 6480464 geraniol results in increased expression of NFE2L2 mRNA CTD PMID:27683099 geraniol multiple interactions EXP 6480464 geraniol promotes the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA], geraniol promotes the reaction [Doxorubicin results in increased expression of NFE2L2 protein] CTD PMID:34343525 geraniol increases expression EXP 6480464 geraniol results in increased expression of NFE2L2 protein CTD PMID:28334550 ginkgolide B multiple interactions ISO RGD:734432 6480464 ginkgolide B inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NFE2L2 protein] CTD PMID:32976958 ginkgolide B multiple interactions ISO RGD:734431 6480464 ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of and affects the localization of NFE2L2 protein] CTD PMID:32976958 ginsenoside Rb1 multiple interactions ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] more ... CTD PMID:19781563 , PMID:22780686 ginsenoside Rb1 affects localization ISO RGD:734432 6480464 ginsenoside Rb1 affects the localization of NFE2L2 protein CTD PMID:25422538 ginsenoside Rb1 multiple interactions ISO RGD:734432 6480464 [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein CTD PMID:25422538 ginsenoside Rb1 increases expression ISO RGD:734431 6480464 ginsenoside Rb1 results in increased expression of NFE2L2 mRNA CTD PMID:22780686 ginsenoside Rg1 increases expression ISO RGD:734431 6480464 ginsenoside Rg1 results in increased expression of NFE2L2 mRNA CTD PMID:22780686 ginsenoside Rg1 affects localization ISO RGD:734432 6480464 ginsenoside Rg1 affects the localization of NFE2L2 protein CTD PMID:25422538 ginsenoside Rg1 multiple interactions ISO RGD:734432 6480464 [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein more ... CTD PMID:25422538 , PMID:29964319 ginsenoside Rg1 multiple interactions ISO RGD:734431 6480464 [ginsenoside Rg1 co-treated with ginsenoside 20S-protopanaxatriol] results in increased expression of NFE2L2 protein CTD PMID:22780686 Ginsenoside Rh4 multiple interactions ISO RGD:734432 6480464 ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of NFE2L2 mRNA], ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of NFE2L2 protein] CTD PMID:33359794 Ginsenoside Rh4 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]] more ... CTD PMID:33359794 gliclazide multiple interactions EXP 6480464 Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA], Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] CTD PMID:21439372 glucoraphanin affects localization ISO RGD:734431 6480464 glucoraphanin analog affects the localization of NFE2L2 protein CTD PMID:20868228 glucose decreases expression EXP 6480464 Glucose results in decreased expression of NFE2L2 mRNA, Glucose results in decreased expression of NFE2L2 protein CTD PMID:21818840 more ... glucose affects localization ISO RGD:734432 6480464 Glucose affects the localization of NFE2L2 protein CTD PMID:33270355 glucose increases expression EXP 6480464 Glucose results in increased expression of NFE2L2 mRNA, Glucose results in increased expression of NFE2L2 protein CTD PMID:29211853 glucose affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to Glucose CTD PMID:20086057 glucose decreases expression ISO RGD:734431 6480464 Glucose results in decreased expression of NFE2L2 mRNA, Glucose results in decreased expression of NFE2L2 protein CTD PMID:21333731 more ... glucose multiple interactions ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] more ... CTD PMID:21333731 more ... glucose multiple interactions ISO RGD:734432 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]] more ... CTD PMID:17928392 more ... glucose increases localization ISO RGD:734432 6480464 Glucose deficiency results in increased localization of NFE2L2 protein CTD PMID:17928392 glucose increases expression ISO RGD:734431 6480464 Glucose deficiency results in increased expression of NFE2L2 mRNA more ... CTD PMID:20103708 more ... glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein more ... CTD PMID:20028456 more ... glutathione multiple interactions ISO RGD:734431 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein] more ... CTD PMID:16631525 more ... glutathione increases abundance ISO RGD:734432 6480464 NFE2L2 protein results in increased abundance of Glutathione CTD PMID:28219650 glutathione decreases abundance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in decreased abundance of Glutathione CTD PMID:27633142 , PMID:29618784 glutathione affects abundance ISO RGD:734431 6480464 NFE2L2 protein affects the abundance of Glutathione CTD PMID:20124447 glutathione multiple interactions EXP 6480464 NFE2L2 protein inhibits the reaction [triptolide results in decreased abundance of Glutathione] CTD PMID:22820427 glutathione multiple interactions ISO RGD:734432 6480464 [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... CTD PMID:19303893 more ... glutathione increases abundance EXP 6480464 NFE2L2 protein results in increased abundance of Glutathione CTD PMID:16524372 glutathione affects abundance ISO RGD:734432 6480464 NFE2L2 affects the abundance of Glutathione, NFE2L2 protein affects the abundance of Glutathione CTD PMID:11287661 , PMID:19303893 glutathione decreases abundance ISO RGD:734431 6480464 NFE2L2 gene mutant form results in decreased abundance of Glutathione CTD PMID:19608619 Glutathione ethyl ester multiple interactions ISO RGD:734432 6480464 S-ethyl glutathione inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] CTD PMID:17980396 glyburide multiple interactions EXP 6480464 Glyburide inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] CTD PMID:30817903 glycogen multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Streptozocin results in decreased abundance of Glycogen] CTD PMID:20086057 glycyrrhetinate multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] CTD PMID:28414158 glycyrrhetinate increases expression ISO RGD:734432 6480464 Glycyrrhetinic Acid results in increased expression of NFE2L2 CTD PMID:23341968 glycyrrhetinate multiple interactions ISO RGD:734432 6480464 [Glycyrrhetinic Acid results in increased expression of NFE2L2] which results in decreased susceptibility to Carbon Tetrachloride, Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] CTD PMID:23341968 glycyrrhetinic acid increases expression ISO RGD:734432 6480464 Glycyrrhetinic Acid results in increased expression of NFE2L2 CTD PMID:23341968 glycyrrhetinic acid multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] CTD PMID:28414158 glycyrrhetinic acid multiple interactions ISO RGD:734432 6480464 [Glycyrrhetinic Acid results in increased expression of NFE2L2] which results in decreased susceptibility to Carbon Tetrachloride, Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] CTD PMID:23341968 glyphosate decreases expression ISO RGD:734431 6480464 glyphosate results in decreased expression of NFE2L2 mRNA CTD PMID:34748853 gold atom increases activity ISO RGD:734431 6480464 Gold results in increased activity of NFE2L2 promoter CTD PMID:21643505 gold(0) increases activity ISO RGD:734431 6480464 Gold results in increased activity of NFE2L2 promoter CTD PMID:21643505 guggulsterone affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to pregna-4 more ... CTD PMID:22851183 GW 501516 increases activity ISO RGD:734432 6480464 GW 501516 results in increased activity of NFE2L2 protein CTD PMID:30114225 heme b multiple interactions ISO RGD:734431 6480464 NFE2L2 mutant form inhibits the reaction [Heme results in increased expression of HMOX1 mRNA] CTD PMID:10874044 hemin multiple interactions ISO RGD:734431 6480464 [Antineoplastic Agents binds to and results in decreased activity of NFE2L2 protein] inhibits the reaction [Hemin results in increased expression of SESN2 protein] more ... CTD PMID:16959797 more ... hemin increases expression ISO RGD:734431 6480464 Hemin results in increased expression of NFE2L2 protein CTD PMID:31054940 hemin increases expression ISO RGD:734432 6480464 Hemin results in increased expression of NFE2L2 protein CTD PMID:27777014 hemin affects localization ISO RGD:734431 6480464 Hemin affects the localization of NFE2L2 protein CTD PMID:16959797 , PMID:21525764 hemin multiple interactions ISO RGD:734432 6480464 NFE2L2 gene mutant form inhibits the reaction [Hemin results in increased expression of CYP2A5 mRNA], NFE2L2 protein affects the reaction [Hemin results in increased expression of HMOX1 mRNA] CTD PMID:10473555 , PMID:22859313 hemin multiple interactions EXP 6480464 [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein more ... CTD PMID:23272707 more ... hemin decreases expression EXP 6480464 Hemin results in decreased expression of NFE2L2 protein CTD PMID:25824035 hemin increases expression EXP 6480464 Hemin results in increased expression of NFE2L2 protein CTD PMID:25824035 heparin increases expression ISO RGD:734431 6480464 Heparin analog results in increased expression of NFE2L2 mRNA CTD PMID:26476401 hesperetin multiple interactions ISO RGD:734432 6480464 hesperetin inhibits the reaction [Benzo(a)pyrene results in decreased expression of NFE2L2 protein], hesperetin promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] CTD PMID:26546711 , PMID:31153982 hesperetin increases expression ISO RGD:734431 6480464 hesperetin results in increased expression of NFE2L2 protein CTD PMID:31153982 hesperetin multiple interactions ISO RGD:734431 6480464 [Cisplatin co-treated with hesperetin] results in increased expression of NFE2L2 protein CTD PMID:31153982 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:28935427 more ... hexachlorobenzene multiple interactions ISO RGD:734432 6480464 [Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein CTD PMID:28634113 hexadecanoic acid multiple interactions ISO RGD:734432 6480464 [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NFE2L2 mRNA, FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NFE2L2 mRNA] CTD PMID:26847930 hexadecanoic acid multiple interactions ISO RGD:734431 6480464 [Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein more ... CTD PMID:32730863 , PMID:32976958 homocysteine affects localization ISO RGD:734431 6480464 Homocysteine affects the localization of NFE2L2 protein modified form CTD PMID:22964297 homocysteine multiple interactions ISO RGD:734432 6480464 acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein] more ... CTD PMID:22964297 homocysteine multiple interactions ISO RGD:734431 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein], Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein CTD PMID:22964297 homocysteine increases expression ISO RGD:734431 6480464 Homocysteine results in increased expression of NFE2L2 mRNA CTD PMID:22964297 homoeriodictyol multiple interactions ISO RGD:734431 6480464 homoeriodictyol results in increased expression of and results in increased localization of NFE2L2 protein more ... CTD PMID:29902531 hydrogen chloride increases localization EXP 6480464 Hydrochloric Acid results in increased localization of NFE2L2 protein CTD PMID:18617559 hydrogen chloride multiple interactions ISO RGD:734432 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Hydrochloric Acid] which results in increased expression of CAR3 mRNA more ... CTD PMID:29618784 hydrogen chloride increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Hydrochloric Acid CTD PMID:29618784 hydrogen peroxide increases localization ISO RGD:734431 6480464 Hydrogen Peroxide results in increased localization of NFE2L2 protein CTD PMID:22021338 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of NFE2L2 protein CTD PMID:34047419 hydrogen peroxide affects localization ISO RGD:734431 6480464 Hydrogen Peroxide affects the localization of NFE2L2 protein CTD PMID:32980322 more ... hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA CTD PMID:29992723 hydrogen peroxide increases expression ISO RGD:734432 6480464 Hydrogen Peroxide results in increased expression of NFE2L2 protein CTD PMID:29950142 , PMID:31194955 hydrogen peroxide decreases expression ISO RGD:734431 6480464 Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA, Hydrogen Peroxide results in decreased expression of NFE2L2 protein CTD PMID:21573189 more ... hydrogen peroxide affects localization EXP 6480464 Hydrogen Peroxide affects the localization of NFE2L2 protein CTD PMID:24437944 , PMID:31412289 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of NFE2L2 protein CTD PMID:22606287 hydrogen peroxide increases activity EXP 6480464 Hydrogen Peroxide results in increased activity of NFE2L2 protein CTD PMID:22606287 hydrogen peroxide multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein more ... CTD PMID:22606287 more ... hydrogen peroxide increases expression ISO RGD:734431 6480464 Hydrogen Peroxide results in increased expression of NFE2L2 mRNA, Hydrogen Peroxide results in increased expression of NFE2L2 protein CTD PMID:23410634 more ... hydrogen peroxide affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Hydrogen Peroxide CTD PMID:19303893 hydrogen peroxide decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to Hydrogen Peroxide CTD PMID:18367636 hydrogen peroxide multiple interactions ISO RGD:734432 6480464 1 more ... CTD PMID:18367636 more ... hydrogen peroxide affects expression ISO RGD:734431 6480464 Hydrogen Peroxide affects the expression of NFE2L2 mRNA, Hydrogen Peroxide affects the expression of NFE2L2 protein CTD PMID:20044591 , PMID:30703377 hydrogen peroxide decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:17360324 hydrogen peroxide multiple interactions ISO RGD:734431 6480464 4-((alpha-L-rhamnosyloxy)benzyl)isothiocyanate inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:14567983 more ... hydrogen sulfide increases expression ISO RGD:734432 6480464 Hydrogen Sulfide results in increased expression of NFE2L2 protein CTD PMID:29932956 hydrogen sulfide multiple interactions EXP 6480464 [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat promotes the reaction [KEAP1 protein binds to NFE2L2 protein]] more ... CTD PMID:32064027 hydroquinone increases activity ISO RGD:734431 6480464 hydroquinone results in increased activity of NFE2L2 promoter CTD PMID:21643505 hydroquinone decreases expression ISO RGD:734431 6480464 hydroquinone results in decreased expression of NFE2L2 mRNA CTD PMID:31967339 hydroquinone increases expression ISO RGD:734432 6480464 hydroquinone results in increased expression of NFE2L2 mRNA, hydroquinone results in increased expression of NFE2L2 protein CTD PMID:23290930 hydroquinone multiple interactions ISO RGD:734432 6480464 NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein] CTD PMID:23290930 hydroquinone increases expression ISO RGD:734431 6480464 hydroquinone results in increased expression of NFE2L2 protein CTD PMID:28645578 more ... hydroquinone multiple interactions ISO RGD:734431 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of NFE2L2 protein] more ... CTD PMID:21059386 more ... hydroquinone O-beta-D-glucopyranoside multiple interactions EXP 6480464 Arbutin inhibits the reaction [Ethanol results in decreased expression of NFE2L2 mRNA] CTD PMID:34346143 hydroquinones decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Hydroquinones CTD PMID:20932822 hydroxyurea decreases expression ISO RGD:734431 6480464 Hydroxyurea results in decreased expression of NFE2L2 mRNA CTD PMID:34748853 hypochlorous acid multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] CTD PMID:18156441 hypochlorous acid increases expression ISO RGD:734432 6480464 Hypochlorous Acid results in increased expression of NFE2L2 protein CTD PMID:17980396 hypochlorous acid multiple interactions ISO RGD:734432 6480464 Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] more ... CTD PMID:17980396 hypochlorous acid affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Hypochlorous Acid CTD PMID:18156441 hypochlorous acid increases expression ISO RGD:734431 6480464 Hypochlorous Acid results in increased expression of NFE2L2 mRNA CTD PMID:18156441 iberin increases expression EXP 6480464 iberin results in increased expression of NFE2L2 protein CTD PMID:22664424 ibuprofen increases expression ISO RGD:734431 6480464 Ibuprofen results in increased expression of NFE2L2 mRNA CTD PMID:25596134 ibuprofen affects activity ISO RGD:734431 6480464 Ibuprofen affects the activity of NFE2L2 protein CTD PMID:25596134 ifosfamide affects activity ISO RGD:734431 6480464 Ifosfamide affects the activity of NFE2L2 protein CTD PMID:25596134 ifosfamide multiple interactions EXP 6480464 morin inhibits the reaction [Ifosfamide results in decreased expression of NFE2L2 protein] CTD PMID:31722249 ifosfamide decreases expression EXP 6480464 Ifosfamide results in decreased expression of NFE2L2 protein CTD PMID:31722249 imperatorin affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to imperatorin CTD PMID:19150646 indirubin increases expression EXP 6480464 indirubin results in increased expression of NFE2L2 mRNA CTD PMID:20951181 indole-3-methanol decreases activity ISO RGD:734431 6480464 indole-3-carbinol results in decreased activity of NFE2L2 protein CTD PMID:16082211 indole-3-methanol multiple interactions ISO RGD:734431 6480464 [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in increased expression of NFE2L2 mRNA CTD PMID:32070777 indole-3-methanol multiple interactions ISO RGD:734432 6480464 indole-3-carbinol inhibits the reaction [Doxorubicin affects the expression of and affects the localization of NFE2L2 protein] CTD PMID:29775573 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA more ... CTD PMID:22129741 , PMID:28619389 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of NFE2L2 mRNA CTD PMID:21396975 indole-3-methanol affects activity ISO RGD:734432 6480464 indole-3-carbinol affects the activity of NFE2L2 protein CTD PMID:11309284 indolin-2-one multiple interactions ISO RGD:734431 6480464 2-oxindole results in decreased ubiquitination of and results in decreased degradation of NFE2L2 protein, 2-oxindole results in increased activity of and results in increased expression of and results in increased stability of NFE2L2 protein CTD PMID:22245129 indoline multiple interactions EXP 6480464 [Thiazoles analog binds to indoline analog] inhibits the reaction [SESN2 protein promotes the reaction [Hydrogen Peroxide results in increased activity of NFE2L2 protein]] more ... CTD PMID:32275923 , PMID:34351043 indometacin affects localization EXP 6480464 Indomethacin affects the localization of NFE2L2 protein CTD PMID:25110317 indometacin multiple interactions ISO RGD:734432 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased activity of NFE2L2 protein CTD PMID:33412187 indometacin multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA], Silymarin inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA] CTD PMID:28648817 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of NFE2L2 mRNA CTD PMID:28648817 indometacin increases localization ISO RGD:734431 6480464 Indomethacin results in increased localization of NFE2L2 protein CTD PMID:11909699 indometacin multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] more ... CTD PMID:11909699 inositol multiple interactions EXP 6480464 Inositol inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] CTD PMID:35243728 iodoform increases activity ISO RGD:734432 6480464 iodoform results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 ionomycin increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Ionomycin CTD PMID:12842875 ionomycin multiple interactions ISO RGD:734431 6480464 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NFE2L2 protein CTD PMID:24632381 ionomycin decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Ionomycin CTD PMID:12842875 irinotecan increases expression ISO RGD:734431 6480464 Irinotecan results in increased expression of NFE2L2 mRNA CTD PMID:34699766 irinotecan multiple interactions ISO RGD:734431 6480464 Luteolin inhibits the reaction [Irinotecan results in increased expression of NFE2L2 mRNA] more ... CTD PMID:34699766 iron atom multiple interactions EXP 6480464 [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA, leonurine promotes the reaction [Iron affects the localization of NFE2L2 protein] CTD PMID:20302851 , PMID:35247364 iron atom affects localization EXP 6480464 Iron affects the localization of NFE2L2 protein CTD PMID:35247364 iron atom multiple interactions ISO RGD:734431 6480464 [Particulate Matter results in increased abundance of Iron] which affects the localization of NFE2L2 protein, [Particulate Matter results in increased abundance of Iron] which results in increased expression of NFE2L2 mRNA CTD PMID:26419736 iron atom increases activity ISO RGD:734431 6480464 Iron results in increased activity of NFE2L2 promoter CTD PMID:21643505 iron atom multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [SLC40A1 protein results in increased export of Iron] CTD PMID:21303654 iron dichloride multiple interactions ISO RGD:734432 6480464 ferrous chloride results in increased expression of and affects the localization of NFE2L2 protein CTD PMID:27037625 iron dichloride increases expression ISO RGD:734432 6480464 ferrous chloride results in increased expression of NFE2L2 mRNA CTD PMID:27037625 iron trichloride multiple interactions ISO RGD:734431 6480464 ferric chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein], ferric chloride promotes the reaction [hydroquinone results in increased expression of NFE2L2 protein] CTD PMID:28645578 iron(0) multiple interactions EXP 6480464 [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA, leonurine promotes the reaction [Iron affects the localization of NFE2L2 protein] CTD PMID:20302851 , PMID:35247364 iron(0) affects localization EXP 6480464 Iron affects the localization of NFE2L2 protein CTD PMID:35247364 iron(0) multiple interactions ISO RGD:734431 6480464 [Particulate Matter results in increased abundance of Iron] which affects the localization of NFE2L2 protein, [Particulate Matter results in increased abundance of Iron] which results in increased expression of NFE2L2 mRNA CTD PMID:26419736 iron(0) multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [SLC40A1 protein results in increased export of Iron] CTD PMID:21303654 iron(0) increases activity ISO RGD:734431 6480464 Iron results in increased activity of NFE2L2 promoter CTD PMID:21643505 iron(2+) sulfate (anhydrous) multiple interactions ISO RGD:734431 6480464 ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]], ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein]] CTD PMID:26945724 iron(2+) sulfate (anhydrous) increases expression EXP 6480464 ferrous sulfate results in increased expression of NFE2L2 mRNA CTD PMID:28583816 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 mRNA] more ... CTD PMID:28583816 iron(III) citrate multiple interactions ISO RGD:734431 6480464 trigonelline inhibits the reaction [ferric citrate affects the localization of NFE2L2 protein] CTD PMID:29959986 iron(III) citrate affects localization ISO RGD:734431 6480464 ferric citrate affects the localization of NFE2L2 protein CTD PMID:29959986 iron(III) nitrilotriacetate affects localization ISO RGD:734432 6480464 ferric nitrilotriacetate affects the localization of NFE2L2 protein CTD PMID:18617210 isoflurane multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [trilobatin inhibits the reaction [Isoflurane results in decreased activity of CAT protein]], trilobatin promotes the reaction [Isoflurane results in increased expression of NFE2L2 protein] CTD PMID:32663520 isoflurane increases expression ISO RGD:734432 6480464 Isoflurane results in increased expression of NFE2L2 protein CTD PMID:32663520 isoimperatorin affects localization EXP 6480464 isoimperatorin affects the localization of NFE2L2 protein CTD PMID:16829687 isoniazide increases expression ISO RGD:734432 6480464 Isoniazid results in increased expression of NFE2L2 mRNA CTD PMID:33771660 isoniazide multiple interactions EXP 6480464 chrysin inhibits the reaction [Isoniazid results in increased expression of NFE2L2 mRNA] CTD PMID:33121995 isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of NFE2L2 mRNA CTD PMID:33121995 isoniazide increases activity ISO RGD:734432 6480464 Isoniazid results in increased activity of NFE2L2 protein CTD PMID:30203046 isophorone diisocyanate affects response to substance ISO RGD:734432 6480464 NFE2L2 affects the susceptibility to isophorone diisocyanate CTD PMID:23564646 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of NFE2L2 mRNA, Isoproterenol results in decreased expression of NFE2L2 protein CTD PMID:28266775 more ... isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of NFE2L2 mRNA, Isoproterenol results in increased expression of NFE2L2 protein CTD PMID:35430261 isoprenaline multiple interactions EXP 6480464 [erdosteine co-treated with Isoproterenol] results in increased expression of NFE2L2 protein more ... CTD PMID:30303030 more ... isorhamnetin affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to 3-methylquercetin CTD PMID:24211276 isorhamnetin increases activity ISO RGD:734432 6480464 3-methylquercetin results in increased activity of NFE2L2 protein CTD PMID:24211276 isorhamnetin affects response to substance ISO RGD:734432 6480464 NFE2L2 protein affects the susceptibility to 3-methylquercetin CTD PMID:24211276 isorhamnetin multiple interactions ISO RGD:734431 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] more ... CTD PMID:24211276 , PMID:27151496 isorhamnetin affects localization ISO RGD:734431 6480464 3-methylquercetin affects the localization of NFE2L2 protein CTD PMID:27151496 isorhamnetin multiple interactions ISO RGD:734432 6480464 [3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein more ... CTD PMID:24211276 isothiocyanate increases activity ISO RGD:734432 6480464 Isothiocyanates results in increased activity of NFE2L2 protein CTD PMID:15570060 kaempferol multiple interactions ISO RGD:734431 6480464 [kaempferol co-treated with Quercetin] results in increased expression of NFE2L2 mRNA, kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] CTD PMID:21256954 , PMID:25111660 kaempferol multiple interactions EXP 6480464 kaempferol inhibits the reaction [Chlorpyrifos results in decreased expression of NFE2L2 mRNA] CTD PMID:30497708 kaempferol multiple interactions ISO RGD:734432 6480464 kaempferol affects the reaction [propacetamol affects the expression of NFE2L2 protein] CTD PMID:29574133 kaempferol increases expression ISO RGD:734431 6480464 kaempferol results in increased expression of NFE2L2 mRNA CTD PMID:21256954 , PMID:25111660 kahweol multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [[cafestol co-treated with kahweol] results in decreased susceptibility to Acrolein], NFE2L2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA] CTD PMID:18028974 kahweol multiple interactions ISO RGD:734431 6480464 NFE2L2 protein affects the reaction [kahweol results in increased expression of HMOX1 protein] CTD PMID:31306736 kahweol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] CTD PMID:17110534 kainic acid affects localization ISO RGD:734432 6480464 Kainic Acid affects the localization of NFE2L2 protein CTD PMID:18619545 ketanserin multiple interactions ISO RGD:734431 6480464 Ketanserin inhibits the reaction [Tobacco Smoke Pollution affects the localization of NFE2L2 protein] CTD PMID:22048642 ketoconazole multiple interactions ISO RGD:734431 6480464 [Ketoconazole results in increased activity of AHR protein] which results in increased activity of and results in increased localization of NFE2L2 protein more ... CTD PMID:21753779 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of NFE2L2 protein CTD PMID:31168027 ketoconazole multiple interactions EXP 6480464 [Ketoconazole co-treated with Carbon Tetrachloride] results in increased expression of NFE2L2 protein CTD PMID:31168027 ketoconazole increases expression ISO RGD:734431 6480464 Ketoconazole results in increased expression of NFE2L2 mRNA, Ketoconazole results in increased expression of NFE2L2 protein CTD PMID:21753779 kresoxim-methyl increases activity ISO RGD:734431 6480464 kresoxim-methyl results in increased activity of NFE2L2 protein CTD PMID:30818834 KT 5823 multiple interactions ISO RGD:734431 6480464 KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA], KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] CTD PMID:27774770 L-1,4-dithiothreitol multiple interactions ISO RGD:734431 6480464 Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] CTD PMID:24489685 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein] more ... CTD PMID:22008531 more ... L-ascorbic acid multiple interactions ISO RGD:734432 6480464 Ascorbic Acid inhibits the reaction [Diquat results in decreased expression of NFE2L2 protein] CTD PMID:33475796 L-ascorbic acid increases expression ISO RGD:734431 6480464 Ascorbic Acid results in increased expression of NFE2L2 mRNA, Ascorbic Acid results in increased expression of NFE2L2 protein CTD PMID:31610155 L-ascorbic acid affects localization EXP 6480464 Ascorbic Acid affects the localization of NFE2L2 protein CTD PMID:23027624 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of NFE2L2 protein CTD PMID:22008531 , PMID:23027624 L-ascorbic acid multiple interactions ISO RGD:734431 6480464 [lead acetate results in increased abundance of Lead] inhibits the reaction [Ascorbic Acid results in increased expression of NFE2L2 protein] more ... CTD PMID:21199573 more ... L-glutamic acid multiple interactions ISO RGD:734431 6480464 [dihydroactinidiolide co-treated with Glutamic Acid] results in increased expression of NFE2L2 mRNA CTD PMID:33617922 L-glutamic acid affects localization ISO RGD:734432 6480464 Glutamic Acid affects the localization of NFE2L2 protein CTD PMID:31698019 L-glutamic acid multiple interactions ISO RGD:734432 6480464 gastrodin affects the reaction [Glutamic Acid affects the localization of NFE2L2 protein] CTD PMID:31698019 L-methionine multiple interactions ISO RGD:734432 6480464 [Methionine deficiency co-treated with Choline deficiency] affects the localization of NFE2L2 protein more ... CTD PMID:20350562 lactacystin increases expression ISO RGD:734431 6480464 lactacystin results in increased expression of NFE2L2 protein CTD PMID:12446695 lactacystin decreases degradation EXP 6480464 lactacystin results in decreased degradation of NFE2L2 protein CTD PMID:26598004 lactacystin increases expression ISO RGD:734432 6480464 lactacystin results in increased expression of NFE2L2 protein CTD PMID:12441344 , PMID:15322212 lactacystin multiple interactions ISO RGD:734432 6480464 lactacystin promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] CTD PMID:12441344 lactacystin multiple interactions EXP 6480464 lactacystin promotes the reaction [manganese chloride affects the localization of and results in increased activity of NFE2L2 protein], lactacystin promotes the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] CTD PMID:21384399 lactulose multiple interactions EXP 6480464 Lactulose promotes the reaction [Methamphetamine results in increased expression of NFE2L2 mRNA] CTD PMID:30450033 lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of NFE2L2 mRNA CTD PMID:28412091 lansoprazole multiple interactions EXP 6480464 Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA] more ... CTD PMID:19628634 , PMID:28412091 lansoprazole increases phosphorylation EXP 6480464 Lansoprazole results in increased phosphorylation of NFE2L2 protein CTD PMID:19628634 lapatinib increases activity ISO RGD:734431 6480464 lapatinib metabolite results in increased activity of NFE2L2 protein CTD PMID:26958860 lapatinib multiple interactions ISO RGD:734431 6480464 [CYP3A4 protein results in increased metabolism of lapatinib] which results in increased activity of NFE2L2 protein, [CYP3A5 protein results in increased metabolism of lapatinib] which results in increased activity of NFE2L2 protein CTD PMID:26958860 lawsone decreases expression ISO RGD:734431 6480464 lawsone results in decreased expression of NFE2L2 mRNA CTD PMID:31967339 lead diacetate multiple interactions EXP 6480464 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein] more ... CTD PMID:23274417 more ... lead diacetate multiple interactions ISO RGD:734432 6480464 Fatty Acids more ... CTD PMID:35527006 lead diacetate increases activity ISO RGD:734432 6480464 lead acetate results in increased activity of NFE2L2 protein CTD PMID:30114225 lead diacetate increases expression ISO RGD:734431 6480464 lead acetate results in increased expression of NFE2L2 mRNA CTD PMID:26498409 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of NFE2L2 mRNA CTD PMID:23274417 , PMID:34051273 lead diacetate multiple interactions ISO RGD:734431 6480464 [lead acetate results in increased abundance of Lead] inhibits the reaction [Ascorbic Acid results in increased expression of NFE2L2 protein] more ... CTD PMID:26498409 more ... lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of NFE2L2 mRNA, lead acetate results in decreased expression of NFE2L2 protein CTD PMID:26797587 , PMID:33862172 lead(0) increases expression ISO RGD:734432 6480464 Lead results in increased expression of NFE2L2 mRNA CTD PMID:16243960 lead(0) increases localization ISO RGD:734431 6480464 Lead results in increased localization of NFE2L2 protein CTD PMID:31756223 lead(0) multiple interactions ISO RGD:734431 6480464 [lead acetate results in increased abundance of Lead] inhibits the reaction [Ascorbic Acid results in increased expression of NFE2L2 protein] more ... CTD PMID:31610155 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of NFE2L2 protein CTD PMID:29630945 lead(0) multiple interactions EXP 6480464 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein] more ... CTD PMID:29630945 , PMID:30476502 lead(0) increases activity ISO RGD:734431 6480464 Lead results in increased activity of NFE2L2 promoter CTD PMID:21643505 lead(0) multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Lead results in increased expression of GSTA1 mRNA], NFE2L2 protein affects the reaction [Lead results in increased expression of NQO1 mRNA] CTD PMID:16243960 lead(2+) increases activity ISO RGD:734431 6480464 Lead results in increased activity of NFE2L2 promoter CTD PMID:21643505 lead(2+) increases localization ISO RGD:734431 6480464 Lead results in increased localization of NFE2L2 protein CTD PMID:31756223 lead(2+) multiple interactions ISO RGD:734431 6480464 [lead acetate results in increased abundance of Lead] inhibits the reaction [Ascorbic Acid results in increased expression of NFE2L2 protein] more ... CTD PMID:31610155 lead(2+) multiple interactions EXP 6480464 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein] more ... CTD PMID:29630945 , PMID:30476502 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of NFE2L2 protein CTD PMID:29630945 lead(2+) multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Lead results in increased expression of GSTA1 mRNA], NFE2L2 protein affects the reaction [Lead results in increased expression of NQO1 mRNA] CTD PMID:16243960 lead(2+) increases expression ISO RGD:734432 6480464 Lead results in increased expression of NFE2L2 mRNA CTD PMID:16243960 lead(II) chloride multiple interactions ISO RGD:734432 6480464 [lead chloride affects the localization of NFE2L2 protein] promotes the reaction [NFE2L2 protein binds to CYP2A5 promoter], NFE2L2 protein affects the reaction [lead chloride results in increased expression of CYP2A5 mRNA] CTD PMID:20402460 lead(II) chloride decreases expression ISO RGD:734431 6480464 lead chloride results in decreased expression of NFE2L2 protein CTD PMID:30359721 lead(II) chloride affects localization ISO RGD:734432 6480464 lead chloride affects the localization of NFE2L2 protein CTD PMID:20402460 leflunomide increases expression ISO RGD:734431 6480464 leflunomide results in increased expression of NFE2L2 mRNA CTD PMID:28988120 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of NFE2L2 mRNA CTD PMID:24136188 lenvatinib decreases expression EXP 6480464 lenvatinib results in decreased expression of NFE2L2 mRNA CTD PMID:34019861 Leonurine multiple interactions EXP 6480464 leonurine promotes the reaction [Iron affects the localization of NFE2L2 protein] CTD PMID:35247364 letrozole multiple interactions EXP 6480464 indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein] more ... CTD PMID:28619389 letrozole decreases expression EXP 6480464 letrozole results in decreased expression of NFE2L2 protein CTD PMID:28619389 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of NFE2L2 mRNA CTD PMID:24136188 linagliptin multiple interactions EXP 6480464 indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] more ... CTD PMID:28619389 linalool multiple interactions ISO RGD:734431 6480464 linalool metabolite results in increased expression of and results in increased activity of NFE2L2 protein CTD PMID:29029310 linoleic acid increases expression ISO RGD:734431 6480464 Linoleic Acid metabolite results in increased expression of NFE2L2 protein more ... CTD PMID:26879219 , PMID:28555106 linoleic acid increases expression ISO RGD:734432 6480464 Linoleic Acid metabolite results in increased expression of NFE2L2 protein CTD PMID:26879219 linoleic acid multiple interactions ISO RGD:734431 6480464 NFE2L2 mRNA promotes the reaction [Linoleic Acid metabolite results in increased expression of HMOX1 mRNA] more ... CTD PMID:26879219 , PMID:28555106 linsidomine multiple interactions ISO RGD:734432 6480464 1, 2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to linsidomine] CTD PMID:18367636 linsidomine decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to linsidomine CTD PMID:16092930 linsidomine multiple interactions ISO RGD:734431 6480464 [linsidomine results in increased expression of NFE2L2 protein] which results in decreased susceptibility to Oxidopamine CTD PMID:16092930 linsidomine multiple interactions EXP 6480464 linsidomine results in increased localization of and results in increased activity of NFE2L2 protein CTD PMID:12446173 linsidomine decreases response to substance ISO RGD:734432 6480464 NFE2L2 results in decreased susceptibility to linsidomine CTD PMID:18367636 lipoamide multiple interactions ISO RGD:734431 6480464 lipoamide inhibits the reaction [Acrolein results in decreased expression of NFE2L2 protein] CTD PMID:18258206 lipoic acid multiple interactions ISO RGD:734431 6480464 [Paraquat co-treated with Thioctic Acid] results in increased expression of and affects the localization of NFE2L2 protein more ... CTD PMID:17197552 more ... lipoic acid affects localization ISO RGD:734431 6480464 Thioctic Acid affects the localization of NFE2L2 protein CTD PMID:30758914 lipoic acid increases expression ISO RGD:734431 6480464 Thioctic Acid results in increased expression of NFE2L2 mRNA, Thioctic Acid results in increased expression of NFE2L2 protein CTD PMID:23649336 more ... lipoic acid increases activity EXP 6480464 Thioctic Acid results in increased activity of NFE2L2 protein CTD PMID:20237067 lipoic acid increases expression EXP 6480464 Thioctic Acid results in increased expression of NFE2L2 protein CTD PMID:20237067 lipoic acid multiple interactions EXP 6480464 [Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA more ... CTD PMID:20237067 more ... lipoic acid decreases expression ISO RGD:734432 6480464 Thioctic Acid results in decreased expression of NFE2L2 mRNA, Thioctic Acid results in decreased expression of NFE2L2 protein CTD PMID:22488045 lipoic acid multiple interactions ISO RGD:734432 6480464 [Thioctic Acid co-treated with cyanoginosin LR] results in increased expression of NFE2L2 protein more ... CTD PMID:22488045 more ... lipopolysaccharide increases expression ISO RGD:734432 6480464 Lipopolysaccharides results in increased expression of NFE2L2 protein CTD PMID:26505893 more ... lipopolysaccharide increases activity ISO RGD:734432 6480464 Lipopolysaccharides results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of NFE2L2 protein CTD PMID:22610192 , PMID:28881715 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of NFE2L2 protein CTD PMID:26497626 lipopolysaccharide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] more ... CTD PMID:22610192 more ... lipopolysaccharide decreases expression ISO RGD:734432 6480464 Lipopolysaccharides results in decreased expression of NFE2L2 protein CTD PMID:26363199 lipopolysaccharide multiple interactions ISO RGD:734432 6480464 [Lipopolysaccharides co-treated with cobaltiprotoporphyrin] results in increased expression of NFE2L2 protein more ... CTD PMID:21382476 more ... lipopolysaccharide increases expression ISO RGD:734431 6480464 Lipopolysaccharides results in increased expression of NFE2L2 protein CTD PMID:17959236 lipopolysaccharide decreases expression ISO RGD:734431 6480464 Lipopolysaccharides results in decreased expression of NFE2L2 protein CTD PMID:26497626 lipopolysaccharide multiple interactions ISO RGD:734431 6480464 [Lipopolysaccharides co-treated with Adenosine Triphosphate] affects the localization of NFE2L2 protein more ... CTD PMID:16890772 more ... lipoxin A4 affects localization EXP 6480464 lipoxin A4 affects the localization of NFE2L2 protein CTD PMID:23826208 lipoxin A4 multiple interactions EXP 6480464 lipoxin A4 promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] CTD PMID:23826208 liquiritigenin decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in decreased susceptibility to liquiritigenin CTD PMID:29908794 liquiritigenin multiple interactions EXP 6480464 liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA] CTD PMID:29908794 liquiritin multiple interactions EXP 6480464 liquiritin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA] CTD PMID:29908794 liquiritin decreases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in decreased susceptibility to liquiritin CTD PMID:29908794 liraglutide multiple interactions EXP 6480464 Liraglutide inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] CTD PMID:31362085 lithium atom multiple interactions ISO RGD:734432 6480464 [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein CTD PMID:18619545 lithium atom multiple interactions ISO RGD:734431 6480464 [Lithium Chloride results in increased abundance of Lithium] which affects the localization of NFE2L2 protein, [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of NFE2L2 mRNA CTD PMID:26074776 lithium atom increases activity ISO RGD:734432 6480464 Lithium results in increased activity of NFE2L2 protein CTD PMID:18619545 lithium chloride multiple interactions EXP 6480464 Lithium Chloride affects the reaction [triptolide affects the expression of NFE2L2 protein], Lithium Chloride inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased activity of NFE2L2 protein] CTD PMID:30926361 , PMID:32763437 lithium chloride multiple interactions ISO RGD:734431 6480464 [Lithium Chloride results in increased abundance of Lithium] which affects the localization of NFE2L2 protein, [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of NFE2L2 mRNA CTD PMID:26074776 lithium hydride increases activity ISO RGD:734432 6480464 Lithium results in increased activity of NFE2L2 protein CTD PMID:18619545 lithium hydride multiple interactions ISO RGD:734431 6480464 [Lithium Chloride results in increased abundance of Lithium] which affects the localization of NFE2L2 protein, [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of NFE2L2 mRNA CTD PMID:26074776 lithium hydride multiple interactions ISO RGD:734432 6480464 [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein CTD PMID:18619545 lithocholic acid multiple interactions ISO RGD:734432 6480464 [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA more ... CTD PMID:17724089 more ... lithocholic acid decreases expression ISO RGD:734432 6480464 Lithocholic Acid results in decreased expression of NFE2L2 mRNA, Lithocholic Acid results in decreased expression of NFE2L2 protein CTD PMID:29794447 lithocholic acid decreases response to substance ISO RGD:734431 6480464 NFE2L2 protein results in decreased susceptibility to Lithocholic Acid CTD PMID:17724089 lithocholic acid multiple interactions ISO RGD:734431 6480464 [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of FTL mRNA more ... CTD PMID:17724089 more ... loganin affects expression ISO RGD:734432 6480464 loganin affects the expression of NFE2L2 protein CTD PMID:21864639 losartan decreases expression EXP 6480464 Losartan results in decreased expression of NFE2L2 mRNA CTD PMID:18765277 losartan multiple interactions ISO RGD:734431 6480464 Losartan inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] CTD PMID:28578904 losartan multiple interactions ISO RGD:734432 6480464 Losartan inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] CTD PMID:28578904 lovastatin multiple interactions ISO RGD:734432 6480464 Doxorubicin inhibits the reaction [Lovastatin results in increased expression of NFE2L2 mRNA], Lovastatin inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] CTD PMID:22712078 , PMID:28710503 Lucidone affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to lucidone CTD PMID:23712098 Lucidone multiple interactions ISO RGD:734431 6480464 [lucidone co-treated with 2 more ... CTD PMID:22484158 , PMID:23712098 lutein multiple interactions ISO RGD:734432 6480464 arsenic trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 mRNA] more ... CTD PMID:25815309 , PMID:26187899 lutein multiple interactions EXP 6480464 Lutein inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 protein] CTD PMID:34435724 lutein increases expression ISO RGD:734432 6480464 Lutein results in increased expression of NFE2L2 mRNA, Lutein results in increased expression of NFE2L2 protein CTD PMID:25815309 , PMID:26187899 luteolin multiple interactions EXP 6480464 [Luteolin results in increased activity of NFE2L2 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium more ... CTD PMID:17982879 more ... luteolin multiple interactions EXP 155882543 luteolin inhibits the reaction [ischemia-reperfusion injury increases expression of Nfe2l2 protein in nucleus] RGD luteolin multiple interactions ISO RGD:734432 6480464 Luteolin promotes the reaction [Rotenone results in increased expression of NFE2L2 mRNA] CTD PMID:30207190 luteolin multiple interactions ISO RGD:734431 6480464 [Luteolin results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of SESN2 mRNA more ... CTD PMID:32407927 more ... luteolin increases activity EXP 6480464 Luteolin results in increased activity of NFE2L2 protein CTD PMID:17982879 LY294002 multiple interactions ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein] more ... CTD PMID:19073151 more ... LY294002 decreases expression ISO RGD:734432 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein CTD PMID:29353218 LY294002 decreases expression EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein CTD PMID:29353218 LY294002 decreases expression ISO RGD:734431 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein CTD PMID:23994249 more ... LY294002 decreases activity EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of NFE2L2 protein CTD PMID:18815141 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one analog inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein] more ... CTD PMID:17640564 more ... LY294002 increases expression EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of NFE2L2 protein CTD PMID:22406437 LY294002 multiple interactions ISO RGD:734432 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [SMARCA4A protein affects the reaction [Glucose affects the localization of NFE2L2 protein]] more ... CTD PMID:19647727 more ... lycopene increases expression EXP 6480464 lycopene results in increased expression of NFE2L2 mRNA, lycopene results in increased expression of NFE2L2 protein CTD PMID:19551842 , PMID:27102619 lycopene multiple interactions ISO RGD:734432 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of NFE2L2 mRNA], Lycopene inhibits the reaction [Atrazine results in increased expression of NFE2L2 protein] CTD PMID:30360616 lycopene multiple interactions EXP 6480464 lycopene promotes the reaction [Atrazine results in increased expression of NFE2L2 mRNA] CTD PMID:27102619 magnesium dichloride multiple interactions EXP 6480464 [2-tert-butylhydroquinone promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA]] which results in decreased susceptibility to Magnesium Chloride CTD PMID:21107535 malathion increases activity ISO RGD:734432 6480464 Malathion results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 maleic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [maleic acid affects the expression of NFE2L2 protein] CTD PMID:25119790 maleic acid affects expression EXP 6480464 maleic acid affects the expression of NFE2L2 protein CTD PMID:25119790 malonaldehyde multiple interactions ISO RGD:734432 6480464 NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of Malondialdehyde] CTD PMID:24633890 malonaldehyde multiple interactions EXP 6480464 NFE2L2 protein promotes the reaction [FNDC5 protein results in decreased abundance of Malondialdehyde] CTD PMID:32165127 maneb increases expression ISO RGD:734431 6480464 [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of GCLC mRNA more ... CTD PMID:21402726 maneb increases response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form results in increased susceptibility to Maneb CTD PMID:23764462 maneb multiple interactions ISO RGD:734432 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in decreased abundance of Glutathione more ... CTD PMID:23764462 manganese atom multiple interactions EXP 6480464 Manganese results in increased expression of and results in increased localization of NFE2L2 protein CTD PMID:17573173 manganese atom multiple interactions ISO RGD:734432 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Manganese CTD PMID:23764462 manganese(0) multiple interactions EXP 6480464 Manganese results in increased expression of and results in increased localization of NFE2L2 protein CTD PMID:17573173 manganese(0) multiple interactions ISO RGD:734432 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Manganese CTD PMID:23764462 manganese(II) chloride multiple interactions ISO RGD:734432 6480464 [manganese chloride co-treated with lipopolysaccharide more ... CTD PMID:21963524 , PMID:25288107 manganese(II) chloride increases expression ISO RGD:734432 6480464 manganese chloride results in increased expression of NFE2L2 protein CTD PMID:21963524 , PMID:25288107 manganese(II) chloride affects expression EXP 6480464 manganese chloride affects the expression of NFE2L2 protein CTD PMID:22154916 manganese(II) chloride decreases response to substance EXP 6480464 NFE2L2 protein results in decreased susceptibility to manganese chloride CTD PMID:21107535 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of NFE2L2 protein CTD PMID:21107535 , PMID:21384399 manganese(II) chloride multiple interactions EXP 6480464 [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] more ... CTD PMID:21107535 more ... mangiferin multiple interactions EXP 6480464 mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein], mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein] CTD PMID:22310181 masoprocol multiple interactions EXP 6480464 Masoprocol affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:18852027 mechlorethamine affects response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form affects the susceptibility to Mechlorethamine CTD PMID:26454883 mechlorethamine decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Mechlorethamine CTD PMID:20932822 medroxyprogesterone acetate increases expression ISO RGD:734431 6480464 Medroxyprogesterone Acetate results in increased expression of NFE2L2 mRNA CTD PMID:18497975 meglumine amidotrizoate multiple interactions EXP 6480464 Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA] more ... CTD PMID:28412091 , PMID:31173751 meglumine amidotrizoate decreases expression EXP 6480464 Diatrizoate Meglumine results in decreased expression of NFE2L2 protein CTD PMID:31173751 meglumine amidotrizoate increases expression EXP 6480464 Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA CTD PMID:28412091 MeIQx increases expression ISO RGD:734431 6480464 2-amino-3 more ... CTD PMID:20307560 MeIQx multiple interactions ISO RGD:734431 6480464 [2-amino-3 more ... CTD PMID:20307560 melatonin multiple interactions ISO RGD:734432 6480464 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein]] more ... CTD PMID:25288107 more ... melatonin increases expression ISO RGD:734431 6480464 Melatonin results in increased expression of NFE2L2 mRNA CTD PMID:33962019 melatonin multiple interactions ISO RGD:734431 6480464 Melatonin inhibits the reaction [cyfluthrin results in increased expression of NFE2L2 mRNA] CTD PMID:31330490 melatonin increases expression ISO RGD:734432 6480464 Melatonin results in increased expression of NFE2L2 protein CTD PMID:25288107 melatonin increases expression EXP 6480464 Melatonin results in increased expression of NFE2L2 protein CTD PMID:20433640 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [[Dietary Fats co-treated with Ethanol] results in decreased expression of NFE2L2 mRNA], Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 protein] CTD PMID:20433640 , PMID:30372842 meloxicam multiple interactions ISO RGD:734431 6480464 meloxicam inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] CTD PMID:20851755 menadione multiple interactions ISO RGD:734431 6480464 [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 CTD PMID:19608619 menadione increases expression ISO RGD:734431 6480464 Vitamin K 3 results in increased expression of NFE2L2 mRNA CTD PMID:23410634 menadione affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Vitamin K 3 CTD PMID:19303893 menadione affects expression ISO RGD:734431 6480464 Vitamin K 3 affects the expression of NFE2L2 mRNA CTD PMID:20044591 menadione multiple interactions ISO RGD:734432 6480464 NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Vitamin K 3] CTD PMID:20932822 mercury atom multiple interactions ISO RGD:734431 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of NFE2L2 protein CTD PMID:30359721 mercury atom increases activity ISO RGD:734431 6480464 Mercury results in increased activity of NFE2L2 promoter CTD PMID:21643505 mercury atom increases expression ISO RGD:734432 6480464 Mercury results in increased expression of NFE2L2 mRNA CTD PMID:16243960 mercury atom multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Mercury results in increased expression of GSTA1 mRNA], NFE2L2 protein affects the reaction [Mercury results in increased expression of NQO1 mRNA] CTD PMID:16243960 mercury dibromide increases expression ISO RGD:734431 6480464 mercuric bromide results in increased expression of NFE2L2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:734431 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA CTD PMID:27188386 mercury dichloride multiple interactions ISO RGD:734431 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of NFE2L2 protein more ... CTD PMID:17959236 more ... mercury dichloride multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of NFE2L2 protein] CTD PMID:32134168 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of NFE2L2 protein CTD PMID:32134168 mercury dichloride affects localization ISO RGD:734431 6480464 Mercuric Chloride affects the localization of NFE2L2 protein CTD PMID:24816296 mercury dichloride decreases expression ISO RGD:734432 6480464 Mercuric Chloride results in decreased expression of NFE2L2 mRNA CTD PMID:23202902 mercury dichloride increases expression ISO RGD:734431 6480464 Mercuric Chloride results in increased expression of NFE2L2 protein CTD PMID:17959236 , PMID:21843634 mercury dichloride affects response to substance ISO RGD:734432 6480464 [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Mercuric Chloride CTD PMID:19303893 mercury(0) multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Mercury results in increased expression of GSTA1 mRNA], NFE2L2 protein affects the reaction [Mercury results in increased expression of NQO1 mRNA] CTD PMID:16243960 mercury(0) multiple interactions ISO RGD:734431 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of NFE2L2 protein CTD PMID:30359721 mercury(0) increases activity ISO RGD:734431 6480464 Mercury results in increased activity of NFE2L2 promoter CTD PMID:21643505 mercury(0) increases expression ISO RGD:734432 6480464 Mercury results in increased expression of NFE2L2 mRNA CTD PMID:16243960 mesalamine multiple interactions EXP 6480464 Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid affects the expression of NFE2L2 protein] CTD PMID:33412153 mesalamine multiple interactions ISO RGD:734431 6480464 [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased activity of NFE2L2 protein CTD PMID:27818126 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] CTD PMID:33639173 metformin increases activity ISO RGD:734432 6480464 Metformin results in increased activity of NFE2L2 protein CTD PMID:30114225 metformin affects activity EXP 6480464 Metformin affects the activity of NFE2L2 protein CTD PMID:25596134 metformin decreases expression EXP 6480464 Metformin results in decreased expression of NFE2L2 mRNA, Metformin results in decreased expression of NFE2L2 protein CTD PMID:22627169 , PMID:25596134 metformin multiple interactions ISO RGD:734431 6480464 Metformin inhibits the reaction [2-tert-butylhydroquinone results in increased stability of and affects the localization of NFE2L2 protein], Metformin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein] CTD PMID:23707609 , PMID:33838154 metformin decreases expression ISO RGD:734431 6480464 Metformin results in decreased expression of NFE2L2 mRNA, Metformin results in decreased expression of NFE2L2 protein CTD PMID:23707609 , PMID:33838154 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of NFE2L2 mRNA CTD PMID:19564919 , PMID:30450033 methamphetamine multiple interactions EXP 6480464 Lactulose promotes the reaction [Methamphetamine results in increased expression of NFE2L2 mRNA] more ... CTD PMID:19564919 , PMID:30450033 methamphetamine affects localization EXP 6480464 Methamphetamine affects the localization of NFE2L2 protein CTD PMID:19564919 methotrexate multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] more ... CTD PMID:28414158 , PMID:31362085 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of NFE2L2 mRNA, Methotrexate results in decreased expression of NFE2L2 protein CTD PMID:28414158 , PMID:31362085 methoxyacetic acid decreases expression ISO RGD:734431 6480464 methoxyacetic acid results in decreased expression of NFE2L2 protein CTD PMID:21573189 methoxyacetic acid multiple interactions ISO RGD:734431 6480464 withanone inhibits the reaction [methoxyacetic acid results in decreased expression of NFE2L2 protein] CTD PMID:21573189 methyl 3,4,5-trihydroxybenzoate increases expression ISO RGD:734432 6480464 methyl gallate results in increased expression of NFE2L2 protein CTD PMID:27777014 methyl methanesulfonate decreases response to substance ISO RGD:734432 6480464 NFE2L2 protein results in decreased susceptibility to Methyl Methanesulfonate CTD PMID:20932822 methyl methanesulfonate multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of BTG2 mRNA], NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA] CTD PMID:22003191 methylarsonic acid decreases expression ISO RGD:734431 6480464 monomethylarsonic acid results in decreased expression of NFE2L2 mRNA CTD PMID:24091636 methylarsonic acid multiple interactions ISO RGD:734431 6480464 monomethylarsonic acid results in increased expression of and affects the localization of NFE2L2 protein, NFE2L2 mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of NQO1 protein] CTD PMID:24161444 methylene blue multiple interactions ISO RGD:734432 6480464 [Methylene Blue co-treated with MAPT protein mutant form] affects the localization of NFE2L2 protein more ... CTD PMID:24556215 methylene blue multiple interactions EXP 6480464 Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA] CTD PMID:31428839 methylglyoxal affects localization EXP 6480464 Pyruvaldehyde affects the localization of NFE2L2 protein CTD PMID:23331247 methylglyoxal decreases expression ISO RGD:734431 6480464 Pyruvaldehyde results in decreased expression of NFE2L2 mRNA CTD PMID:30447388 methylglyoxal multiple interactions ISO RGD:734432 6480464 bergenin affects the reaction [Pyruvaldehyde affects the expression of NFE2L2 protein] CTD PMID:29148590 methylglyoxal affects expression ISO RGD:734432 6480464 Pyruvaldehyde affects the expression of NFE2L2 protein CTD PMID:29148590 methylglyoxal affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to Pyruvaldehyde CTD PMID:28263721 methylglyoxal affects localization ISO RGD:734431 6480464 Pyruvaldehyde affects the localization of NFE2L2 protein CTD PMID:25451587 , PMID:33930484 methylglyoxal decreases phosphorylation ISO RGD:734431 6480464 Pyruvaldehyde results in decreased phosphorylation of NFE2L2 protein CTD PMID:22917016 methylglyoxal multiple interactions ISO RGD:734431 6480464 [Resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Pyruvaldehyde more ... CTD PMID:22917016 more ... methylisothiazolinone multiple interactions ISO RGD:734431 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of and results in increased activity of NFE2L2 protein CTD PMID:30806763 methylmercury chloride affects localization EXP 6480464 methylmercuric chloride affects the localization of NFE2L2 protein CTD PMID:20421342 , PMID:28736149 methylmercury chloride multiple interactions ISO RGD:734431 6480464 Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein], Sodium Selenite affects the reaction [methylmercuric chloride affects the localization of NFE2L2 protein] CTD PMID:24816296 , PMID:27917510 methylmercury chloride affects localization ISO RGD:734431 6480464 methylmercuric chloride affects the localization of NFE2L2 protein CTD PMID:24816296 methylmercury chloride decreases expression ISO RGD:734432 6480464 methylmercuric chloride results in decreased expression of NFE2L2 mRNA CTD PMID:23202902 , PMID:29850906 methylmercury chloride increases expression ISO RGD:734431 6480464 methylmercuric chloride results in increased expression of NFE2L2 mRNA, methylmercuric chloride results in increased expression of NFE2L2 protein CTD PMID:23179753 more ... methylmercury chloride affects localization ISO RGD:734432 6480464 methylmercuric chloride affects the localization of NFE2L2 protein CTD PMID:20402460 methylmercury chloride decreases response to substance EXP 6480464 NFE2L2 protein results in decreased susceptibility to methylmercuric chloride CTD PMID:20421342 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of NFE2L2 mRNA, methylmercuric chloride results in increased expression of NFE2L2 protein CTD PMID:20421342 more ... methylmercury chloride multiple interactions EXP 6480464 [methylmercuric chloride affects the localization of NFE2L2 protein] which results in increased expression of HMOX1 mRNA more ... CTD PMID:20421342 more ... methylparaben increases expression ISO RGD:734431 6480464 methylparaben results in increased expression of NFE2L2 mRNA CTD PMID:31745603 Methysticin affects localization ISO RGD:734432 6480464 methysticin affects the localization of NFE2L2 protein CTD PMID:28448946 metolachlor increases activity ISO RGD:734431 6480464 metolachlor results in increased activity of NFE2L2 protein CTD PMID:20143881 microcystin-LR multiple interactions ISO RGD:734431 6480464 [cyanoginosin LR affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA more ... CTD PMID:20600217 , PMID:20722399 microcystin-LR multiple interactions ISO RGD:734432 6480464 [Thioctic Acid co-treated with cyanoginosin LR] results in increased expression of NFE2L2 protein CTD PMID:32061150 microcystin-LR affects expression ISO RGD:734431 6480464 cyanoginosin LR affects the expression of NFE2L2 protein CTD PMID:20600217 microcystin-LR affects response to substance ISO RGD:734431 6480464 NFE2L2 protein affects the susceptibility to cyanoginosin LR CTD PMID:20722399 microcystin-LR decreases degradation ISO RGD:734431 6480464 cyanoginosin LR results in decreased degradation of NFE2L2 protein CTD PMID:20722399 mifepristone multiple interactions ISO RGD:734431 6480464 [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]] more ... CTD PMID:22606287 , PMID:22736252 mifepristone multiple interactions EXP 6480464 [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [HSD11B1 protein results in decreased activity of NFE2L2 protein] more ... CTD PMID:22606287 , PMID:24812154 MK-2206 multiple interactions EXP 6480464 MK 2206 inhibits the reaction [PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]] CTD PMID:34351043 monascin increases phosphorylation ISO RGD:734431 6480464 monascin results in increased phosphorylation of NFE2L2 protein CTD PMID:23954466 monascin increases expression EXP 6480464 monascin results in increased expression of NFE2L2 mRNA CTD PMID:23954466 monascin multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA], PPARG mutant form inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA] CTD PMID:23954466 monascin multiple interactions ISO RGD:734431 6480464 monascin inhibits the reaction [S100B protein results in decreased expression of NFE2L2 protein] more ... CTD PMID:23331247 monascin affects localization ISO RGD:734431 6480464 monascin affects the localization of NFE2L2 protein CTD PMID:23331247 monascin increases expression ISO RGD:734431 6480464 monascin results in increased expression of NFE2L2 mRNA CTD PMID:23331247 Monobutylphthalate decreases expression ISO RGD:734431 6480464 monobutyl phthalate results in decreased expression of NFE2L2 protein CTD PMID:30965081 monocrotaline multiple interactions EXP 6480464 liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA], liquiritin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA] CTD PMID:29908794 monocrotaline affects response to substance ISO RGD:734432 6480464 NFE2L2 gene mutant form affects the susceptibility to Monocrotaline CTD PMID:31504964 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of NFE2L2 mRNA CTD PMID:29908794 monocrotophos multiple interactions ISO RGD:734431 6480464 Monocrotophos promotes the reaction [AIFM1 protein binds to NFE2L2 protein] CTD PMID:33078895 monocrotophos increases expression ISO RGD:734431 6480464 Monocrotophos results in increased expression of NFE2L2 protein CTD PMID:28887667 monosodium L-glutamate multiple interactions ISO RGD:734432 6480464 Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 mRNA], Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 protein] CTD PMID:29679905 monosodium L-glutamate increases expression ISO RGD:734432 6480464 Sodium Glutamate results in increased expression of NFE2L2 mRNA CTD PMID:25473020 monosodium L-glutamate decreases expression ISO RGD:734432 6480464 Sodium Glutamate results in decreased expression of NFE2L2 mRNA, Sodium Glutamate results in decreased expression of NFE2L2 protein CTD PMID:29679905 morin multiple interactions EXP 6480464 morin inhibits the reaction [Acetaminophen results in decreased expression of and affects the localization of NFE2L2 protein] more ... CTD PMID:26767949 , PMID:31722249 Morroniside affects expression ISO RGD:734432 6480464 morroniside affects the expression of NFE2L2 protein CTD PMID:21963495 Morroniside multiple interactions ISO RGD:734432 6480464 morroniside promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and affects the localization of NFE2L2 protein], morroniside results in increased expression of and results in increased phosphorylation of NFE2L2 protein CTD PMID:34029560 myricetin increases expression ISO RGD:734431 6480464 myricetin results in increased expression of NFE2L2 protein CTD PMID:16799064 N'-(2,4-dimethylphenyl)-N-methylformamidine multiple interactions EXP 6480464 KEAP1 protein affects the reaction [U 40481 results in decreased expression of NFE2L2 protein] CTD PMID:31029719 N'-(2,4-dimethylphenyl)-N-methylformamidine decreases expression EXP 6480464 U 40481 results in decreased expression of NFE2L2 protein CTD PMID:31029719 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein CTD PMID:28659758 N-(1-naphthyl)ethylenediamine increases activity ISO RGD:734432 6480464 N-(1-naphthyl)ethylenediamine results in increased activity of NFE2L2 protein CTD PMID:30114225 , PMID:30203046 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of NFE2L2 protein] CTD PMID:29870751 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases expression EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of NFE2L2 protein CTD PMID:29870751 N-acetyl-1,4-benzoquinone imine affects localization ISO RGD:734432 6480464 N-acetyl-4-benzoquinoneimine affects the localization of NFE2L2 protein CTD PMID:18785192 N-acetyl-1,4-benzoquinone imine multiple interactions ISO RGD:734432 6480464 NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA], NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] CTD PMID:18785192 , PMID:19246624 N-acetyl-1,4-benzoquinone imine increases activity ISO RGD:734432 6480464 N-acetyl-4-benzoquinoneimine results in increased activity of NFE2L2 protein CTD PMID:18785192 N-acetyl-L-cysteine multiple interactions ISO RGD:734431 6480464 Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of NFE2L2 protein] more ... CTD PMID:11909699 more ... 
